# 34600737 ---------
## -> Scan Factor Gender
[TARGET] => found male in adjusted means los were higher for patients with picc lines compared to midlines, in both females and males
[RISK] => found high in adjusted means los were higher for patients with picc lines compared to midlines, in both females and males
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in outcomes of interest were line-related infections and thromboembolic events after the placement of these catheters
# 34218708 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in more than 1 million peripherally inserted central catheters (picc) are placed annually in the us and are used to provide convenient vascular access for a variety of reasons including long term antibiotic treatment, chemotherapy, parenteral nutrition, and blood draws
[RISK] => found more in more than 1 million peripherally inserted central catheters (picc) are placed annually in the us and are used to provide convenient vascular access for a variety of reasons including long term antibiotic treatment, chemotherapy, parenteral nutrition, and blood draws
## -> Scan Factor Age
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in more than 1 million peripherally inserted central catheters (picc) are placed annually in the us and are used to provide convenient vascular access for a variety of reasons including long term antibiotic treatment, chemotherapy, parenteral nutrition, and blood draws
[RISK] => found more in more than 1 million peripherally inserted central catheters (picc) are placed annually in the us and are used to provide convenient vascular access for a variety of reasons including long term antibiotic treatment, chemotherapy, parenteral nutrition, and blood draws
## -> Scan Factor PICC infection
[TARGET] => found infection in although they are relatively easy to place and inexpensive, picc line use is associated with many complications such as phlebitis/thrombophlebitis, venous thrombosis, catheter-related infection, wound infection, and central vein stenosis
[RISK] => found associate in although they are relatively easy to place and inexpensive, picc line use is associated with many complications such as phlebitis/thrombophlebitis, venous thrombosis, catheter-related infection, wound infection, and central vein stenosis
# 23472835 ---------
## -> Scan Factor Age
# 37314592 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in purpose: there is a lack of studies that systematically evaluate the clinical factors of picc-rvt such as treatment, tumor stage, metastasis, and chemotherapy drugs in cancer patients
[RISK] => found factor in purpose: there is a lack of studies that systematically evaluate the clinical factors of picc-rvt such as treatment, tumor stage, metastasis, and chemotherapy drugs in cancer patients
[TARGET] => found chemotherapy in meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients
[RISK] => found risk in meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients
[RISK] => found factor in meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients
## -> Scan Factor Cancer
[TARGET] => found cancer in clinical factors of picc-rvt in cancer patients: a meta-analysis
[RISK] => found factor in clinical factors of picc-rvt in cancer patients: a meta-analysis
[TARGET] => found cancer in purpose: there is a lack of studies that systematically evaluate the clinical factors of picc-rvt such as treatment, tumor stage, metastasis, and chemotherapy drugs in cancer patients
[RISK] => found factor in purpose: there is a lack of studies that systematically evaluate the clinical factors of picc-rvt such as treatment, tumor stage, metastasis, and chemotherapy drugs in cancer patients
[TARGET] => found cancer in this study, therefore, aims to evaluate the clinical factors of catheter-related venous thrombosis in cancer patients with indwelling picc to provide a basis for the clinical prevention and reduction of thrombosis
[RISK] => found factor in this study, therefore, aims to evaluate the clinical factors of catheter-related venous thrombosis in cancer patients with indwelling picc to provide a basis for the clinical prevention and reduction of thrombosis
[TARGET] => found cancer in meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients
[RISK] => found risk in meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients
[RISK] => found factor in meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients
[TARGET] => found cancer in based on the present evidence at hand, radiotherapy cannot be considered to be related to the formation of picc-rvt in cancer patients
## -> Scan Factor Age
# 24811591 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in there are no randomized controlled trials (rcts) on the best treatment of picc-related thrombosis in the intensive care unit (icu) setting and in most cohort studies, anticoagulation strategies with or without picc removal have been used
[TARGET] => found icu in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
[RISK] => found risk in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
[RISK] => found associate in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
[RISK] => found increase in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
[TARGET] => found icu in there are no randomized controlled trials (rcts) on the best treatment of picc-related thrombosis in the intensive care unit (icu) setting and in most cohort studies, anticoagulation strategies with or without picc removal have been used
[TARGET] => found icu in there is lack of high-quality evidence assessing prevention strategies and management of picc-related thrombosis in the icu
[RISK] => found high in there is lack of high-quality evidence assessing prevention strategies and management of picc-related thrombosis in the icu
[TARGET] => found icu in well-designed rcts are required to estimate the prevalence of uevt in icu patients with piccs and evaluate the efficacy and magnitude of clinical benefit and cost-effectiveness of therapeutic strategies
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
[RISK] => found risk in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
[RISK] => found associate in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
[RISK] => found increase in however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection
## -> Scan Factor Anticoagulants therapy
# 30697126 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in aims: peripherally inserted central catheters(picc) lines are becoming increasingly popular in solid cancer patients for the administration of chemotherapy
[TARGET] => found chemotherapy in conclusions: vte is a common complication in medical oncology patients who underwent insertion picc line insertion for chemotherapy
[TARGET] => found chemotherapy in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found risk in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found factor in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found high in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
## -> Scan Factor Cancer
[TARGET] => found cancer in predictive risk factors of venous thromboembolism (vte) associated with peripherally inserted central catheters (picc) in ambulant solid cancer patients: retrospective single centre cohort study
[RISK] => found risk in predictive risk factors of venous thromboembolism (vte) associated with peripherally inserted central catheters (picc) in ambulant solid cancer patients: retrospective single centre cohort study
[RISK] => found factor in predictive risk factors of venous thromboembolism (vte) associated with peripherally inserted central catheters (picc) in ambulant solid cancer patients: retrospective single centre cohort study
[RISK] => found associate in predictive risk factors of venous thromboembolism (vte) associated with peripherally inserted central catheters (picc) in ambulant solid cancer patients: retrospective single centre cohort study
[TARGET] => found cancer in aims: peripherally inserted central catheters(picc) lines are becoming increasingly popular in solid cancer patients for the administration of chemotherapy
## -> Scan Factor BMI
[TARGET] => found bmi in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found risk in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found factor in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found high in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
## -> Scan Factor Smoking
[TARGET] => found smoking in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found risk in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found factor in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
[RISK] => found high in we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in risk of distant vte is high as well as the picc line related dvt and the risk of the picc line related dvt is higher in the first two weeks after picc insertion
[RISK] => found risk in risk of distant vte is high as well as the picc line related dvt and the risk of the picc line related dvt is higher in the first two weeks after picc insertion
[RISK] => found high in risk of distant vte is high as well as the picc line related dvt and the risk of the picc line related dvt is higher in the first two weeks after picc insertion
# 28796444 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
[RISK] => found risk in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
[RISK] => found factor in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
[RISK] => found associate in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in conclusion the michigan picc-dvt risk score offers a novel way to estimate risk of dvt associated with piccs and can help inform appropriateness of picc insertion
[RISK] => found risk in conclusion the michigan picc-dvt risk score offers a novel way to estimate risk of dvt associated with piccs and can help inform appropriateness of picc insertion
[RISK] => found associate in conclusion the michigan picc-dvt risk score offers a novel way to estimate risk of dvt associated with piccs and can help inform appropriateness of picc insertion
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found blood cell in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
[RISK] => found risk in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
[RISK] => found factor in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
[RISK] => found associate in risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000
# 31324590 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in there were 382 men and 340 women with a mean age of 66.8±15.8 (sd) years (range: 18-94years); of these, 442/722 patients (61.22%) were included in the cooperation program with 433/722 patients (59.97%) who effectively had picc placement by technicians and 289/722 (40.03%) by radiologists
## -> Scan Factor PICC infection
[TARGET] => found infection in numbers of picc delegated to technicians, and picc placement difficulties, were prospectively recorded for the whole study population whereas complications such as picc infection, deep venous thrombosis and catheter occlusion were prospectively recorded until picc removal for a subgroup of patients included during one month
[RISK] => found group in numbers of picc delegated to technicians, and picc placement difficulties, were prospectively recorded for the whole study population whereas complications such as picc infection, deep venous thrombosis and catheter occlusion were prospectively recorded until picc removal for a subgroup of patients included during one month
[TARGET] => found infection in complications included 8 picc-related infections (8/77; 10.4%), 3 deep venous thromboses (3/77; 3.9%) and 9 catheter occlusions (9/77; 11.7%)
# 36601900 ---------
## -> Scan Factor Slower blood flow velocity
[TARGET] => found blood flow velocity in conclusions: exercise therapy improved venous blood flow velocity and effectively reduced the incidence of picc-associated vte
[RISK] => found associate in conclusions: exercise therapy improved venous blood flow velocity and effectively reduced the incidence of picc-associated vte
[RISK] => found low in conclusions: exercise therapy improved venous blood flow velocity and effectively reduced the incidence of picc-associated vte
# 35802673 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in in 2017, 5 of 429 piccs developed a central line-associated infection (1.2%) and 29 of 429 piccs developed symptomatic venous thromboembolism (6.7%)
[RISK] => found associate in in 2017, 5 of 429 piccs developed a central line-associated infection (1.2%) and 29 of 429 piccs developed symptomatic venous thromboembolism (6.7%)
# 33889013 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy
[RISK] => found risk in risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy
[RISK] => found factor in risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy
[TARGET] => found chemotherapy in background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures
[RISK] => found risk in background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures
[RISK] => found factor in background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures
[TARGET] => found chemotherapy in methods: data of 780 patients with breast cancer who underwent picc chemotherapy in our hospital from january 2014 to june 2015 were retrospectively analyzed
[TARGET] => found chemotherapy in thrombosis was not associated with age, punctured limb, platelet count, or chemotherapy drugs (p > 0.05)
[RISK] => found associate in thrombosis was not associated with age, punctured limb, platelet count, or chemotherapy drugs (p > 0.05)
[TARGET] => found chemotherapy in conclusion: blood vessel puncture was the main factor that affected picc-related thrombosis in breast cancer chemotherapy
[RISK] => found factor in conclusion: blood vessel puncture was the main factor that affected picc-related thrombosis in breast cancer chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy
[RISK] => found risk in risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy
[RISK] => found factor in risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy
[TARGET] => found cancer in background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures
[RISK] => found risk in background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures
[RISK] => found factor in background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures
[TARGET] => found cancer in methods: data of 780 patients with breast cancer who underwent picc chemotherapy in our hospital from january 2014 to june 2015 were retrospectively analyzed
[TARGET] => found cancer in results: among the 780 patients with breast cancer, 36 developed picc-related venous thrombosis
[TARGET] => found cancer in conclusion: blood vessel puncture was the main factor that affected picc-related thrombosis in breast cancer chemotherapy
[RISK] => found factor in conclusion: blood vessel puncture was the main factor that affected picc-related thrombosis in breast cancer chemotherapy
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in thrombosis was not associated with age, punctured limb, platelet count, or chemotherapy drugs (p > 0.05)
[RISK] => found associate in thrombosis was not associated with age, punctured limb, platelet count, or chemotherapy drugs (p > 0.05)
# 33719694 ---------
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in diagnosis and management of secondary malposition of picc into the azygos vein
[TARGET] => found position in the catheter-related complications might occur and the reports of secondary malposition into azygos veins were rare
[TARGET] => found position in methods: this retrospective review summarized the experience in diagnosis and management of secondary malposition of picc into azygos veins in 25 cases
[TARGET] => found position in results: when the catheter dysfunction occurred in the picc on the left limb, it was necessary to consider whether there would be malposition into azygos veins after other reasons were excluded
[TARGET] => found position in the malposition could be diagnosed by chest lateral radiograph or chest computed tomography
[TARGET] => found position in the secondary malposition into azygos veins was resolved by repositioning or withdrawing the picc
[TARGET] => found position in after re-inserting the catheter, it should be closely monitored whether the malposition occurred again
[TARGET] => found position in intracavitary electrocardiogram positioning technology was used to confirm the catheter tip position before using corrosive drug
[TARGET] => found position in after the catheters withdrawn from the azygos veins, close attention should be paid to the property and concentration of the infusion drug strictly and the complications such as blockage and re-malposition
[TARGET] => found position in conclusions: the results of our study suggested that the right limb is recommended for picc catheterization in order to avoid secondary malposition into azygos veins and the malposition into azygos veins should be dealt with in time
## -> Scan Factor PICC infection
[TARGET] => found infection in no serious complications such as infection, thrombosis and extravasation occurred in this group of patients after treatment
[RISK] => found group in no serious complications such as infection, thrombosis and extravasation occurred in this group of patients after treatment
# 36897677 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in synthesized outcomes indicated that compared with willful grip exercises, quantified grip exercises reduced the incidence of picc-related thrombosis (odds ratio = 0.19, 95% confidence interval [ci]: 0.12-0.31) and infection (odds ratio = 0.30, 95% ci: 0.15-0.60) in picc patients, increased the maximum venous velocity (mean difference = 3.02, 95% ci: 1.87-4.17) and mean blood flow (mean difference = 3.10, 95%ci: 1.57-4.62) in picc patients (all p < .05)
[RISK] => found low in synthesized outcomes indicated that compared with willful grip exercises, quantified grip exercises reduced the incidence of picc-related thrombosis (odds ratio = 0.19, 95% confidence interval [ci]: 0.12-0.31) and infection (odds ratio = 0.30, 95% ci: 0.15-0.60) in picc patients, increased the maximum venous velocity (mean difference = 3.02, 95% ci: 1.87-4.17) and mean blood flow (mean difference = 3.10, 95%ci: 1.57-4.62) in picc patients (all p < .05)
[RISK] => found increase in synthesized outcomes indicated that compared with willful grip exercises, quantified grip exercises reduced the incidence of picc-related thrombosis (odds ratio = 0.19, 95% confidence interval [ci]: 0.12-0.31) and infection (odds ratio = 0.30, 95% ci: 0.15-0.60) in picc patients, increased the maximum venous velocity (mean difference = 3.02, 95% ci: 1.87-4.17) and mean blood flow (mean difference = 3.10, 95%ci: 1.57-4.62) in picc patients (all p < .05)
[TARGET] => found infection in conclusion: quantified grip exercises can effectively reduce the occurrence of picc-related thrombosis and infection, improve the venous hemodynamics
# 23715775 ---------
## -> Scan Factor Diabete
[TARGET] => found diabetes in a diagnosis of diabetes was the only factor that significantly predicted complications (hazard ratio, 2.71; 95% confidence interval, 1.13-6.13)
[RISK] => found factor in a diagnosis of diabetes was the only factor that significantly predicted complications (hazard ratio, 2.71; 95% confidence interval, 1.13-6.13)
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in however, little is known about the consequences of picc insertion in these patients
[TARGET] => found picc insertion in materials and methods: pregnant women with picc insertion between january 2000 and june 2006 were studied retrospectively
[TARGET] => found picc insertion in conclusions: picc insertion in pregnant women is associated with a high complication rate, which appears to be independent of the type of infusate and occurs in the majority of women
[RISK] => found associate in conclusions: picc insertion in pregnant women is associated with a high complication rate, which appears to be independent of the type of infusate and occurs in the majority of women
[RISK] => found high in conclusions: picc insertion in pregnant women is associated with a high complication rate, which appears to be independent of the type of infusate and occurs in the majority of women
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in piccs were used for intravenous fluid (ivf, 59.4%), parenteral nutrition (pn, 34.5%), and antibiotics (6%)
## -> Scan Factor PICC infection
[TARGET] => found infection in minor complications, including phlebitis, picc malfunction, early picc removal, infection requiring oral antibiotics, or hospitalization for picc evaluation, were also studied
# 32951711 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
# 37573601 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in predictive model for picc occlusion risk for patients in intensive care units: a retrospective clinical study
[RISK] => found risk in predictive model for picc occlusion risk for patients in intensive care units: a retrospective clinical study
[TARGET] => found intensive care unit in context: peripherally inserted central catheters (piccs) have a high incidence of catheter occlusion, but research exploring the risk factors for such an occlusion for patients in intensive care units (icus) is lacking
[RISK] => found risk in context: peripherally inserted central catheters (piccs) have a high incidence of catheter occlusion, but research exploring the risk factors for such an occlusion for patients in intensive care units (icus) is lacking
[RISK] => found factor in context: peripherally inserted central catheters (piccs) have a high incidence of catheter occlusion, but research exploring the risk factors for such an occlusion for patients in intensive care units (icus) is lacking
[RISK] => found high in context: peripherally inserted central catheters (piccs) have a high incidence of catheter occlusion, but research exploring the risk factors for such an occlusion for patients in intensive care units (icus) is lacking
## -> Scan Factor Diabete
[TARGET] => found diabetes in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found factor in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found associate in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found increase in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[TARGET] => found diabetes in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[RISK] => found risk in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[RISK] => found factor in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[TARGET] => found diabetes in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
[RISK] => found risk in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
[RISK] => found factor in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
## -> Scan Factor BMI
[TARGET] => found bmi in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found factor in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found associate in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found increase in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[TARGET] => found bmi in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[RISK] => found risk in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[RISK] => found factor in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[TARGET] => found bmi in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
[RISK] => found risk in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
[RISK] => found factor in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
## -> Scan Factor Age
[TARGET] => found  age  in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found factor in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found associate in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found increase in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[TARGET] => found  age  in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[RISK] => found risk in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[RISK] => found factor in the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001
[TARGET] => found  age  in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
[RISK] => found risk in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
[RISK] => found factor in conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found factor in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found associate in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found increase in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
## -> Scan Factor Hypertension
[TARGET] => found hypertension in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found factor in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found associate in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
[RISK] => found increase in results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)
# 35381735 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in peripheral insertion of reverse-tapered and non-tapered central catheters (picc) in patients receiving tumor chemotherapy
[TARGET] => found chemotherapy in objective: the objective of the study is to investigate the effect of the reverse-tapered peripherally inserted central catheters (picc) and the nontapered picc in tumor chemotherapy
[TARGET] => found chemotherapy in conclusion: the reverse-tapered picc and the nontapered picc catheters have similar safety performance in tumor chemotherapy; different design types of picc were selected according to the treatment needs of patients
# 34540095 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in predisposing factors and effect of bundle nursing in picc-related upper extremity deep venous thrombosis in patients with non-hodgkin's lymphoma undergoing chemotherapy
[RISK] => found factor in predisposing factors and effect of bundle nursing in picc-related upper extremity deep venous thrombosis in patients with non-hodgkin's lymphoma undergoing chemotherapy
[TARGET] => found chemotherapy in objective: to explore the effects of bundle nursing on picc-related upper extremity deep venous thrombosis (picc-uedvt) in patients with non-hodgkin's lymphoma (nhl) who are undergoing chemotherapy, and contributing factors toward picc-uedvt
[RISK] => found factor in objective: to explore the effects of bundle nursing on picc-related upper extremity deep venous thrombosis (picc-uedvt) in patients with non-hodgkin's lymphoma (nhl) who are undergoing chemotherapy, and contributing factors toward picc-uedvt
[TARGET] => found chemotherapy in methods: 370 nhl patients undergoing chemotherapy in the department of hematology were selected prospectively and randomized into a control group (receiving routine nursing) and an observation group (receiving bundle nursing) using random number method
[RISK] => found group in methods: 370 nhl patients undergoing chemotherapy in the department of hematology were selected prospectively and randomized into a control group (receiving routine nursing) and an observation group (receiving bundle nursing) using random number method
## -> Scan Factor Cancer
[TARGET] => found lymphoma in predisposing factors and effect of bundle nursing in picc-related upper extremity deep venous thrombosis in patients with non-hodgkin's lymphoma undergoing chemotherapy
[RISK] => found factor in predisposing factors and effect of bundle nursing in picc-related upper extremity deep venous thrombosis in patients with non-hodgkin's lymphoma undergoing chemotherapy
[TARGET] => found lymphoma in objective: to explore the effects of bundle nursing on picc-related upper extremity deep venous thrombosis (picc-uedvt) in patients with non-hodgkin's lymphoma (nhl) who are undergoing chemotherapy, and contributing factors toward picc-uedvt
[RISK] => found factor in objective: to explore the effects of bundle nursing on picc-related upper extremity deep venous thrombosis (picc-uedvt) in patients with non-hodgkin's lymphoma (nhl) who are undergoing chemotherapy, and contributing factors toward picc-uedvt
## -> Scan Factor Age
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found ecog in tumor stage, ecog score >2, hemoglobin <100 g/l, and d-dimer >0.5 mg/l were factors that contributed to the occurrence of picc-uedvt in nhl patients (p<0.05)
[RISK] => found factor in tumor stage, ecog score >2, hemoglobin <100 g/l, and d-dimer >0.5 mg/l were factors that contributed to the occurrence of picc-uedvt in nhl patients (p<0.05)
[TARGET] => found ecog in conclusion: tumor stage, ecog score >2, reduced hemoglobin, and increased d-dimer levels are predisposing factors for picc-uedvt in nhl patients
[RISK] => found factor in conclusion: tumor stage, ecog score >2, reduced hemoglobin, and increased d-dimer levels are predisposing factors for picc-uedvt in nhl patients
[RISK] => found increase in conclusion: tumor stage, ecog score >2, reduced hemoglobin, and increased d-dimer levels are predisposing factors for picc-uedvt in nhl patients
# 34738565 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in peripherally inserted central venous catheters (picc) versus totally implantable venous access device (port) for chemotherapy administration: a meta-analysis on gynecological cancer patients
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central venous catheters (picc) versus totally implantable venous access device (port) for chemotherapy administration: a meta-analysis on gynecological cancer patients
[TARGET] => found cancer in background and aim: ninety-four thousand gynecological cancer diagnoses are performed each year in the united states
[TARGET] => found cancer in this meta-analysis aims to compare port and peripherally inserted central catheter (picc) outcomes during adjuvant treatment for gynecological cancer
[TARGET] => found cancer in unless specific contraindications, ports can be preferred for systemic treatment in gynecological cancer patients
[RISK] => found less in unless specific contraindications, ports can be preferred for systemic treatment in gynecological cancer patients
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in no difference was found in operative complication, migration, malposition, extravasation, infection, and complication requiring catheter removal
## -> Scan Factor PICC infection
[TARGET] => found infection in no difference was found in operative complication, migration, malposition, extravasation, infection, and complication requiring catheter removal
# 36747971 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in predictive value of red cell distribution width in the diagnosis of peripherally inserted central catheter (picc)-related thrombosis among cancer patients
[TARGET] => found cancer in a total of 98 cancer patients undergoing picc placement from january 2017 to december 2019 at the icu venous access center of peking university cancer hospital were retrospectively analyzed
## -> Scan Factor Smoking
[TARGET] => found smoking in additionally, the number of smoking histories in the thrombosis group (18, 38.30%) was significantly higher than that in the nonthrombosis group (5, 9.80%)
[RISK] => found high in additionally, the number of smoking histories in the thrombosis group (18, 38.30%) was significantly higher than that in the nonthrombosis group (5, 9.80%)
[RISK] => found group in additionally, the number of smoking histories in the thrombosis group (18, 38.30%) was significantly higher than that in the nonthrombosis group (5, 9.80%)
[TARGET] => found smoking in b) logistic regression analysis indicated that rdw and smoking history were independent risk factors for picc-related thrombosis (or: 3.028, p<0.001; or: 5.640, p=0.023)
[RISK] => found risk in b) logistic regression analysis indicated that rdw and smoking history were independent risk factors for picc-related thrombosis (or: 3.028, p<0.001; or: 5.640, p=0.023)
[RISK] => found factor in b) logistic regression analysis indicated that rdw and smoking history were independent risk factors for picc-related thrombosis (or: 3.028, p<0.001; or: 5.640, p=0.023)
[TARGET] => found smoking in c) the area under the receiver operating characteristic (roc) curve of the combination of rdw and smoking history was 86.8%, and the sensitivity and specificity for predicting thrombosis after picc were 85.1% and 80%, respectively
[TARGET] => found smoking in d) cox regression analysis revealed that rdw and smoking history were independent risk factors for picc-related thrombosis (p<0.001)
[RISK] => found risk in d) cox regression analysis revealed that rdw and smoking history were independent risk factors for picc-related thrombosis (p<0.001)
[RISK] => found factor in d) cox regression analysis revealed that rdw and smoking history were independent risk factors for picc-related thrombosis (p<0.001)
[TARGET] => found smoking in conclusion: the combined use of rdw and smoking history has early evaluation and predictive value in the diagnosis of picc-related thrombosis
# 34723657 ---------
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in bridging the gap: introduction of an antimicrobial peripherally inserted central catheter (picc) in response to high picc central line-associated bloodstream infection incidence
[RISK] => found associate in bridging the gap: introduction of an antimicrobial peripherally inserted central catheter (picc) in response to high picc central line-associated bloodstream infection incidence
[RISK] => found high in bridging the gap: introduction of an antimicrobial peripherally inserted central catheter (picc) in response to high picc central line-associated bloodstream infection incidence
[TARGET] => found infection in objective: to reduce the incidence of central line-associated bloodstream infection (clabsi) in peripherally inserted central catheters (picc) through the introduction of an antimicrobial (am) catheter as recommended in evidence-based guidelines and standards
[RISK] => found associate in objective: to reduce the incidence of central line-associated bloodstream infection (clabsi) in peripherally inserted central catheters (picc) through the introduction of an antimicrobial (am) catheter as recommended in evidence-based guidelines and standards
[TARGET] => found infection in design: quality improvement project comparing incidence of infections pre-implementation and postimplementation of the new catheter
# 31387422 ---------
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in the overall rate of complication ranged from 7.40 to 26.4/1000 catheter days (cds)
## -> Scan Factor Transplantation
[TARGET] => found transplantation in patients with hematological malignancies (hm) or undergoing hematopoietic cell transplantation (hct) require reliable vascular access
## -> Scan Factor PICC infection
[TARGET] => found infection in the rate of deep vein thrombosis (0.31-1.48/1000 cds) and occlusion differed across the picc types, while the rate of central line-associated bloodstream infection (0.53-0.74/1000 cds) did not
[RISK] => found associate in the rate of deep vein thrombosis (0.31-1.48/1000 cds) and occlusion differed across the picc types, while the rate of central line-associated bloodstream infection (0.53-0.74/1000 cds) did not
# 32195936 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in peripherally inserted central venous catheter (picc) is the main venous access for cancer patients when they receive chemotherapy and nutritional support, but picc-related venous thrombosis has become one of the most common and serious complications
## -> Scan Factor Cancer
[TARGET] => found cancer in the clinical features and related factors of picc-related upper extremity asymptomatic venous thrombosis in cancer patients: a prospective study
[RISK] => found factor in the clinical features and related factors of picc-related upper extremity asymptomatic venous thrombosis in cancer patients: a prospective study
[TARGET] => found cancer in peripherally inserted central venous catheter (picc) is the main venous access for cancer patients when they receive chemotherapy and nutritional support, but picc-related venous thrombosis has become one of the most common and serious complications
[TARGET] => found cancer in it is very important to further explore the relationship among these features, so that prevent and treat the picc-related thrombosis.to investigate the clinical features and the related factors of picc-related upper extremity asymptomatic venous thrombosis in cancer patients, and to provide theoretical basis for the prevention of venous thrombosis.a total of 127 tumor patients with picc catheterization were selected
[RISK] => found factor in it is very important to further explore the relationship among these features, so that prevent and treat the picc-related thrombosis.to investigate the clinical features and the related factors of picc-related upper extremity asymptomatic venous thrombosis in cancer patients, and to provide theoretical basis for the prevention of venous thrombosis.a total of 127 tumor patients with picc catheterization were selected
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Slower blood flow velocity
[TARGET] => found blood flow velocity in the clinical characteristics and influencing factors of asymptomatic thrombosis such as vessel diameter, blood flow velocity, thrombosis time, location, and the thrombosis stages were recorded.the incidence of picc-related upper limbs asymptomatic thrombosis was 48.82% (62/127), and the median time was 3 days
[RISK] => found factor in the clinical characteristics and influencing factors of asymptomatic thrombosis such as vessel diameter, blood flow velocity, thrombosis time, location, and the thrombosis stages were recorded.the incidence of picc-related upper limbs asymptomatic thrombosis was 48.82% (62/127), and the median time was 3 days
[RISK] => found low in the clinical characteristics and influencing factors of asymptomatic thrombosis such as vessel diameter, blood flow velocity, thrombosis time, location, and the thrombosis stages were recorded.the incidence of picc-related upper limbs asymptomatic thrombosis was 48.82% (62/127), and the median time was 3 days
[TARGET] => found blood flow velocity in the group trajectory analysis indicated the 3 changes of blood flow velocity during the follow-up period: downward trend, upward trend, and steady fluctuations
[RISK] => found low in the group trajectory analysis indicated the 3 changes of blood flow velocity during the follow-up period: downward trend, upward trend, and steady fluctuations
[RISK] => found group in the group trajectory analysis indicated the 3 changes of blood flow velocity during the follow-up period: downward trend, upward trend, and steady fluctuations
[TARGET] => found blood flow velocity in cox proportional hazards model suggested that the patient's eastern cooperative oncology group score (hazard ratio [hr] 2.791, 95% confidence interval [ci] 0.08-0.76) and blood flow velocity (hr 0.250, 95% ci 2.01-3.87) was the risk of picc-related asymptomatic thrombosis.picc catheterization can affect blood flow and asymptomatic thrombosis can occur at an early stage
[RISK] => found risk in cox proportional hazards model suggested that the patient's eastern cooperative oncology group score (hazard ratio [hr] 2.791, 95% confidence interval [ci] 0.08-0.76) and blood flow velocity (hr 0.250, 95% ci 2.01-3.87) was the risk of picc-related asymptomatic thrombosis.picc catheterization can affect blood flow and asymptomatic thrombosis can occur at an early stage
[RISK] => found low in cox proportional hazards model suggested that the patient's eastern cooperative oncology group score (hazard ratio [hr] 2.791, 95% confidence interval [ci] 0.08-0.76) and blood flow velocity (hr 0.250, 95% ci 2.01-3.87) was the risk of picc-related asymptomatic thrombosis.picc catheterization can affect blood flow and asymptomatic thrombosis can occur at an early stage
[RISK] => found group in cox proportional hazards model suggested that the patient's eastern cooperative oncology group score (hazard ratio [hr] 2.791, 95% confidence interval [ci] 0.08-0.76) and blood flow velocity (hr 0.250, 95% ci 2.01-3.87) was the risk of picc-related asymptomatic thrombosis.picc catheterization can affect blood flow and asymptomatic thrombosis can occur at an early stage
# 27161689 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in introduction: peripherally inserted central catheters (picc) have been increasingly used for administration of chemotherapy, antibiotics and blood products in patients with haematological malignancies
## -> Scan Factor Cancer
[TARGET] => found lymphoma in whereas those with picc associated infection (n=18), 5 had non-hodgkin's lymphoma and 5 had acute lymphoid leukaemia
[RISK] => found associate in whereas those with picc associated infection (n=18), 5 had non-hodgkin's lymphoma and 5 had acute lymphoid leukaemia
## -> Scan Factor Age
[TARGET] => found  age  in the mean age of patients who has picc associated thrombosis was 51.6 years (±8.1 years)
[RISK] => found associate in the mean age of patients who has picc associated thrombosis was 51.6 years (±8.1 years)
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in men were found to experience complications earlier with 80% of men having complications 1-50 days post picc insertion and 12% 51-100 days post insertion
## -> Scan Factor PICC infection
[TARGET] => found infection in although generally regarded safe, infections and thrombotic events have occurred with picc use, necessitating study to guide future clinical prophylaxis and management
[TARGET] => found infection in the main outcome measures were picc associated thrombosis and/or infection results: of 131 picc placements in a total of 90 patients
[RISK] => found associate in the main outcome measures were picc associated thrombosis and/or infection results: of 131 picc placements in a total of 90 patients
[TARGET] => found infection in thrombosis was found in 14.5% (n=19), 13.7% developed infection (n=18) and remaining were without complications
[TARGET] => found infection in whereas those with picc associated infection (n=18), 5 had non-hodgkin's lymphoma and 5 had acute lymphoid leukaemia
[RISK] => found associate in whereas those with picc associated infection (n=18), 5 had non-hodgkin's lymphoma and 5 had acute lymphoid leukaemia
[TARGET] => found infection in decreased in picc lumen size was shown to influence the risk of complications; of 5 french catheters, 20% had thrombosis and 15% had infection, vs
[RISK] => found risk in decreased in picc lumen size was shown to influence the risk of complications; of 5 french catheters, 20% had thrombosis and 15% had infection, vs
[RISK] => found decrease in decreased in picc lumen size was shown to influence the risk of complications; of 5 french catheters, 20% had thrombosis and 15% had infection, vs
# 31724074 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in over time, almost all patients became used to the device and perceived greater security during chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in purpose: the use of central venous catheters with peripheral insertion (picc) has increased rapidly in recent years, particularly in cancer patients
[RISK] => found increase in purpose: the use of central venous catheters with peripheral insertion (picc) has increased rapidly in recent years, particularly in cancer patients
## -> Scan Factor Gender
[TARGET] => found male in results: sixty patients were enrolled (41 males and 19 females, with a median age of 56.2 years)
[TARGET] => found female in results: sixty patients were enrolled (41 males and 19 females, with a median age of 56.2 years)
## -> Scan Factor Age
[TARGET] => found  age  in results: sixty patients were enrolled (41 males and 19 females, with a median age of 56.2 years)
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in immediate complications mainly included hematoma (8), accidental arterial puncture (4), and primary malpositioning (3)
[TARGET] => found picc insertion in picc-related complications were recorded immediately (during the procedure), early (within 1 week after picc insertion), and late (1-3-5 months after picc placement)
## -> Scan Factor PICC infection
[TARGET] => found infection in the benefits provided may occasionally be affected by relevant complications, such as infections and thrombotic events, especially in neuro-oncological patients
[TARGET] => found infection in regarding early and late complications, 3 device-related infections, 8 thrombotic events, and 20 mechanical complications were registered
# 37445515 ---------
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in study precision was evaluated by using a funnel plot for platelets level
[TARGET] => found platelet in picc-related dvt was associated with higher d-dimers (0.37 μg/ml, 95% ci 0.02, 0.72; p = 0.04, i(2) = 92%; p for heterogeneity < 0.00001) and with higher platelets (8.76 × 10(9)/l, 95% ci 1.62, 15.91; p = 0.02, i(2) = 41%; p for heterogeneity = 0.06)
[RISK] => found associate in picc-related dvt was associated with higher d-dimers (0.37 μg/ml, 95% ci 0.02, 0.72; p = 0.04, i(2) = 92%; p for heterogeneity < 0.00001) and with higher platelets (8.76 × 10(9)/l, 95% ci 1.62, 15.91; p = 0.02, i(2) = 41%; p for heterogeneity = 0.06)
[RISK] => found high in picc-related dvt was associated with higher d-dimers (0.37 μg/ml, 95% ci 0.02, 0.72; p = 0.04, i(2) = 92%; p for heterogeneity < 0.00001) and with higher platelets (8.76 × 10(9)/l, 95% ci 1.62, 15.91; p = 0.02, i(2) = 41%; p for heterogeneity = 0.06)
[TARGET] => found platelet in conclusions: high levels of d-dimer and platelet were associated with dvt in patients with picc
[RISK] => found associate in conclusions: high levels of d-dimer and platelet were associated with dvt in patients with picc
[RISK] => found high in conclusions: high levels of d-dimer and platelet were associated with dvt in patients with picc
# 35071472 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in most patients who underwent catheter removal alone had hematological malignancies, and thrombocytopenia had occurred during chemotherapy
## -> Scan Factor Age
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in results: after picc removal, no patients in the anticoagulation therapy group developed progressive thrombosis, while 10 patients in the catheter removal alone group developed progressive thrombosis or pulmonary embolism (pe), including one case of pe, four cases of secondary upper extremity deep vein thrombosis (uedvt), and five patients showed obvious aggravation of thrombosis after catheter removal, and were administered repeated anticoagulant therapy
[RISK] => found group in results: after picc removal, no patients in the anticoagulation therapy group developed progressive thrombosis, while 10 patients in the catheter removal alone group developed progressive thrombosis or pulmonary embolism (pe), including one case of pe, four cases of secondary upper extremity deep vein thrombosis (uedvt), and five patients showed obvious aggravation of thrombosis after catheter removal, and were administered repeated anticoagulant therapy
# 33617142 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the pooled incidence of picc-rt in cancer patients was 19% (95% ci, 0.13-0.26)
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in most asymptomatic thrombosis occurred 3-12 days after the picc insertion
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found ecog in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found risk in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found factor in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found high in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found low in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found group in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
## -> Scan Factor Slower blood flow velocity
[TARGET] => found blood flow velocity in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found risk in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found factor in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found high in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found low in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
[RISK] => found group in a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis
# 32921123 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in effects of tai chi on catheter management and quality of life in tumor patients with picc at the intermission of chemotherapy: a non-inferiority randomized controlled trial
[TARGET] => found chemotherapy in background: peripherally inserted central catheter (picc) is widely used in chemotherapy due to its minimal complications and simple wound care
[TARGET] => found chemotherapy in this study explored the effects of tai chi on catheterrelated complications, catheter management ability, and quality of life in tumor patients with picc at the intermission of chemotherapy
[TARGET] => found chemotherapy in a total of 98 patients with malignant tumors who underwent long-term chemotherapy with picc were randomly divided into an observation group (49 cases) and a control group (49 cases)
[RISK] => found group in a total of 98 patients with malignant tumors who underwent long-term chemotherapy with picc were randomly divided into an observation group (49 cases) and a control group (49 cases)
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found fibrinogen in results: after the intervention, the activated partial thromboplastin time (aptt) and prothrombin time (pt) in the observation group were longer than those in the control group, while fibrinogen (fib) was lower than that in the control group (all p<0.05)
[RISK] => found low in results: after the intervention, the activated partial thromboplastin time (aptt) and prothrombin time (pt) in the observation group were longer than those in the control group, while fibrinogen (fib) was lower than that in the control group (all p<0.05)
[RISK] => found group in results: after the intervention, the activated partial thromboplastin time (aptt) and prothrombin time (pt) in the observation group were longer than those in the control group, while fibrinogen (fib) was lower than that in the control group (all p<0.05)
# 25726426 ---------
## -> Scan Factor Gender
[TARGET] => found gender in for each case, at least two contemporaneous controls were identified and matched by age and gender
## -> Scan Factor Age
[TARGET] => found  age  in for each case, at least two contemporaneous controls were identified and matched by age and gender
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in indications for picc placement included long-term intravenous antibiotic therapy (n=447; 49.1%), in-hospital venous access for blood draws or infusion of medications (n=342; 44.2%), and total parenteral nutrition (n=120; 6.7%)
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in patients with picc-dvt were more likely to have a history of venous thromboembolism (or 1.70, 95% ci=1.02-2.82) or have undergone surgery while the picc was in situ (or 2.17, 95%ci=1.17-4.01 for surgeries longer than two hours)
[RISK] => found more in patients with picc-dvt were more likely to have a history of venous thromboembolism (or 1.70, 95% ci=1.02-2.82) or have undergone surgery while the picc was in situ (or 2.17, 95%ci=1.17-4.01 for surgeries longer than two hours)
# 28386787 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in in 31 patients, the picc line was used at home for hydration (18), antibiotics (3), intravenous human ig (7), transfusions (10), extracorporeal photopheresis (3), chemotherapy (2), artificial nutrition (1), and/or palliative care (1)
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Transplantation
[TARGET] => found transplantation in prospective evaluation of systematic use of peripherally inserted central catheters (picc lines) for the home care after allogeneic hematopoietic stem cells transplantation
[TARGET] => found transplantation in purpose: long-term catheters are often necessary for outpatient care after an allogeneic hematopoietic stem cell transplantation (hsct), however, there is paucity of data on the use of peripherally inserted central catheter (picc) in post-hsct setting
## -> Scan Factor PICC infection
[TARGET] => found infection in reasons for removal were that picc was not considered to be useful any longer (16), suspicion of infection (inflammation without documentation) (5) or infection (2), patient's wish (4), death (4), accidental withdrawal (2), puncture site bleeding (1), and catheter change due to extracorporeal photopheresis (1)
[TARGET] => found infection in three venous thromboses were reported (8%), requesting one picc removal because of associated infection
[RISK] => found associate in three venous thromboses were reported (8%), requesting one picc removal because of associated infection
# 37553006 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in upper limb lymphedema impacts the risk of peripherally inserted central catheter-related thrombosis in patients with breast cancer
[RISK] => found risk in upper limb lymphedema impacts the risk of peripherally inserted central catheter-related thrombosis in patients with breast cancer
[RISK] => found impact in upper limb lymphedema impacts the risk of peripherally inserted central catheter-related thrombosis in patients with breast cancer
[TARGET] => found cancer in there is little information on the risk for catheter-related thrombosis in patients with upper limb lymphedema following breast cancer treatment
[RISK] => found risk in there is little information on the risk for catheter-related thrombosis in patients with upper limb lymphedema following breast cancer treatment
[RISK] => found low in there is little information on the risk for catheter-related thrombosis in patients with upper limb lymphedema following breast cancer treatment
[TARGET] => found cancer in we investigated the association between upper limb lymphedema and the risk of peripherally inserted central catheterrelated thrombosis (picc-rt) occurring in the contralateral limb of patients with breast cancer
[RISK] => found risk in we investigated the association between upper limb lymphedema and the risk of peripherally inserted central catheterrelated thrombosis (picc-rt) occurring in the contralateral limb of patients with breast cancer
[TARGET] => found cancer in a retrospective review analyzed all patients with breast cancer who underwent picc insertion at a cancer hospital in hunan province from 2015 to 2019
[TARGET] => found cancer in in breast cancer patients, upper limb lymphedema may be an important predictor for picc-rt in the contralateral limb and information should be provided to patients
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in a retrospective review analyzed all patients with breast cancer who underwent picc insertion at a cancer hospital in hunan province from 2015 to 2019
# 34613657 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in methods: we reviewed consecutive cancer patients receiving chemotherapy through a picc inserted april 2017 to july 2018
## -> Scan Factor Cancer
[TARGET] => found cancer in development of a risk score to predict peripherally inserted central catheter thrombosis in active cancer
[RISK] => found risk in development of a risk score to predict peripherally inserted central catheter thrombosis in active cancer
[TARGET] => found cancer in aims: to explore the prevalence of symptomatic picc thrombosis and pulmonary embolism (pe)/deep vein thrombosis (dvt) in cancer and non-cancer cohorts
[TARGET] => found cancer in in active cancer, we assessed the khorana risk score (krs) and michigan risk score (mrs) for predicting picc thrombosis and modifications to improve discriminative accuracy
[RISK] => found risk in in active cancer, we assessed the khorana risk score (krs) and michigan risk score (mrs) for predicting picc thrombosis and modifications to improve discriminative accuracy
[TARGET] => found cancer in methods: we reviewed consecutive cancer patients receiving chemotherapy through a picc inserted april 2017 to july 2018
[TARGET] => found cancer in for each case, we identified a contemporaneous non-cancer control
[TARGET] => found cancer in results: among 147 cancer patients, median age 64 years, picc duration 70 days (range, 2-452), 7% developed picc thrombosis (95% confidence interval (ci) 3.6-12.2) and 4% (95% ci 2-9) pe/dvt
[TARGET] => found cancer in in our cancer cohort, no krs < 1 patients developed picc thrombosis (95% ci 0-11) compared with 9% (95% ci 5-16) in krs ≥ 1 (p = 0.12)
[TARGET] => found cancer in conclusion: cancer patients had longer picc durations and higher picc thrombosis rates than those without (7% vs 0.7%)
[RISK] => found high in conclusion: cancer patients had longer picc durations and higher picc thrombosis rates than those without (7% vs 0.7%)
## -> Scan Factor Age
[TARGET] => found  age  in results: among 147 cancer patients, median age 64 years, picc duration 70 days (range, 2-452), 7% developed picc thrombosis (95% confidence interval (ci) 3.6-12.2) and 4% (95% ci 2-9) pe/dvt
[TARGET] => found  age  in among 147 controls, median age 68 years, picc duration 18.3 days (range, 0.5-210), 0.7% (95% ci 0-4) developed picc thrombosis and 2% (95% ci 0.4-6) pe/dvt
# 35216538 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in furthermore, the authors found that only 1.85% of all catheters developed local infection within d8, and only 0.83% evolved in vein thrombosis
[RISK] => found more in furthermore, the authors found that only 1.85% of all catheters developed local infection within d8, and only 0.83% evolved in vein thrombosis
[TARGET] => found infection in total bloodstream infection was at 0.1%
# 33148905 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in safe central venous catheters for esophageal cancer treatment
[TARGET] => found cancer in  introduction : central venous catheter (cvc) use is essential for treating esophageal cancer
[TARGET] => found cancer in methods : we retrospectively investigated complications at the catheter insertion and post-insertion for 199 patients' esophageal cancer treatment (cicc : 45, picc : 154) from 2013 to 2018
[TARGET] => found cancer in conclusion : piccs are safer and more effective than ciccs for the treatment of esophageal cancer, and reduce the incidence of crbsi
[RISK] => found more in conclusion : piccs are safer and more effective than ciccs for the treatment of esophageal cancer, and reduce the incidence of crbsi
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found insertion procedure in we hope to standardize the insertion procedures, conventionalize techniques, and establish training systems
[TARGET] => found picc insertion in we compared centrally inserted central catheters (cicc) and picc insertions and examined their safety
## -> Scan Factor Surgery_type of surgery
## -> Scan Factor PICC infection
[TARGET] => found infection in the incidence of catheter-related blood stream infection (crbsi) was significantly lower in picc than cicc patients (0.3 vs
[RISK] => found low in the incidence of catheter-related blood stream infection (crbsi) was significantly lower in picc than cicc patients (0.3 vs
# 25910751 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in purpose: the use of peripherally inserted central catheters (picc) as an alternative to other central venous access devices (cvad) is becoming very frequent in cancer patients
[TARGET] => found leukemia in cox regression analyses of variables associated to crbsis and to crtcs showed that only the type of disease (acute leukemia compared to other diseases) was significantly associated to a higher incidence of crbsis, while no feature was predictive for a higher risk of crtcs
[RISK] => found risk in cox regression analyses of variables associated to crbsis and to crtcs showed that only the type of disease (acute leukemia compared to other diseases) was significantly associated to a higher incidence of crbsis, while no feature was predictive for a higher risk of crtcs
[RISK] => found associate in cox regression analyses of variables associated to crbsis and to crtcs showed that only the type of disease (acute leukemia compared to other diseases) was significantly associated to a higher incidence of crbsis, while no feature was predictive for a higher risk of crtcs
[RISK] => found high in cox regression analyses of variables associated to crbsis and to crtcs showed that only the type of disease (acute leukemia compared to other diseases) was significantly associated to a higher incidence of crbsis, while no feature was predictive for a higher risk of crtcs
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (picc)
[RISK] => found risk in catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (picc)
[RISK] => found associate in catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (picc)
[TARGET] => found infection in to evaluate the impact of complications associated to these devices in patients with hematologic malignancies, we revised the catheter-related bloodstream infections (crbsi) and the catheter-related thrombotic complications (crtc) observed at our institute between january 2009 and december 2012
[RISK] => found impact in to evaluate the impact of complications associated to these devices in patients with hematologic malignancies, we revised the catheter-related bloodstream infections (crbsi) and the catheter-related thrombotic complications (crtc) observed at our institute between january 2009 and december 2012
[RISK] => found associate in to evaluate the impact of complications associated to these devices in patients with hematologic malignancies, we revised the catheter-related bloodstream infections (crbsi) and the catheter-related thrombotic complications (crtc) observed at our institute between january 2009 and december 2012
# 25593110 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in results: data were available for 136 patients (50% cancer; 44% infection; 6% other indication for picc)
## -> Scan Factor Gender
[TARGET] => found male in mean age was 57 years with 54% males
## -> Scan Factor Age
[TARGET] => found  age  in mean age was 57 years with 54% males
## -> Scan Factor Large catheter
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in the size of the vein used for picc insertion and thus the catheter to vein ratio is thought to be a controllable factor in the reduction of vte rates in patients who have a picc
[RISK] => found factor in the size of the vein used for picc insertion and thus the catheter to vein ratio is thought to be a controllable factor in the reduction of vte rates in patients who have a picc
[TARGET] => found picc insertion in however, an optimal catheter to vein ratio for picc insertion has not previously been investigated to inform clinical practice
[TARGET] => found picc insertion in method: adult patients waiting for picc insertion at a large metropolitan teaching hospital were recruited between may and december 2013
[TARGET] => found picc insertion in vein diameter at the picc insertion site was measured using ultrasound with in-built callipers
## -> Scan Factor PICC infection
[TARGET] => found infection in results: data were available for 136 patients (50% cancer; 44% infection; 6% other indication for picc)
# 35126715 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in peripherally inserted central catheters (piccs) are used for the administration of chemotherapy drugs, including vinorelbine
[TARGET] => found chemotherapy in collectively, the present study observed the formation and specific evolution of phlebitis and venous thrombosis after vinorelbine administration, providing a reference for the early prediction, timely prevention and treatment of picc-related chemotherapy complications
# 32441173 ---------
## -> Scan Factor Gender
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcomes were maternal infection (cellulitis, sepsis), venous thromboembolism (vte), or combined major complication rate
[TARGET] => found infection in the risk of infection associated with picc use was the most variable, with rates ranging from 4% to 37%
[RISK] => found risk in the risk of infection associated with picc use was the most variable, with rates ranging from 4% to 37%
[RISK] => found associate in the risk of infection associated with picc use was the most variable, with rates ranging from 4% to 37%
[TARGET] => found infection in this suggests that infection risk may be modifiable and further studies are needed to assess interventions that may lower this risk
[RISK] => found risk in this suggests that infection risk may be modifiable and further studies are needed to assess interventions that may lower this risk
[RISK] => found low in this suggests that infection risk may be modifiable and further studies are needed to assess interventions that may lower this risk
# 33782091 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found multilumen in hospital performance on three appropriateness criteria was measured: short-term picc use (≤5 days), use of multilumen piccs and picc placement in patients with chronic kidney disease
## -> Scan Factor PICC infection
[TARGET] => found infection in logistic regression and poisson models were fit to assess the association between appropriateness and complications (composite of catheter occlusion, venous thromboembolism (vte) and central line-associated bloodstream infection (clabsi))
[RISK] => found associate in logistic regression and poisson models were fit to assess the association between appropriateness and complications (composite of catheter occlusion, venous thromboembolism (vte) and central line-associated bloodstream infection (clabsi))
# 34511570 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[RISK] => found risk in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[RISK] => found factor in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[RISK] => found associate in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[TARGET] => found chemotherapy in however, the risks of picc-related complications during chemotherapy for acute myeloid leukemia (aml) are not fully understood
[RISK] => found risk in however, the risks of picc-related complications during chemotherapy for acute myeloid leukemia (aml) are not fully understood
[TARGET] => found chemotherapy in conclusion low picc-related complication rates, possibly associated with high rates of catheter removal, were observed during intensive chemotherapy for aml
[RISK] => found associate in conclusion low picc-related complication rates, possibly associated with high rates of catheter removal, were observed during intensive chemotherapy for aml
[RISK] => found high in conclusion low picc-related complication rates, possibly associated with high rates of catheter removal, were observed during intensive chemotherapy for aml
[RISK] => found low in conclusion low picc-related complication rates, possibly associated with high rates of catheter removal, were observed during intensive chemotherapy for aml
## -> Scan Factor Cancer
[TARGET] => found leukemia in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[RISK] => found risk in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[RISK] => found factor in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[RISK] => found associate in risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia
[TARGET] => found leukemia in however, the risks of picc-related complications during chemotherapy for acute myeloid leukemia (aml) are not fully understood
[RISK] => found risk in however, the risks of picc-related complications during chemotherapy for acute myeloid leukemia (aml) are not fully understood
## -> Scan Factor Gender
## -> Scan Factor BMI
[TARGET] => found obesity in obesity put patients at an increased risk for crt
[RISK] => found risk in obesity put patients at an increased risk for crt
[RISK] => found increase in obesity put patients at an increased risk for crt
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods we conducted a retrospective review of 128 adult patients with aml who received induction therapy by way of picc insertion between 2012 and 2019
[TARGET] => found picc insertion in results the median duration of picc insertion was 30 days
## -> Scan Factor PICC indwelling time
[TARGET] => found duration of picc in results the median duration of picc insertion was 30 days
## -> Scan Factor PICC infection
[TARGET] => found infection in the incidence rate of catheter-related bloodstream infection (crbsi) was 2.4% at 30 days, and women were more likely to suffer from crbsi than men
[RISK] => found more in the incidence rate of catheter-related bloodstream infection (crbsi) was 2.4% at 30 days, and women were more likely to suffer from crbsi than men
# 33249623 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found carboplatin in based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt
[RISK] => found risk in based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt
[RISK] => found factor in based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt
## -> Scan Factor Cancer
[TARGET] => found cancer in incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer
[RISK] => found risk in incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer
[RISK] => found factor in incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer
[TARGET] => found cancer in aims: to determine the incidence and risk factors associated with peripherally inserted central catheter-related thrombosis (picc-rt) in patients with lung cancer
[RISK] => found risk in aims: to determine the incidence and risk factors associated with peripherally inserted central catheter-related thrombosis (picc-rt) in patients with lung cancer
[RISK] => found factor in aims: to determine the incidence and risk factors associated with peripherally inserted central catheter-related thrombosis (picc-rt) in patients with lung cancer
[RISK] => found associate in aims: to determine the incidence and risk factors associated with peripherally inserted central catheter-related thrombosis (picc-rt) in patients with lung cancer
[TARGET] => found cancer in methods: patients with lung cancer receiving picc insertion during 1 march 2014-31 may 2019 at a tertiary hospital in shanghai, china were enrolled (n = 748)
[TARGET] => found cancer in our findings provided evidence for the management of picc-rt in patients with lung cancer
## -> Scan Factor Gender
[TARGET] => found male in results: among the patients (mean age, 60.7 years; males, 67.1%), 55 (7.35%) had symptomatic picc-rt
## -> Scan Factor Smoking
[TARGET] => found smoking in based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt
[RISK] => found risk in based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt
[RISK] => found factor in based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: patients with lung cancer receiving picc insertion during 1 march 2014-31 may 2019 at a tertiary hospital in shanghai, china were enrolled (n = 748)
[TARGET] => found picc insertion in meanwhile, healthcare professionals are recommended to perform a comprehensive assessment of the patients receiving picc insertion
# 31900609 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in background: central venous catheters (cvc) are essential for the management of patients with hematologic malignancies, facilitating chemotherapy infusion, antibiotics, parenteral nutrition, blood products, and blood samples collection
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found duration of picc in results: the median duration of picc placement was 117 days
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in background: central venous catheters (cvc) are essential for the management of patients with hematologic malignancies, facilitating chemotherapy infusion, antibiotics, parenteral nutrition, blood products, and blood samples collection
## -> Scan Factor Transplantation
## -> Scan Factor PICC infection
[TARGET] => found infection in catheter-related bloodstream infections (crbsi) occurred in 32% of patients (2.5/1000 picc days), associated with thrombosis in 8 cases
[RISK] => found associate in catheter-related bloodstream infections (crbsi) occurred in 32% of patients (2.5/1000 picc days), associated with thrombosis in 8 cases
# 34794291 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the inclusion criteria were patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome; bedridden patients; and patients without mental disorders; who could understand the content of this study and agreed to participate in this study
[TARGET] => found cancer in conclusion: the indications for picc through the lower limbs in adults include patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome, and mainly bedridden patients
[RISK] => found low in conclusion: the indications for picc through the lower limbs in adults include patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome, and mainly bedridden patients
## -> Scan Factor Age
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found bedridden in the inclusion criteria were patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome; bedridden patients; and patients without mental disorders; who could understand the content of this study and agreed to participate in this study
[TARGET] => found bedridden in conclusion: the indications for picc through the lower limbs in adults include patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome, and mainly bedridden patients
[RISK] => found low in conclusion: the indications for picc through the lower limbs in adults include patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome, and mainly bedridden patients
[TARGET] => found bedridden in key words: lower limb picc, deep venous catheterisation, advanced malignant tumor, bedridden
[RISK] => found low in key words: lower limb picc, deep venous catheterisation, advanced malignant tumor, bedridden
## -> Scan Factor PICC infection
[TARGET] => found infection in no catheter-related infection was found in the two groups of patients
[RISK] => found group in no catheter-related infection was found in the two groups of patients
# 30683751 ---------
## -> Scan Factor Gender
[TARGET] => found male in results: of the 438 patients in the analytic cohort (91.4% of those consented), two-thirds were male with a mean age of 56 years
## -> Scan Factor Age
[TARGET] => found  age  in results: of the 438 patients in the analytic cohort (91.4% of those consented), two-thirds were male with a mean age of 56 years
## -> Scan Factor PICC infection
[TARGET] => found infection in during the 70-day follow-up period, 61.4% of patients reported signs of at least one complication, including potentially serious complications, such as bloodstream infection (17.6%) and deep vein thrombosis (30.6%)
[RISK] => found low in during the 70-day follow-up period, 61.4% of patients reported signs of at least one complication, including potentially serious complications, such as bloodstream infection (17.6%) and deep vein thrombosis (30.6%)
# 37333869 ---------
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: a retrospective analysis of picc insertions and follow-up during a 9 years period to look at patient demographics and infections related to picc was carried out
[RISK] => found low in methods: a retrospective analysis of picc insertions and follow-up during a 9 years period to look at patient demographics and infections related to picc was carried out
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in pabsi noted in this study was 1.34 per 1000 catheter days
[TARGET] => found duration of picc in the average duration of picc days for occurrence of pabsi was 14 days and the majority occurred in in-patients
## -> Scan Factor PICC infection
[TARGET] => found infection in peripherally inserted central catheters-associated blood stream infections-occurrence, risk factors, and pathogens, a single center study
[RISK] => found risk in peripherally inserted central catheters-associated blood stream infections-occurrence, risk factors, and pathogens, a single center study
[RISK] => found factor in peripherally inserted central catheters-associated blood stream infections-occurrence, risk factors, and pathogens, a single center study
[RISK] => found associate in peripherally inserted central catheters-associated blood stream infections-occurrence, risk factors, and pathogens, a single center study
[TARGET] => found infection in aim: this study was carried out to understand picc-related complications, specifically infections and causal pathogens, in a tertiary care hospital in kerala, south india
[TARGET] => found infection in methods: a retrospective analysis of picc insertions and follow-up during a 9 years period to look at patient demographics and infections related to picc was carried out
[RISK] => found low in methods: a retrospective analysis of picc insertions and follow-up during a 9 years period to look at patient demographics and infections related to picc was carried out
[TARGET] => found infection in commonest complication was thrombosis followed by infection, either picc-associated bloodstream infection (pabsi) or local infection (li)
[RISK] => found associate in commonest complication was thrombosis followed by infection, either picc-associated bloodstream infection (pabsi) or local infection (li)
[RISK] => found low in commonest complication was thrombosis followed by infection, either picc-associated bloodstream infection (pabsi) or local infection (li)
[TARGET] => found infection in conclusion: thrombosis and infection were the commonest picc-related complications
# 26207019 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy
[RISK] => found risk in we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy
[RISK] => found factor in we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy
[TARGET] => found chemotherapy in patients and methods: we performed a retrospective cohort study of patients with lung cancer with picc insertion undergoing chemotherapy
[TARGET] => found chemotherapy in results: a total of 328 patients with lung cancer having picc undergoing chemotherapy were included, for a total of 34 895 catheter days
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheter-related vein thrombosis in patients with lung cancer
[TARGET] => found cancer in background: peripherally inserted central venous catheters (piccs) are widely used in patients with cancer
[TARGET] => found cancer in we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy
[RISK] => found risk in we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy
[RISK] => found factor in we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy
[TARGET] => found cancer in patients and methods: we performed a retrospective cohort study of patients with lung cancer with picc insertion undergoing chemotherapy
[TARGET] => found cancer in patient-, catheter-, and insertion-related factors were analyzed in univariable and multivariable logistic regression to identify significant independent risk factors for picc-uevt in patients with lung cancer
[RISK] => found risk in patient-, catheter-, and insertion-related factors were analyzed in univariable and multivariable logistic regression to identify significant independent risk factors for picc-uevt in patients with lung cancer
[RISK] => found factor in patient-, catheter-, and insertion-related factors were analyzed in univariable and multivariable logistic regression to identify significant independent risk factors for picc-uevt in patients with lung cancer
[TARGET] => found cancer in results: a total of 328 patients with lung cancer having picc undergoing chemotherapy were included, for a total of 34 895 catheter days
[TARGET] => found cancer in conclusion: patients with lung cancer harboring an advanced disease or treating with etoposide were at higher risk of picc-uevt
[RISK] => found risk in conclusion: patients with lung cancer harboring an advanced disease or treating with etoposide were at higher risk of picc-uevt
[RISK] => found high in conclusion: patients with lung cancer harboring an advanced disease or treating with etoposide were at higher risk of picc-uevt
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in patients and methods: we performed a retrospective cohort study of patients with lung cancer with picc insertion undergoing chemotherapy
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: a total of 328 patients with lung cancer having picc undergoing chemotherapy were included, for a total of 34 895 catheter days
[TARGET] => found catheter day in seventeen (5.2%) patients developed picc-related uevt, with an incidence of 0.49 per 1000 catheter days
# 33499716 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in catheter-associated infections, dislodgement or migration, malfunction, and picc-associated thrombosis were recorded
[RISK] => found associate in catheter-associated infections, dislodgement or migration, malfunction, and picc-associated thrombosis were recorded
[TARGET] => found infection in line associated infection was the most common complication (17.2%)
[RISK] => found associate in line associated infection was the most common complication (17.2%)
# 35875074 ---------
## -> Scan Factor Non-O blood type_ group B
[TARGET] => found blood type in meta-analysis of the studies showed that the risk of picc-associated vte was significantly higher in blood types a [odds ratio (or)=1.54, 95% ci=1.17-2.03), p=0.002], b (or=2.35, 95% ci=1.71-3.23, p<0.0001), and ab (or=2.55, 95% ci=1.68-3.88, p<0.0001) and lower in blood types o (or=0.58, 95% ci=0.45-0.74, p<0.0001)
[RISK] => found risk in meta-analysis of the studies showed that the risk of picc-associated vte was significantly higher in blood types a [odds ratio (or)=1.54, 95% ci=1.17-2.03), p=0.002], b (or=2.35, 95% ci=1.71-3.23, p<0.0001), and ab (or=2.55, 95% ci=1.68-3.88, p<0.0001) and lower in blood types o (or=0.58, 95% ci=0.45-0.74, p<0.0001)
[RISK] => found associate in meta-analysis of the studies showed that the risk of picc-associated vte was significantly higher in blood types a [odds ratio (or)=1.54, 95% ci=1.17-2.03), p=0.002], b (or=2.35, 95% ci=1.71-3.23, p<0.0001), and ab (or=2.55, 95% ci=1.68-3.88, p<0.0001) and lower in blood types o (or=0.58, 95% ci=0.45-0.74, p<0.0001)
[RISK] => found high in meta-analysis of the studies showed that the risk of picc-associated vte was significantly higher in blood types a [odds ratio (or)=1.54, 95% ci=1.17-2.03), p=0.002], b (or=2.35, 95% ci=1.71-3.23, p<0.0001), and ab (or=2.55, 95% ci=1.68-3.88, p<0.0001) and lower in blood types o (or=0.58, 95% ci=0.45-0.74, p<0.0001)
[RISK] => found low in meta-analysis of the studies showed that the risk of picc-associated vte was significantly higher in blood types a [odds ratio (or)=1.54, 95% ci=1.17-2.03), p=0.002], b (or=2.35, 95% ci=1.71-3.23, p<0.0001), and ab (or=2.55, 95% ci=1.68-3.88, p<0.0001) and lower in blood types o (or=0.58, 95% ci=0.45-0.74, p<0.0001)
[TARGET] => found blood type in subgroup analysis based on ethnicity demonstrated that blood type o may be a genetic protective factor for picc-associated vte in asians
[RISK] => found factor in subgroup analysis based on ethnicity demonstrated that blood type o may be a genetic protective factor for picc-associated vte in asians
[RISK] => found associate in subgroup analysis based on ethnicity demonstrated that blood type o may be a genetic protective factor for picc-associated vte in asians
[RISK] => found group in subgroup analysis based on ethnicity demonstrated that blood type o may be a genetic protective factor for picc-associated vte in asians
[TARGET] => found blood type in among caucasians, individuals with blood types b and ab have a higher risk of picc-associated vte
[RISK] => found risk in among caucasians, individuals with blood types b and ab have a higher risk of picc-associated vte
[RISK] => found associate in among caucasians, individuals with blood types b and ab have a higher risk of picc-associated vte
[RISK] => found high in among caucasians, individuals with blood types b and ab have a higher risk of picc-associated vte
[TARGET] => found blood type in blood types a, b, and ab are risk factors for picc-associated vte in asians
[RISK] => found risk in blood types a, b, and ab are risk factors for picc-associated vte in asians
[RISK] => found factor in blood types a, b, and ab are risk factors for picc-associated vte in asians
[RISK] => found associate in blood types a, b, and ab are risk factors for picc-associated vte in asians
[TARGET] => found blood type in conclusions: blood type o is associated with a decreased risk of picc-associated vte, especially in asian populations
[RISK] => found risk in conclusions: blood type o is associated with a decreased risk of picc-associated vte, especially in asian populations
[RISK] => found associate in conclusions: blood type o is associated with a decreased risk of picc-associated vte, especially in asian populations
[RISK] => found decrease in conclusions: blood type o is associated with a decreased risk of picc-associated vte, especially in asian populations
[TARGET] => found blood type in moreover, blood types a, b, and ab are risk factors for picc-associated vte
[RISK] => found risk in moreover, blood types a, b, and ab are risk factors for picc-associated vte
[RISK] => found factor in moreover, blood types a, b, and ab are risk factors for picc-associated vte
[RISK] => found associate in moreover, blood types a, b, and ab are risk factors for picc-associated vte
[RISK] => found more in moreover, blood types a, b, and ab are risk factors for picc-associated vte
# 35958406 ---------
# 24268631 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in there was a statistically significantly higher thrombosis rate in patients with cancer (71.9% vs 66.7%, p = .002)
[RISK] => found high in there was a statistically significantly higher thrombosis rate in patients with cancer (71.9% vs 66.7%, p = .002)
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found old in all patients 18-90 years old requiring picc insertion were considered for the study
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in all patients 18-90 years old requiring picc insertion were considered for the study
[TARGET] => found picc insertion in conclusions: this study showed a high incidence of thrombosis of peripheral veins used for picc insertion
[RISK] => found high in conclusions: this study showed a high incidence of thrombosis of peripheral veins used for picc insertion
# 38072566 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in the majority of patients receiving chemotherapy undergo picc catheterization
[TARGET] => found chemotherapy in participants with malignant tumors receiving chemotherapy who accepted picc insertion operation were randomly allocated to the aspirin treatment group (n = 235) or the control group (n = 246)
[RISK] => found group in participants with malignant tumors receiving chemotherapy who accepted picc insertion operation were randomly allocated to the aspirin treatment group (n = 235) or the control group (n = 246)
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in participants with malignant tumors receiving chemotherapy who accepted picc insertion operation were randomly allocated to the aspirin treatment group (n = 235) or the control group (n = 246)
[RISK] => found group in participants with malignant tumors receiving chemotherapy who accepted picc insertion operation were randomly allocated to the aspirin treatment group (n = 235) or the control group (n = 246)
## -> Scan Factor PICC infection
[TARGET] => found infection in however, piccs are significantly associated with catheter related complications, including deep vein thrombosis, blood infection, fibrin sheath, catheter prolapse, catheter displacement and blockage
[RISK] => found associate in however, piccs are significantly associated with catheter related complications, including deep vein thrombosis, blood infection, fibrin sheath, catheter prolapse, catheter displacement and blockage
# 34373674 ---------
## -> Scan Factor Gender
[TARGET] => found sex in age, sex, and medical comorbidities were extracted from the emr
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found risk in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found factor in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found associate in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found decrease in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[TARGET] => found comorbiditie in age, sex, and medical comorbidities were extracted from the emr
[TARGET] => found comorbiditie in mann-whitney non-parametric tests, fisher's exact tests, chi-square tests, and cochran-mantel-haenszel (cmh) tests were used to determine associations with dvt events for those with piccs based on medical comorbidities, picc lumen size, team placing the picc, impact of implant removal, and protective effect of dvt chemoprophylaxis
[RISK] => found impact in mann-whitney non-parametric tests, fisher's exact tests, chi-square tests, and cochran-mantel-haenszel (cmh) tests were used to determine associations with dvt events for those with piccs based on medical comorbidities, picc lumen size, team placing the picc, impact of implant removal, and protective effect of dvt chemoprophylaxis
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found risk in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found factor in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found associate in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found decrease in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[TARGET] => found surgery in the results of this study should be of particular interest to surgeons who do not typically give dvt prophylaxis and plan to perform surgery on patients with chf, a history of a dvt, or plan to manipulate the intramedullary canal
## -> Scan Factor PICC infection
[TARGET] => found infection in background: peripherally inserted central catheter (picc) placement is necessary for delivery of intravenous (iv) antibiotics to treat bone and soft tissue infections
[TARGET] => found infection in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found risk in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found factor in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found associate in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
[RISK] => found decrease in the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period
# 29615373 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in results: the incidence of cvo was 3.2% (71/2232), and 59 patients were analyzed (23 men; mean age, 69 ± 11 years; median age, 80 years; age range, 31-92 years)
## -> Scan Factor PICC indwelling time
[TARGET] => found indwelling time in the picc indwelling time was statistically different between the group with successful catheter advancement (n = 36, success group) and the group with failed catheter advancement (n = 18, failure group; p = .007) with ipsilateral trimmed piccs
[RISK] => found group in the picc indwelling time was statistically different between the group with successful catheter advancement (n = 36, success group) and the group with failed catheter advancement (n = 18, failure group; p = .007) with ipsilateral trimmed piccs
# 29683035 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in we excluded pregnant women, patients on anticoagulation initiated before picc insertion, and patients with active cancer
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in we excluded pregnant women, patients on anticoagulation initiated before picc insertion, and patients with active cancer
# 26349890 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy
[RISK] => found risk in purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy
[RISK] => found factor in purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy
[TARGET] => found chemotherapy in methods: we performed a retrospective cohort study of breast cancer patients with picc insertion undergoing chemotherapy
[TARGET] => found chemotherapy in results: a total of 568 breast cancer patients with picc undergoing chemotherapy were included, for a total of 54,769 catheter days; 8 patients (1.4%) developed picc-related uevt
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheter-related vein thrombosis in breast cancer patients
[TARGET] => found cancer in purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy
[RISK] => found risk in purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy
[RISK] => found factor in purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy
[TARGET] => found cancer in methods: we performed a retrospective cohort study of breast cancer patients with picc insertion undergoing chemotherapy
[TARGET] => found cancer in results: a total of 568 breast cancer patients with picc undergoing chemotherapy were included, for a total of 54,769 catheter days; 8 patients (1.4%) developed picc-related uevt
[TARGET] => found cancer in conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients
[RISK] => found risk in conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients
[RISK] => found factor in conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in in multivariable analysis, metastasis (p = 0.002) and malposition (p = 0.013) were shown to be significant risk factors for picc-related uevt
[RISK] => found risk in in multivariable analysis, metastasis (p = 0.002) and malposition (p = 0.013) were shown to be significant risk factors for picc-related uevt
[RISK] => found factor in in multivariable analysis, metastasis (p = 0.002) and malposition (p = 0.013) were shown to be significant risk factors for picc-related uevt
[TARGET] => found position in conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients
[RISK] => found risk in conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients
[RISK] => found factor in conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: a total of 568 breast cancer patients with picc undergoing chemotherapy were included, for a total of 54,769 catheter days; 8 patients (1.4%) developed picc-related uevt
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in with early diagnosis and standardized anticoagulant treatment, a better clinical outcome could be achieved
# 33383236 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in background: a peripherally inserted central catheter (picc) is often necessary for patients receiving chemotherapy, but there is a risk of picc-related venous thrombosis (vt)
[RISK] => found risk in background: a peripherally inserted central catheter (picc) is often necessary for patients receiving chemotherapy, but there is a risk of picc-related venous thrombosis (vt)
[TARGET] => found chemotherapy in we sought to use the caprini thrombosis risk model and color doppler flow imaging for the dynamic monitoring of an eventual thrombosis in patients receiving chemotherapy
[RISK] => found risk in we sought to use the caprini thrombosis risk model and color doppler flow imaging for the dynamic monitoring of an eventual thrombosis in patients receiving chemotherapy
[RISK] => found low in we sought to use the caprini thrombosis risk model and color doppler flow imaging for the dynamic monitoring of an eventual thrombosis in patients receiving chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in the caprini thrombosis risk model predicts the risk of peripherally inserted central catheter-related upper extremity venous thrombosis in patients with cancer
[RISK] => found risk in the caprini thrombosis risk model predicts the risk of peripherally inserted central catheter-related upper extremity venous thrombosis in patients with cancer
[TARGET] => found cancer in conclusions: the caprini score is an independent predictor of the development of picc-related vt in patients with cancer
## -> Scan Factor Gender
## -> Scan Factor Age
# 24612469 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt
[RISK] => found associate in on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt
[RISK] => found associate in on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt
## -> Scan Factor Cancer
[TARGET] => found cancer in on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt
[RISK] => found associate in on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt
[TARGET] => found cancer in following multivariable adjustment, recent cancer diagnosis (or 1.95 [95% ci 1.01-3.76]) and picc gauge (hr 2.21 [95%ci 1.04-4.70] and hr 3.56 [95%ci 1.31-9.66] for 5-fr and 6-fr piccs, respectively) remained associated with thrombosis
[RISK] => found associate in following multivariable adjustment, recent cancer diagnosis (or 1.95 [95% ci 1.01-3.76]) and picc gauge (hr 2.21 [95%ci 1.04-4.70] and hr 3.56 [95%ci 1.31-9.66] for 5-fr and 6-fr piccs, respectively) remained associated with thrombosis
[RISK] => found low in following multivariable adjustment, recent cancer diagnosis (or 1.95 [95% ci 1.01-3.76]) and picc gauge (hr 2.21 [95%ci 1.04-4.70] and hr 3.56 [95%ci 1.31-9.66] for 5-fr and 6-fr piccs, respectively) remained associated with thrombosis
[TARGET] => found cancer in conclusions: recent diagnosis of cancer and picc gauge are associated with picc-dvt
[RISK] => found associate in conclusions: recent diagnosis of cancer and picc gauge are associated with picc-dvt
[TARGET] => found cancer in these findings have important clinical ramifications and suggest that placement of large gauge piccs or piccs in patients with cancer may provoke thrombosis
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Large catheter
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found ecog in because piccs are also recognized risk factors for lower-extremity dvt, lower-extremity dvt occurring while the picc was in situ was included
[RISK] => found risk in because piccs are also recognized risk factors for lower-extremity dvt, lower-extremity dvt occurring while the picc was in situ was included
[RISK] => found factor in because piccs are also recognized risk factors for lower-extremity dvt, lower-extremity dvt occurring while the picc was in situ was included
[RISK] => found low in because piccs are also recognized risk factors for lower-extremity dvt, lower-extremity dvt occurring while the picc was in situ was included
# 32269677 ---------
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found fibrinogen in serum d-dimer (d2d) and fibrinogen (fg) levels were detected using enzyme-linked immunosorbent assay (elisa)
# 35236188 ---------
## -> Scan Factor Gender
[TARGET] => found male in 58.6% were females and 41.4% were males
[TARGET] => found female in 58.6% were females and 41.4% were males
## -> Scan Factor PICC infection
[TARGET] => found infection in central line-associated bloodstream infection (28.1%) and symptomatic deep vein thrombosis (20.7%) were the most common complications
[RISK] => found associate in central line-associated bloodstream infection (28.1%) and symptomatic deep vein thrombosis (20.7%) were the most common complications
[TARGET] => found infection in the most reasons for piccs removal were occlusion (425, 12.9%) and exit-site infections (189, 5.8%)
# 29408616 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in the effect size of picc exchange on thrombosis was second in magnitude to device lumens (hr 2.06; 95% ci, 1.59-2.66 and hr 2.31; 95% ci, 1.6-3.33 for double- and triple-lumen devices, respectively)
[TARGET] => found triple-lumen in the effect size of picc exchange on thrombosis was second in magnitude to device lumens (hr 2.06; 95% ci, 1.59-2.66 and hr 2.31; 95% ci, 1.6-3.33 for double- and triple-lumen devices, respectively)
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found old in following adjustment, picc exchange was independently associated with twofold greater risk of thrombosis (hazard ratio [hr] 1.98; 95% confidence interval [ci], 1.37-2.85) vs no exchange
[RISK] => found risk in following adjustment, picc exchange was independently associated with twofold greater risk of thrombosis (hazard ratio [hr] 1.98; 95% confidence interval [ci], 1.37-2.85) vs no exchange
[RISK] => found associate in following adjustment, picc exchange was independently associated with twofold greater risk of thrombosis (hazard ratio [hr] 1.98; 95% confidence interval [ci], 1.37-2.85) vs no exchange
[RISK] => found low in following adjustment, picc exchange was independently associated with twofold greater risk of thrombosis (hazard ratio [hr] 1.98; 95% confidence interval [ci], 1.37-2.85) vs no exchange
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in results: of 23,010 patients that underwent picc insertion in the study, 589 patients (2.6%) experienced a picc exchange
# 34103988 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the incidence, risk factors, and patterns of peripherally inserted central catheter-related venous thrombosis in cancer patients followed up by ultrasound
[RISK] => found risk in the incidence, risk factors, and patterns of peripherally inserted central catheter-related venous thrombosis in cancer patients followed up by ultrasound
[RISK] => found factor in the incidence, risk factors, and patterns of peripherally inserted central catheter-related venous thrombosis in cancer patients followed up by ultrasound
[RISK] => found low in the incidence, risk factors, and patterns of peripherally inserted central catheter-related venous thrombosis in cancer patients followed up by ultrasound
[TARGET] => found cancer in purpose: a peripherally inserted central catheter (picc) is associated with venous thromboembolism (vte) especially in patients suffering from cancer
[RISK] => found associate in purpose: a peripherally inserted central catheter (picc) is associated with venous thromboembolism (vte) especially in patients suffering from cancer
[TARGET] => found cancer in we analyzed the incidence, risk factors, and patterns of picc-related vte in cancer patients
[RISK] => found risk in we analyzed the incidence, risk factors, and patterns of picc-related vte in cancer patients
[RISK] => found factor in we analyzed the incidence, risk factors, and patterns of picc-related vte in cancer patients
[TARGET] => found cancer in patients and methods: patients with cancer who underwent picc placement were evaluated retrospectively
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found triglycerides in after adjustment of multivariable analysis, patients with picc-related vte were more likely to have a ratio of picc diameter:vein diameter >0.35 (adjusted or, 1.689; 95% ci, 1.023-2.789) and high level of triglycerides (1.561; 1.096-2.223)
[RISK] => found more in after adjustment of multivariable analysis, patients with picc-related vte were more likely to have a ratio of picc diameter:vein diameter >0.35 (adjusted or, 1.689; 95% ci, 1.023-2.789) and high level of triglycerides (1.561; 1.096-2.223)
[RISK] => found high in after adjustment of multivariable analysis, patients with picc-related vte were more likely to have a ratio of picc diameter:vein diameter >0.35 (adjusted or, 1.689; 95% ci, 1.023-2.789) and high level of triglycerides (1.561; 1.096-2.223)
[TARGET] => found triglycerides in conclusion: the non-o blood group, larger ratio of picc diameter:vein diameter, and high level of triglycerides were significantly associated with picc-related vte
[RISK] => found associate in conclusion: the non-o blood group, larger ratio of picc diameter:vein diameter, and high level of triglycerides were significantly associated with picc-related vte
[RISK] => found high in conclusion: the non-o blood group, larger ratio of picc diameter:vein diameter, and high level of triglycerides were significantly associated with picc-related vte
[RISK] => found group in conclusion: the non-o blood group, larger ratio of picc diameter:vein diameter, and high level of triglycerides were significantly associated with picc-related vte
# 29125332 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found risk in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found associate in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found more in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found increase in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found group in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
## -> Scan Factor Cancer
[TARGET] => found cancer in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found risk in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found associate in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found more in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found increase in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[RISK] => found group in univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt
[TARGET] => found cancer in in the multivariate analysis, picc diameter, cancer diagnosis and blood group b were all independently associated with increased risk of vt
[RISK] => found risk in in the multivariate analysis, picc diameter, cancer diagnosis and blood group b were all independently associated with increased risk of vt
[RISK] => found associate in in the multivariate analysis, picc diameter, cancer diagnosis and blood group b were all independently associated with increased risk of vt
[RISK] => found increase in in the multivariate analysis, picc diameter, cancer diagnosis and blood group b were all independently associated with increased risk of vt
[RISK] => found group in in the multivariate analysis, picc diameter, cancer diagnosis and blood group b were all independently associated with increased risk of vt
[TARGET] => found cancer in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
[RISK] => found risk in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
[RISK] => found high in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
[RISK] => found group in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in a cohort of patients who underwent picc insertion from september 2010 to august 2014 were followed up for symptomatic vt presentations diagnosed by ultrasound
[RISK] => found low in a cohort of patients who underwent picc insertion from september 2010 to august 2014 were followed up for symptomatic vt presentations diagnosed by ultrasound
[TARGET] => found picc insertion in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
[RISK] => found risk in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
[RISK] => found high in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
[RISK] => found group in conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis
# 27078849 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central venous catheters (piccs) are widely used in cancer patients
[TARGET] => found cancer in the risk factors for deep vein thrombosis associated with the use of piccs in cancer patients are largely unexplored
[RISK] => found risk in the risk factors for deep vein thrombosis associated with the use of piccs in cancer patients are largely unexplored
[RISK] => found factor in the risk factors for deep vein thrombosis associated with the use of piccs in cancer patients are largely unexplored
[RISK] => found associate in the risk factors for deep vein thrombosis associated with the use of piccs in cancer patients are largely unexplored
[TARGET] => found cancer in this study aimed to investigate the incidence of picc-associated thrombosis in lymphoma compared with its incidences in other types of cancer
[RISK] => found associate in this study aimed to investigate the incidence of picc-associated thrombosis in lymphoma compared with its incidences in other types of cancer
[TARGET] => found cancer in a total of 8028 adult cancer patients inserted with picc between june 2007 and june 2015 were included in this study
[TARGET] => found cancer in logistic analysis revealed that a lymphoma diagnosis was a risk factor for uedvt in cancer patients inserted with picc (or: 3.849, 95% ci: 2.334-6.347)
[RISK] => found risk in logistic analysis revealed that a lymphoma diagnosis was a risk factor for uedvt in cancer patients inserted with picc (or: 3.849, 95% ci: 2.334-6.347)
[RISK] => found factor in logistic analysis revealed that a lymphoma diagnosis was a risk factor for uedvt in cancer patients inserted with picc (or: 3.849, 95% ci: 2.334-6.347)
## -> Scan Factor Gender
## -> Scan Factor Age
# 30632436 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in the logistic regression results revealed that picc-related venous thrombosis was associated with a history of venous thrombosis (or, 6.745 [3.237–14.056]), number of lumens (or, 1.934 [1.362–2.572] and or, 3.762 [1.672–5.932] for dual and triple lumens, respectively), and picc gauge (or, 1.821 [1.256–2.537] and or, 3.864 [1.367–8.251] for 5-fr and 6-fr, respectively)
[RISK] => found associate in the logistic regression results revealed that picc-related venous thrombosis was associated with a history of venous thrombosis (or, 6.745 [3.237–14.056]), number of lumens (or, 1.934 [1.362–2.572] and or, 3.762 [1.672–5.932] for dual and triple lumens, respectively), and picc gauge (or, 1.821 [1.256–2.537] and or, 3.864 [1.367–8.251] for 5-fr and 6-fr, respectively)
[TARGET] => found lumens in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
[RISK] => found risk in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
[RISK] => found factor in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
[RISK] => found high in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in objective: this study was performed to determine the risk factors associated with peripherally inserted central catheter (picc)-related venous thrombosis in patients of advanced age (>65 years)
[RISK] => found risk in objective: this study was performed to determine the risk factors associated with peripherally inserted central catheter (picc)-related venous thrombosis in patients of advanced age (>65 years)
[RISK] => found factor in objective: this study was performed to determine the risk factors associated with peripherally inserted central catheter (picc)-related venous thrombosis in patients of advanced age (>65 years)
[RISK] => found associate in objective: this study was performed to determine the risk factors associated with peripherally inserted central catheter (picc)-related venous thrombosis in patients of advanced age (>65 years)
## -> Scan Factor History Of Thrombosis
[TARGET] => found history of thrombo in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
[RISK] => found risk in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
[RISK] => found factor in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
[RISK] => found high in conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement
# 34498477 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in a comparative study on the tip position of peripherally inserted central catheter inserted at two forward p-wave amplitudes by intracavitary electrocardiogram in cancer patients
[TARGET] => found cancer in methods: the data of 300 cancer patients with picc insertion were collected retrospectively
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in a comparative study on the tip position of peripherally inserted central catheter inserted at two forward p-wave amplitudes by intracavitary electrocardiogram in cancer patients
[TARGET] => found position in for the observation group, the position of the catheter tip was left at the level when p wave amplitude was its autonomous peak (168 patients catheterized in 2018)
[RISK] => found group in for the observation group, the position of the catheter tip was left at the level when p wave amplitude was its autonomous peak (168 patients catheterized in 2018)
[TARGET] => found position in the total compliance rate [picc tip was located in the lower third of the superior vena cava (svc) and the cavo-atrial junction (caj)], the optimal position compliance rate (picc tip was located in the caj), and the incidence of the catheter tip malposition were compared between the two groups
[RISK] => found low in the total compliance rate [picc tip was located in the lower third of the superior vena cava (svc) and the cavo-atrial junction (caj)], the optimal position compliance rate (picc tip was located in the caj), and the incidence of the catheter tip malposition were compared between the two groups
[RISK] => found group in the total compliance rate [picc tip was located in the lower third of the superior vena cava (svc) and the cavo-atrial junction (caj)], the optimal position compliance rate (picc tip was located in the caj), and the incidence of the catheter tip malposition were compared between the two groups
[TARGET] => found position in results: there was no difference in the total compliance rate of picc tip position and the incidence of the catheter malposition in the two groups (p>0.05)
[RISK] => found group in results: there was no difference in the total compliance rate of picc tip position and the incidence of the catheter malposition in the two groups (p>0.05)
[TARGET] => found position in but the optimal position compliance rate of the observation group was higher than that of the control group (p<0.05)
[RISK] => found high in but the optimal position compliance rate of the observation group was higher than that of the control group (p<0.05)
[RISK] => found group in but the optimal position compliance rate of the observation group was higher than that of the control group (p<0.05)
[TARGET] => found position in conclusions: the picc tip position at the autonomous peak of the p wave is significantly better than that at the p wave amplitude being 50-80% of the qrs main wave under the ic-ekg guidance for picc insertion
## -> Scan Factor PICC infection
[TARGET] => found infection in the complications after catheterization including arrhythmia after catheterization within 24 hours, catheter-related thrombosis, catheter dysfunction, and catheter infection within 90 days were also compared
[TARGET] => found infection in the incidence of catheter-related thrombosis, catheter dysfunction, and catheter infection within 90 days in the observation group was lower than those in the control group (p<0.05)
[RISK] => found low in the incidence of catheter-related thrombosis, catheter dysfunction, and catheter infection within 90 days in the observation group was lower than those in the control group (p<0.05)
[RISK] => found group in the incidence of catheter-related thrombosis, catheter dysfunction, and catheter infection within 90 days in the observation group was lower than those in the control group (p<0.05)
# 33836784 ---------
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in ledvt-related factors and d-dimer value were analyzed before and after picc insertion
[RISK] => found factor in ledvt-related factors and d-dimer value were analyzed before and after picc insertion
[TARGET] => found picc insertion in results: univariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 9 times and promoted the increase of d-dimer by 5 times
[RISK] => found risk in results: univariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 9 times and promoted the increase of d-dimer by 5 times
[RISK] => found increase in results: univariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 9 times and promoted the increase of d-dimer by 5 times
[TARGET] => found picc insertion in after risk adjustment, multivariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 4 times and tripled the risk of d-dimer increase
[RISK] => found risk in after risk adjustment, multivariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 4 times and tripled the risk of d-dimer increase
[RISK] => found increase in after risk adjustment, multivariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 4 times and tripled the risk of d-dimer increase
[TARGET] => found picc insertion in the concentration of d-dimer was significantly increased after picc insertion
[RISK] => found increase in the concentration of d-dimer was significantly increased after picc insertion
[TARGET] => found picc insertion in conclusions: picc insertion increases the level of d-dimer and the risk of ledvt
[RISK] => found risk in conclusions: picc insertion increases the level of d-dimer and the risk of ledvt
[RISK] => found increase in conclusions: picc insertion increases the level of d-dimer and the risk of ledvt
# 32928286 ---------
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in secondary outcomes were central line-associated bloodstream infection, local infection, occlusion, thrombosis, fracture and dislodgement, phlebitis, local or systemic allergic reaction, and picc dwell time
[RISK] => found associate in secondary outcomes were central line-associated bloodstream infection, local infection, occlusion, thrombosis, fracture and dislodgement, phlebitis, local or systemic allergic reaction, and picc dwell time
# 25295962 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found triple lumen in however, univariate analysis revealed that insertion of a 4f sl picc instead of either 5f double lumen or 6f triple lumen was associated with a reduction in picc-associated dvt (p = 0.001)
[RISK] => found associate in however, univariate analysis revealed that insertion of a 4f sl picc instead of either 5f double lumen or 6f triple lumen was associated with a reduction in picc-associated dvt (p = 0.001)
## -> Scan Factor Age
[TARGET] => found old in methods: this was a 5-year retrospective cohort study with subsequent 21-month prospective observation following implementation of a qi intervention in adults (aged 18 yr or older) with cf
[RISK] => found low in methods: this was a 5-year retrospective cohort study with subsequent 21-month prospective observation following implementation of a qi intervention in adults (aged 18 yr or older) with cf
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in picc insertions were analyzed, and nine risk factors for dvt were analyzed to formulate a qi initiative to reduce risk of picc-associated dvt
[RISK] => found risk in picc insertions were analyzed, and nine risk factors for dvt were analyzed to formulate a qi initiative to reduce risk of picc-associated dvt
[RISK] => found factor in picc insertions were analyzed, and nine risk factors for dvt were analyzed to formulate a qi initiative to reduce risk of picc-associated dvt
[RISK] => found associate in picc insertions were analyzed, and nine risk factors for dvt were analyzed to formulate a qi initiative to reduce risk of picc-associated dvt
[TARGET] => found picc insertion in zero episodes of dvt associated with 4f picc insertion prevented use of picc size in regression analysis
[RISK] => found associate in zero episodes of dvt associated with 4f picc insertion prevented use of picc size in regression analysis
## -> Scan Factor Anticoagulants therapy
# 34107707 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in methods: patients with malignant tumor treated with picc in gansu provincial cancer hospital from march 2017 to january 2020 were retrospectively investigated
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found fibrinogen in the incidence of infection and the differences in saa, pct, crp, prothrombin time (pt), activated partial thromboplastin time (aptt), thrombin time (tt), fibrinogen (fig), interleukin-18 (il-18), and interleukin-16 (il-6) between the infected group and noninfected group were observed
[RISK] => found group in the incidence of infection and the differences in saa, pct, crp, prothrombin time (pt), activated partial thromboplastin time (aptt), thrombin time (tt), fibrinogen (fig), interleukin-18 (il-18), and interleukin-16 (il-6) between the infected group and noninfected group were observed
## -> Scan Factor PICC infection
[TARGET] => found infection in analysis of the relationship between serum amyloid protein a, procalcitonin, c-reactive protein, and peripherally inserted central catheter infection in patients with malignant tumor
[TARGET] => found infection in background: compared with a central venous catheter, a peripherally inserted central catheter (picc) has the advantages of less trauma and a lower risk of bleeding and bloodstream infection
[RISK] => found risk in background: compared with a central venous catheter, a peripherally inserted central catheter (picc) has the advantages of less trauma and a lower risk of bleeding and bloodstream infection
[RISK] => found low in background: compared with a central venous catheter, a peripherally inserted central catheter (picc) has the advantages of less trauma and a lower risk of bleeding and bloodstream infection
[RISK] => found less in background: compared with a central venous catheter, a peripherally inserted central catheter (picc) has the advantages of less trauma and a lower risk of bleeding and bloodstream infection
[TARGET] => found infection in however, patients with tumors are commonly immunocompromised and therefore susceptible to infection during the course of picc indwelling
[TARGET] => found infection in this study aimed to investigate the relationship between serum amyloid protein a (saa), procalcitonin (pct), c-reactive protein (crp), and picc infection in patients with malignant tumor
[TARGET] => found infection in the incidence of infection and the differences in saa, pct, crp, prothrombin time (pt), activated partial thromboplastin time (aptt), thrombin time (tt), fibrinogen (fig), interleukin-18 (il-18), and interleukin-16 (il-6) between the infected group and noninfected group were observed
[RISK] => found group in the incidence of infection and the differences in saa, pct, crp, prothrombin time (pt), activated partial thromboplastin time (aptt), thrombin time (tt), fibrinogen (fig), interleukin-18 (il-18), and interleukin-16 (il-6) between the infected group and noninfected group were observed
[TARGET] => found infection in the correlations of saa, pct, and crp levels in different infection sites and infection degrees were analyzed
[RISK] => found correlation in the correlations of saa, pct, and crp levels in different infection sites and infection degrees were analyzed
[TARGET] => found infection in results: a total of 414 eligible patients were included with 93 in the infection group and 321 in the noninfection group
[RISK] => found group in results: a total of 414 eligible patients were included with 93 in the infection group and 321 in the noninfection group
[TARGET] => found infection in the overall incidence of infection was 22.4%
[TARGET] => found infection in the levels of saa, pct and crp in the infection group were significantly higher than those in the noninfection group (p<0.001)
[RISK] => found high in the levels of saa, pct and crp in the infection group were significantly higher than those in the noninfection group (p<0.001)
[RISK] => found group in the levels of saa, pct and crp in the infection group were significantly higher than those in the noninfection group (p<0.001)
[TARGET] => found infection in compared with the local infection group, the levels of saa, pct, and crp in the bloodstream infection group were significantly higher (p<0.001)
[RISK] => found high in compared with the local infection group, the levels of saa, pct, and crp in the bloodstream infection group were significantly higher (p<0.001)
[RISK] => found group in compared with the local infection group, the levels of saa, pct, and crp in the bloodstream infection group were significantly higher (p<0.001)
[TARGET] => found infection in furthermore, the levels of saa, pct, and crp were positively correlated with the degree of picc catheter infection
[RISK] => found correlate in furthermore, the levels of saa, pct, and crp were positively correlated with the degree of picc catheter infection
[RISK] => found more in furthermore, the levels of saa, pct, and crp were positively correlated with the degree of picc catheter infection
[TARGET] => found infection in conclusions: in patients with malignant tumors, picc catheter infection were associated with increased risk of bleeding and the levels of saa, pct, and crp can be used as predictive diagnostic indexes for picc catheter infection
[RISK] => found risk in conclusions: in patients with malignant tumors, picc catheter infection were associated with increased risk of bleeding and the levels of saa, pct, and crp can be used as predictive diagnostic indexes for picc catheter infection
[RISK] => found associate in conclusions: in patients with malignant tumors, picc catheter infection were associated with increased risk of bleeding and the levels of saa, pct, and crp can be used as predictive diagnostic indexes for picc catheter infection
[RISK] => found increase in conclusions: in patients with malignant tumors, picc catheter infection were associated with increased risk of bleeding and the levels of saa, pct, and crp can be used as predictive diagnostic indexes for picc catheter infection
[TARGET] => found infection in furthermore, these parameters were positively correlated with the degree of picc catheter infection
[RISK] => found correlate in furthermore, these parameters were positively correlated with the degree of picc catheter infection
[RISK] => found more in furthermore, these parameters were positively correlated with the degree of picc catheter infection
# 37070255 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in method: we conducted a retrospective observational study at a mixed intensive care unit (icu)
[TARGET] => found icu in method: we conducted a retrospective observational study at a mixed intensive care unit (icu)
[TARGET] => found icu in adult patients (⩾18 years) who were emergently admitted to the icu and underwent cvc insertion between april 2019 and march 2021 were enrolled
[TARGET] => found icu in conclusion: we found no significant differences in catheter-related complications between patients treated using ciccs and those treated using piccs after emergency icu admission
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in there was no significant intergroup difference in the overall rate of catheter-related complications (picc: 9.4% vs cicc: 3.8%; odds ratio [or]: 2.65; 95% confidence interval [ci]: 0.63-10.2, p = 0.145), and there were 7.7 and 9.0 complications per 1000 catheter days in the picc and cicc groups, respectively (hazard ratio [hr]: 0.61; 95% ci: 0.14-2.65, p = 0.513)
[RISK] => found group in there was no significant intergroup difference in the overall rate of catheter-related complications (picc: 9.4% vs cicc: 3.8%; odds ratio [or]: 2.65; 95% confidence interval [ci]: 0.63-10.2, p = 0.145), and there were 7.7 and 9.0 complications per 1000 catheter days in the picc and cicc groups, respectively (hazard ratio [hr]: 0.61; 95% ci: 0.14-2.65, p = 0.513)
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was the overall rate of catheter-related complications, including bloodstream infections, thrombosis, insertional trauma, catheter malfunction, and accidental removal
# 25501778 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in four cases of symptomatic upper extremity deep vein thrombosis (5.5%) and three cases of central line-associated bloodstream infection (4.3%, 2.72 infections per 1000 line days) were identified
[RISK] => found associate in four cases of symptomatic upper extremity deep vein thrombosis (5.5%) and three cases of central line-associated bloodstream infection (4.3%, 2.72 infections per 1000 line days) were identified
## -> Scan Factor Hospitalisation/ Medical department admission/ discharged to a skilled-nursing facility
[TARGET] => found admission to in the methodology involved is a single institution retrospective cohort review of patients who received a picc line during admission to a regional burn unit between 2008 and 2013
# 24439240 ---------
## -> Scan Factor Age
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in a comparative study of peripherally-inserted and broviac catheter complications in home parenteral nutrition patients
[TARGET] => found parenteral nutrition in background & aims: peripherally inserted central venous catheters (picc) have become increasingly popular for medium to long-term parenteral nutrition (pn) but there is limited data on the complication rates in this sub-group
[RISK] => found group in background & aims: peripherally inserted central venous catheters (picc) have become increasingly popular for medium to long-term parenteral nutrition (pn) but there is limited data on the complication rates in this sub-group
## -> Scan Factor PICC infection
[TARGET] => found infection in catheter infection rate was lower in picc (1.87 vs
[RISK] => found low in catheter infection rate was lower in picc (1.87 vs
[TARGET] => found infection in however, the broviac catheter could be associated with an increase in catheter infection
[RISK] => found associate in however, the broviac catheter could be associated with an increase in catheter infection
[RISK] => found increase in however, the broviac catheter could be associated with an increase in catheter infection
# 23876203 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in results: two hundred and sixty-seven picc were inserted in 222 patients for intravenous antibiotic therapy (68%), parenteral nutrition (13%), or chemotherapy (9%)
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found duration of picc in the median duration of picc use was 17 days (min-max: 1-140) for the 200 picc monitored until removal
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in results: two hundred and sixty-seven picc were inserted in 222 patients for intravenous antibiotic therapy (68%), parenteral nutrition (13%), or chemotherapy (9%)
## -> Scan Factor PICC infection
[TARGET] => found infection in the overall infection rate was 2.3 per 1000 catheter-days with 0.86 per 1000 catheter-days for central line-associated bloodstream infection
[RISK] => found associate in the overall infection rate was 2.3 per 1000 catheter-days with 0.86 per 1000 catheter-days for central line-associated bloodstream infection
# 25935657 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in however, there are few studies on use of piccs in patients with haematological malignancies (hm) receiving intensive chemotherapy
[TARGET] => found chemotherapy in conclusions: this study highlights the utility of a multidisciplinary approach for picc care in adults with hm receiving intensive chemotherapy
[RISK] => found high in conclusions: this study highlights the utility of a multidisciplinary approach for picc care in adults with hm receiving intensive chemotherapy
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in major late complications were obstruction in 13.6% (1.19/1000 picc days) of patients, catheter-related bloodstream infection in 6.8% (0.59/1000 picc days), and catheter-related thrombosis in 4.5% (0.39/1000 picc days)
# 28149507 ---------
## -> Scan Factor Age
[TARGET] => found  age  in occlusion and accidental withdrawal were the most common complications, with age > 65 and catheter pre-occlusive event associated with an increased likelihood of catheter occlusion
[RISK] => found associate in occlusion and accidental withdrawal were the most common complications, with age > 65 and catheter pre-occlusive event associated with an increased likelihood of catheter occlusion
[RISK] => found increase in occlusion and accidental withdrawal were the most common complications, with age > 65 and catheter pre-occlusive event associated with an increased likelihood of catheter occlusion
## -> Scan Factor PICC infection
[TARGET] => found infection in despite many advantages, picc-related complications can occur such as infection, thrombosis or mechanical complications
[TARGET] => found infection in complications included occlusion (8.9%), accidental withdrawal (8.9%), infections (6.3%) including 9 local infections (4.7%) and 3 bloodstream infections (1.6%), venous thrombosis (1.6%) and hematoma (1%)
# 30912181 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in the median dwell-time between picc insertion and its removal because of an ae was 67 days (interquartile range 28-180 days)
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in all adult inpatients and outpatients who had a picc inserted for the administration of parenteral supportive treatments (i.e., parenteral nutrition, intravenous fluids, blood products, or antibiotics) between september 2007 and december 2014 in four public italian hospitals were included
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was picc removal because of an adverse event (ae, defined as occlusion, exit-site infection, or symptomatic thrombosis)
[TARGET] => found infection in rates of picc removal because of occlusion, exit-site infection, and symptomatic thrombosis were 1.08, 0.32, and 0.23 per 1,000 picc days, respectively
# 30755503 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in can peripherally inserted central catheters be safely placed in patients with cancer receiving chemotherapy? a retrospective study of almost 400,000 catheter-days
[TARGET] => found chemotherapy in background: peripherally inserted central catheters (piccs) are central venous catheters (cvcs) that are commonly used in onco-hematologic settings for chemotherapy administration
[TARGET] => found chemotherapy in as there is insufficient evidence to recommend a specific cvc for chemotherapy administration, we aimed to ascertain picc-related adverse events (aes) and identify independent predictors of picc removal in patients with cancer receiving chemotherapy
[TARGET] => found chemotherapy in materials and methods: information on adult patients with cancer with a picc inserted for chemotherapy administration between september 2007 and december 2014 was extracted from six hospital databases
[TARGET] => found chemotherapy in conclusion: use of picc for chemotherapy administration was associated with a low all-aes rate
[RISK] => found associate in conclusion: use of picc for chemotherapy administration was associated with a low all-aes rate
[RISK] => found low in conclusion: use of picc for chemotherapy administration was associated with a low all-aes rate
[TARGET] => found chemotherapy in implications for practice: these findings provide clinicians with evidence that peripherally inserted central catheters (piccs) are safe for chemotherapy administration
[TARGET] => found chemotherapy in they also suggest that clinicians should limit the use of open systems when long chemotherapy regimens are scheduled
[TARGET] => found chemotherapy in moreover, alternatives to piccs should be considered when administering chemotherapy to young men
[RISK] => found more in moreover, alternatives to piccs should be considered when administering chemotherapy to young men
## -> Scan Factor Cancer
[TARGET] => found cancer in can peripherally inserted central catheters be safely placed in patients with cancer receiving chemotherapy? a retrospective study of almost 400,000 catheter-days
[TARGET] => found cancer in as there is insufficient evidence to recommend a specific cvc for chemotherapy administration, we aimed to ascertain picc-related adverse events (aes) and identify independent predictors of picc removal in patients with cancer receiving chemotherapy
[TARGET] => found cancer in materials and methods: information on adult patients with cancer with a picc inserted for chemotherapy administration between september 2007 and december 2014 was extracted from six hospital databases
## -> Scan Factor Gender
[TARGET] => found sex in more research is needed to explore the interaction between aes, sex, and age
[RISK] => found more in more research is needed to explore the interaction between aes, sex, and age
## -> Scan Factor Age
[TARGET] => found old in aes increased when picc was inserted at the brachial site (hazard ratio [hr], 1.37; 95% confidence interval [ci], 1.02-1.84) and with open systems (hr, 1.89; 95% ci, 1.24-2.88) and decreased in older men (hr, 0.63; 95% ci, 0.49-0.81)
[RISK] => found increase in aes increased when picc was inserted at the brachial site (hazard ratio [hr], 1.37; 95% confidence interval [ci], 1.02-1.84) and with open systems (hr, 1.89; 95% ci, 1.24-2.88) and decreased in older men (hr, 0.63; 95% ci, 0.49-0.81)
[RISK] => found decrease in aes increased when picc was inserted at the brachial site (hazard ratio [hr], 1.37; 95% confidence interval [ci], 1.02-1.84) and with open systems (hr, 1.89; 95% ci, 1.24-2.88) and decreased in older men (hr, 0.63; 95% ci, 0.49-0.81)
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was picc removal due to picc-related aes (occlusion, infection, or symptomatic thrombosis)
# 25673995 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in background: peripherally inserted central catheters (piccs) are widely used in chemotherapy, but the reported picc thrombosis incidence varies greatly, and risks of picc thrombosis are not well defined
[RISK] => found risk in background: peripherally inserted central catheters (piccs) are widely used in chemotherapy, but the reported picc thrombosis incidence varies greatly, and risks of picc thrombosis are not well defined
[TARGET] => found chemotherapy in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[RISK] => found associate in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[RISK] => found less in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation
[RISK] => found risk in peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation
[RISK] => found factor in peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation
[TARGET] => found cancer in this study was to investigate the incidence and risk factors of picc-related upper extremity vein thrombosis in cancer patients
[RISK] => found risk in this study was to investigate the incidence and risk factors of picc-related upper extremity vein thrombosis in cancer patients
[RISK] => found factor in this study was to investigate the incidence and risk factors of picc-related upper extremity vein thrombosis in cancer patients
[TARGET] => found cancer in cancer patients who were subject to picc placement were enrolled and checked by doppler ultrasound weekly for at least 1 month
[TARGET] => found cancer in results: three hundred and eleven cancer patients were enrolled in the study
## -> Scan Factor BMI
[TARGET] => found obesity in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[RISK] => found associate in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[RISK] => found less in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[TARGET] => found obesity in multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis
[RISK] => found associate in multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis
[RISK] => found less in multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis
[TARGET] => found obesity in less activity and obesity are risk factors of picc-related thrombosis
[RISK] => found risk in less activity and obesity are risk factors of picc-related thrombosis
[RISK] => found factor in less activity and obesity are risk factors of picc-related thrombosis
[RISK] => found less in less activity and obesity are risk factors of picc-related thrombosis
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in the mean time interval from picc insertion to thrombosis onset was 11.04±5.538 days
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found less activity in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[RISK] => found associate in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[RISK] => found less in the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis
[TARGET] => found less activity in multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis
[RISK] => found associate in multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis
[RISK] => found less in multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis
[TARGET] => found less activity in less activity and obesity are risk factors of picc-related thrombosis
[RISK] => found risk in less activity and obesity are risk factors of picc-related thrombosis
[RISK] => found factor in less activity and obesity are risk factors of picc-related thrombosis
[RISK] => found less in less activity and obesity are risk factors of picc-related thrombosis
# 25767338 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in "peripherally inserted central catheters: our experience from a cancer research centre"
[TARGET] => found cancer in piccs inserted in patients registered at dharamshila cancer hospital and research centre from 1st july 2012 to 30th june 2013 were studied
## -> Scan Factor PICC insertion procedure
# 23440314 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheter placement in cancer patients with profound thrombocytopaenia: a prospective analysis
[TARGET] => found cancer in we prospectively determined the frequency of haemorrhagic complications of picc placement in cancer patients with uncorrected profound thrombocytopaenia
[TARGET] => found cancer in results: one hundred and forty-three picc implantations in 101 cancer patients were prospectively included in the study: seven patients (7 %) had a solid tumour and 94 (93 %) a haematological malignancy
[TARGET] => found cancer in conclusions: in cancer patients with uncorrected profound thrombocytopaenia, the incidence of adverse events after picc implantation was low, and was limited to minor haemorrhagic adverse events
[RISK] => found low in conclusions: in cancer patients with uncorrected profound thrombocytopaenia, the incidence of adverse events after picc implantation was low, and was limited to minor haemorrhagic adverse events
[TARGET] => found cancer in key points: • picc placement has high technical success in profound thrombocytopaenic cancer patients
[RISK] => found high in key points: • picc placement has high technical success in profound thrombocytopaenic cancer patients
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in methods: profound thrombocytopaenia was defined as a platelet count <50 × 10(9)/l
[TARGET] => found platelet in among these 143 procedures in thrombocytopaenic patients, 93 (65 %) were performed with a platelet count 20-50 × 10(9)/l and 50 (35 %) had lower than 20 × 10(9)/l
[RISK] => found low in among these 143 procedures in thrombocytopaenic patients, 93 (65 %) were performed with a platelet count 20-50 × 10(9)/l and 50 (35 %) had lower than 20 × 10(9)/l
[TARGET] => found platelet in in patients with a platelet count <20 × 10(9)/l, 1/50 (2 %) had minor oozing and none had minor haematoma
[TARGET] => found platelet in • picc placement does not routinely require platelet transfusion in patients with thrombocytopaenia
[TARGET] => found platelet in • such picc placement still seems safe when the platelet count is <20 × 10 (9) /l
# 27978519 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: twenty-five als patients in the later stages of the disease underwent picc insertion followed by parenteral nutrition (pn)
[RISK] => found low in methods: twenty-five als patients in the later stages of the disease underwent picc insertion followed by parenteral nutrition (pn)
[TARGET] => found picc insertion in results: picc insertion was successful in all patients
[TARGET] => found picc insertion in conclusion: picc insertion for pn at a later stage of als, in patients for whom gastrostomy is non-feasible, appears to be a useful option compared to the central venous catheter
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in methods: twenty-five als patients in the later stages of the disease underwent picc insertion followed by parenteral nutrition (pn)
[RISK] => found low in methods: twenty-five als patients in the later stages of the disease underwent picc insertion followed by parenteral nutrition (pn)
# 29872323 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in patients and methods: this was a retrospective cohort study of npc patients with picc insertions from february 2, 2007 to december 25, 2014 in sun yat-sen university cancer centre
[TARGET] => found carcinoma in the incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma
[RISK] => found associate in the incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma
[TARGET] => found carcinoma in background: despite wide usage, peripherally inserted central catheter (picc)-related venous thromboembolism (vte) is common in nasopharyngeal carcinoma (npc) patients
## -> Scan Factor BMI
[TARGET] => found body mass index in in univariable analysis, body mass index (bmi), eastern cooperative oncology group (ecog) score, metastasis stage (m stage), and vte history were associated with symptomatic picc-vte
[RISK] => found associate in in univariable analysis, body mass index (bmi), eastern cooperative oncology group (ecog) score, metastasis stage (m stage), and vte history were associated with symptomatic picc-vte
[RISK] => found group in in univariable analysis, body mass index (bmi), eastern cooperative oncology group (ecog) score, metastasis stage (m stage), and vte history were associated with symptomatic picc-vte
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in patients and methods: this was a retrospective cohort study of npc patients with picc insertions from february 2, 2007 to december 25, 2014 in sun yat-sen university cancer centre
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found performance score in those with vte history and lower bmi and worse ecog performance score metastatic npc patients are more susceptible to symptomatic picc-related thrombosis and thus may require prophylactic anticoagulation
[RISK] => found more in those with vte history and lower bmi and worse ecog performance score metastatic npc patients are more susceptible to symptomatic picc-related thrombosis and thus may require prophylactic anticoagulation
[RISK] => found low in those with vte history and lower bmi and worse ecog performance score metastatic npc patients are more susceptible to symptomatic picc-related thrombosis and thus may require prophylactic anticoagulation
# 25664112 ---------
## -> Scan Factor BMI
[TARGET] => found body mass index in the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected
[RISK] => found risk in the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected
## -> Scan Factor Smoking
[TARGET] => found smoking in the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected
[RISK] => found risk in the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[RISK] => found risk in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[RISK] => found factor in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[RISK] => found more in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[TARGET] => found comorbiditie in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
[RISK] => found risk in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
[RISK] => found factor in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
[RISK] => found increase in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found bedridden in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[RISK] => found risk in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[RISK] => found factor in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[RISK] => found more in being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis
[TARGET] => found bedridden in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
[RISK] => found risk in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
[RISK] => found factor in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
[RISK] => found increase in being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected
[RISK] => found risk in the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected
# 27033138 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in limiting the number of lumens in peripherally inserted central catheters to improve outcomes and reduce cost: a simulation study
[TARGET] => found lumens in background the number of peripherally inserted central catheter (picc) lumens is associated with thrombotic and infectious complications
[RISK] => found associate in background the number of peripherally inserted central catheter (picc) lumens is associated with thrombotic and infectious complications
[TARGET] => found lumens in conclusion hospital policies that limit the number of picc lumens may enhance patient safety and reduce healthcare costs
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in cost savings and reduction in central line-associated bloodstream infection and deep vein thrombosis events from institution of a single-lumen picc default policy were reported
[RISK] => found associate in cost savings and reduction in central line-associated bloodstream infection and deep vein thrombosis events from institution of a single-lumen picc default policy were reported
[TARGET] => found infection in in such facilities, every 5% increase in single-lumen picc use would prevent 0.5 picc-related central line-associated bloodstream infections and 0.5 picc-related deep vein thrombosis events, while saving $23,500
[RISK] => found associate in in such facilities, every 5% increase in single-lumen picc use would prevent 0.5 picc-related central line-associated bloodstream infections and 0.5 picc-related deep vein thrombosis events, while saving $23,500
[RISK] => found increase in in such facilities, every 5% increase in single-lumen picc use would prevent 0.5 picc-related central line-associated bloodstream infections and 0.5 picc-related deep vein thrombosis events, while saving $23,500
# 29552318 ---------
# 32057552 ---------
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in control subjects were matched by type of antimicrobial, causative microorganism of the infection that was being treated and duration of treatment
# 26900912 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in to estimate cost savings, picc supplies and each occurrence of blood stream infection (bsi) and thrombotic complication was assigned a cost on the basis of the available literature
[TARGET] => found infection in blood stream infections occurred in 5.9% of patients and thrombosis in 2.7%
# 27500259 ---------
# 24246096 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in five baseline exposure factors, including primary lung cancer, metastatic lung cancer, chest radiotherapy, vigorous coughing and severe vomiting, were significant risk factors of picc spontaneous dislodgment
[RISK] => found risk in five baseline exposure factors, including primary lung cancer, metastatic lung cancer, chest radiotherapy, vigorous coughing and severe vomiting, were significant risk factors of picc spontaneous dislodgment
[RISK] => found factor in five baseline exposure factors, including primary lung cancer, metastatic lung cancer, chest radiotherapy, vigorous coughing and severe vomiting, were significant risk factors of picc spontaneous dislodgment
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in the picc insertion team, nurses, interventional radiologists and oncology doctors collected longitudinal data
# 27179394 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs
[RISK] => found associate in results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs
[RISK] => found decrease in results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs
## -> Scan Factor PICC infection
[TARGET] => found infection in a novel infection prevention approach: leveraging a mandatory electronic communication tool to decrease peripherally inserted central catheter infections, complications, and cost
[RISK] => found decrease in a novel infection prevention approach: leveraging a mandatory electronic communication tool to decrease peripherally inserted central catheter infections, complications, and cost
[TARGET] => found infection in background: peripherally inserted central catheters (piccs) removed prematurely for unconfirmed infection or thrombosis lead to subsequent reinsertions and associated complications
[RISK] => found associate in background: peripherally inserted central catheters (piccs) removed prematurely for unconfirmed infection or thrombosis lead to subsequent reinsertions and associated complications
[TARGET] => found infection in results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs
[RISK] => found associate in results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs
[RISK] => found decrease in results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs
[TARGET] => found infection in conclusion: a novel infection prevention approach leveraging a mect resulted in 0 central line-associated bloodstream infections and provider-led premature picc removals
[RISK] => found associate in conclusion: a novel infection prevention approach leveraging a mect resulted in 0 central line-associated bloodstream infections and provider-led premature picc removals
# 24954426 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in picc aes accounted for increased intensive care unit admissions, ht list inactivations, and overall cost
[RISK] => found increase in picc aes accounted for increased intensive care unit admissions, ht list inactivations, and overall cost
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found duration of picc in median duration of picc support was 63 (interquartile range [iqr] 34-131) days, and median time to first picc infection was 44 (iqr 14-76) days
## -> Scan Factor Transplantation
[TARGET] => found transplantation in are peripherally inserted central catheters associated with increased risk of adverse events in status 1b patients awaiting transplantation on continuous intravenous milrinone? 
[RISK] => found risk in are peripherally inserted central catheters associated with increased risk of adverse events in status 1b patients awaiting transplantation on continuous intravenous milrinone? 
[RISK] => found associate in are peripherally inserted central catheters associated with increased risk of adverse events in status 1b patients awaiting transplantation on continuous intravenous milrinone? 
[RISK] => found increase in are peripherally inserted central catheters associated with increased risk of adverse events in status 1b patients awaiting transplantation on continuous intravenous milrinone? 
[TARGET] => found transplantation in background: peripherally inserted central catheters (piccs) are used to deliver continuous intravenous (iv) milrinone in stage d heart failure (hf) patients awaiting heart transplantation (ht)
## -> Scan Factor PICC infection
[TARGET] => found infection in results: fifty-three picc aes occurred in 35 patients (27%), consisting of 48 infections, 4 thromboses, and 1 bleeding event
[TARGET] => found infection in median duration of picc support was 63 (interquartile range [iqr] 34-131) days, and median time to first picc infection was 44 (iqr 14-76) days
[TARGET] => found infection in among picc infections, 9% required defibrillator removal and 30% were inactivated on the ht list for a mean of 23 ± 17 days
[TARGET] => found infection in regression analysis found that a double lumen picc was associated with a shorter time to first picc infection (hazard ratio 7.59, 95% ci 1.97-29.23; p = .003)
[RISK] => found associate in regression analysis found that a double lumen picc was associated with a shorter time to first picc infection (hazard ratio 7.59, 95% ci 1.97-29.23; p = .003)
[TARGET] => found infection in median cost per picc infection was $10,704 (iqr $7,401-$26,083)
[TARGET] => found infection in conclusions: picc infections were the most frequent aes
[TARGET] => found infection in piccs with >1 lumen were associated with increased risk of infection
[RISK] => found risk in piccs with >1 lumen were associated with increased risk of infection
[RISK] => found associate in piccs with >1 lumen were associated with increased risk of infection
[RISK] => found increase in piccs with >1 lumen were associated with increased risk of infection
# 23838218 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi
[RISK] => found associate in immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi
[TARGET] => found lumens in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
[RISK] => found risk in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
[RISK] => found associate in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
[RISK] => found increase in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
## -> Scan Factor Power injectable PICC
[TARGET] => found power-injectable in immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi
[RISK] => found associate in immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi
[TARGET] => found power-injectable in power-injectable piccs were also associated with increased vt formation (p=.03)
[RISK] => found associate in power-injectable piccs were also associated with increased vt formation (p=.03)
[RISK] => found increase in power-injectable piccs were also associated with increased vt formation (p=.03)
[TARGET] => found power-injectable in power-injectable piccs were associated with increased risk of clabsi and vt formation
[RISK] => found risk in power-injectable piccs were associated with increased risk of clabsi and vt formation
[RISK] => found associate in power-injectable piccs were associated with increased risk of clabsi and vt formation
[RISK] => found increase in power-injectable piccs were associated with increased risk of clabsi and vt formation
## -> Scan Factor Immunosuppression
[TARGET] => found immunosuppression in immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi
[RISK] => found associate in immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi
[TARGET] => found immunosuppression in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
[RISK] => found risk in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
[RISK] => found associate in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
[RISK] => found increase in conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in objective: peripherally inserted central catheter (picc) tip malposition is potentially associated with complications, and postplacement adjustment of piccs is widely performed
[RISK] => found associate in objective: peripherally inserted central catheter (picc) tip malposition is potentially associated with complications, and postplacement adjustment of piccs is widely performed
## -> Scan Factor PICC infection
[TARGET] => found infection in impact of postplacement adjustment of peripherally inserted central catheters on the risk of bloodstream infection and venous thrombus formation
[RISK] => found risk in impact of postplacement adjustment of peripherally inserted central catheters on the risk of bloodstream infection and venous thrombus formation
[RISK] => found impact in impact of postplacement adjustment of peripherally inserted central catheters on the risk of bloodstream infection and venous thrombus formation
[TARGET] => found infection in we sought to characterize the association between central line-associated bloodstream infection (clabsi) or venous thrombus (vt) and picc adjustment
[RISK] => found associate in we sought to characterize the association between central line-associated bloodstream infection (clabsi) or venous thrombus (vt) and picc adjustment
# 24005884 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in comparison of peripherally inserted central venous catheters (picc) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies
[TARGET] => found chemotherapy in purpose: indwelling central venous catheters (cvcs) have been increasingly used to enable delivery of intravenous chemotherapy
[TARGET] => found chemotherapy in we aimed to compare the safety and cost of two commonly used cvcs, peripherally inserted central venous catheter (piccs) and ports, in the delivery of chemotherapy in patients with non-haematological malignancies
[TARGET] => found chemotherapy in conclusions: port devices are associated with a lower risk of complications, with no difference in cost, compared to picc lines in patients with non-haematological malignancies receiving intravenous chemotherapy
[RISK] => found risk in conclusions: port devices are associated with a lower risk of complications, with no difference in cost, compared to picc lines in patients with non-haematological malignancies receiving intravenous chemotherapy
[RISK] => found associate in conclusions: port devices are associated with a lower risk of complications, with no difference in cost, compared to picc lines in patients with non-haematological malignancies receiving intravenous chemotherapy
[RISK] => found low in conclusions: port devices are associated with a lower risk of complications, with no difference in cost, compared to picc lines in patients with non-haematological malignancies receiving intravenous chemotherapy
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in major complication rate was lower in the port arm compared to the picc arm (0.047 versus 0.193 major complications/100 catheter days, p = 0.034) with 6 versus 20 % of patients experiencing major complications, respectively
[RISK] => found low in major complication rate was lower in the port arm compared to the picc arm (0.047 versus 0.193 major complications/100 catheter days, p = 0.034) with 6 versus 20 % of patients experiencing major complications, respectively
# 32664112 ---------
## -> Scan Factor Age
# 27895356 ---------
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections
[RISK] => found risk in the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections
[RISK] => found factor in the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections
## -> Scan Factor PICC infection
[TARGET] => found infection in the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections
[RISK] => found risk in the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections
[RISK] => found factor in the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections
## -> Scan Factor Hypertension
# 31970514 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: a total of 18,292 catheter days were documented
[TARGET] => found catheter day in the overall complication rate was 4.1 per 1000 catheter days (n = 75, 14.4%)
[TARGET] => found catheter day in complications were similar between the cohort of outpatient 3.6 per 1000 catheter days and the cohort of inpatient 4.8 per 1000 catheter days (or 0.976; 95% ci [0.598; 1.619]; p = 0.924)
[TARGET] => found catheter day in severe bloodstream infections occurred at a rate of 0.60 per 1000 catheter days (n = 11, 2.1%), deep vein thrombosis at a rate of 0.82 per 1.000 catheter days (n = 15, 2.9%) and local inflammation at a rate of 1.26 per 1.000 catheter days (n = 23, 4.4%)
## -> Scan Factor PICC infection
[TARGET] => found infection in severe bloodstream infections occurred at a rate of 0.60 per 1000 catheter days (n = 11, 2.1%), deep vein thrombosis at a rate of 0.82 per 1.000 catheter days (n = 15, 2.9%) and local inflammation at a rate of 1.26 per 1.000 catheter days (n = 23, 4.4%)
[TARGET] => found infection in particular attention should be payed to early identification of picc associated bloodstream infections
[RISK] => found associate in particular attention should be payed to early identification of picc associated bloodstream infections
# 30704933 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in a frontline approach with peripherally inserted versus centrally inserted central venous catheters for remission induction chemotherapy phase of acute myeloid leukemia: a randomized comparison
[TARGET] => found chemotherapy in thereafter, all patients underwent intensive chemotherapy for hematologic remission induction
[TARGET] => found chemotherapy in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
[RISK] => found risk in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
[RISK] => found low in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
## -> Scan Factor Cancer
[TARGET] => found leukemia in a frontline approach with peripherally inserted versus centrally inserted central venous catheters for remission induction chemotherapy phase of acute myeloid leukemia: a randomized comparison
[TARGET] => found leukemia in background: the incidence of peripherally inserted central catheter (picc)-related adverse events has been uncertain in the setting of acute myeloid leukemia (aml) compared with the incidence of centrally inserted central catheter (cicc) adverse events
[TARGET] => found leukemia in conclusion: our data have confirmed that bsi and symptomatic vt are the major complications affecting frontline central intravascular device-related morbidity in the leukemia setting
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found old in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
[RISK] => found risk in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
[RISK] => found low in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary endpoint was catheter-related (cr)-bloodstream infection (bsi) and venous thrombosis (vt) rate
[TARGET] => found infection in using piccs, the reduction in bsi and symptomatic vt decreased mortality from cr infection and venous thromboembolism
[RISK] => found decrease in using piccs, the reduction in bsi and symptomatic vt decreased mortality from cr infection and venous thromboembolism
[TARGET] => found infection in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
[RISK] => found risk in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
[RISK] => found low in the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days
# 34432170 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in a model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer: a retrospective cohort study
[RISK] => found risk in a model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer: a retrospective cohort study
[TARGET] => found cancer in purpose: limited risk assessment tool to stratify the risk of picc-related thrombosis (picc-rvt) in breast cancer patients
[RISK] => found risk in purpose: limited risk assessment tool to stratify the risk of picc-related thrombosis (picc-rvt) in breast cancer patients
[TARGET] => found cancer in this study developed a model to assess the risk of picc-rvt in breast cancer patients
[RISK] => found risk in this study developed a model to assess the risk of picc-rvt in breast cancer patients
[TARGET] => found cancer in methods: we conducted a retrospective cohort study of 1284 breast cancer patients receiving picc insertion from january 1, 2015, to august 31, 2019, at a cancer specialized hospital in hunan province, china
[TARGET] => found cancer in conclusion: several disease-specific factors of breast cancer (e.g., menopause, endocrine therapy, and upper extremity lymphedema) play important roles in the development of picc-rvt
[RISK] => found factor in conclusion: several disease-specific factors of breast cancer (e.g., menopause, endocrine therapy, and upper extremity lymphedema) play important roles in the development of picc-rvt
## -> Scan Factor Gender
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: we conducted a retrospective cohort study of 1284 breast cancer patients receiving picc insertion from january 1, 2015, to august 31, 2019, at a cancer specialized hospital in hunan province, china
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
[RISK] => found high in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
[RISK] => found low in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
[RISK] => found high in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
[RISK] => found low in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
## -> Scan Factor Menopause_endocrine therapy_hormone use
[TARGET] => found menopause in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
[RISK] => found high in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
[RISK] => found low in multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy
[TARGET] => found menopause in conclusion: several disease-specific factors of breast cancer (e.g., menopause, endocrine therapy, and upper extremity lymphedema) play important roles in the development of picc-rvt
[RISK] => found factor in conclusion: several disease-specific factors of breast cancer (e.g., menopause, endocrine therapy, and upper extremity lymphedema) play important roles in the development of picc-rvt
# 27542955 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the prevalence and incidence rates of crt in our al patients were higher than predicted for a general cancer patient population
[RISK] => found high in the prevalence and incidence rates of crt in our al patients were higher than predicted for a general cancer patient population
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in the incidence rates were 1.89 and 0.52 per 1000 catheter day in the picc and cicc groups, respectively
[RISK] => found group in the incidence rates were 1.89 and 0.52 per 1000 catheter day in the picc and cicc groups, respectively
# 27020965 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in peripherally inserted central catheters (piccs) in cancer patients under chemotherapy: a prospective study on the incidence of complications and overall failures
[TARGET] => found chemotherapy in background and objectives: the increasing use of peripherally inserted central venous catheters (piccs) for chemotherapy has led to the observation of an elevated risk of complications and failures
[RISK] => found risk in background and objectives: the increasing use of peripherally inserted central venous catheters (piccs) for chemotherapy has led to the observation of an elevated risk of complications and failures
[TARGET] => found chemotherapy in methods: a prospective study was conducted at a single cancer institution on 291 picc placement for chemotherapy
[TARGET] => found chemotherapy in statistically significant risk factors were previous dvt (hr 2.95, 95%ci 1.33-6.53), reason for picc implant (hr 3.65, 95%ci 1.12-10.34) and 5-fluorouracil, oxaliplatin and bevacizumab based chemotherapy (hr 3.11, 95%ci 1.17-8.26)
[RISK] => found risk in statistically significant risk factors were previous dvt (hr 2.95, 95%ci 1.33-6.53), reason for picc implant (hr 3.65, 95%ci 1.12-10.34) and 5-fluorouracil, oxaliplatin and bevacizumab based chemotherapy (hr 3.11, 95%ci 1.17-8.26)
[RISK] => found factor in statistically significant risk factors were previous dvt (hr 2.95, 95%ci 1.33-6.53), reason for picc implant (hr 3.65, 95%ci 1.12-10.34) and 5-fluorouracil, oxaliplatin and bevacizumab based chemotherapy (hr 3.11, 95%ci 1.17-8.26)
[TARGET] => found chemotherapy in conclusions: picc is a safe venous device for chemotherapy delivery
[TARGET] => found chemotherapy in nevertheless, a 15% rate of failure has to be taken in account when planning picc insertion for chemotherapy purposes
[RISK] => found less in nevertheless, a 15% rate of failure has to be taken in account when planning picc insertion for chemotherapy purposes
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheters (piccs) in cancer patients under chemotherapy: a prospective study on the incidence of complications and overall failures
[TARGET] => found cancer in this study investigates picc failures in cancer patients
[TARGET] => found cancer in methods: a prospective study was conducted at a single cancer institution on 291 picc placement for chemotherapy
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in nevertheless, a 15% rate of failure has to be taken in account when planning picc insertion for chemotherapy purposes
[RISK] => found less in nevertheless, a 15% rate of failure has to be taken in account when planning picc insertion for chemotherapy purposes
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in reasons for failures were upper extremity deep venous thrombosis (uedvt) 12 (4.1%), central line associate bloodstream infection (clabsi) 5 (1.7%) with an infection rate of 0.95 per 1,000 catheter days, exit site infection 9 (3.1%) with a rate of 1.46 per 1,000 catheter days, catheter dislodgment 11 (3.8%), and occlusion 7 (2.4%)
[RISK] => found associate in reasons for failures were upper extremity deep venous thrombosis (uedvt) 12 (4.1%), central line associate bloodstream infection (clabsi) 5 (1.7%) with an infection rate of 0.95 per 1,000 catheter days, exit site infection 9 (3.1%) with a rate of 1.46 per 1,000 catheter days, catheter dislodgment 11 (3.8%), and occlusion 7 (2.4%)
## -> Scan Factor PICC infection
[TARGET] => found infection in reasons for failures were upper extremity deep venous thrombosis (uedvt) 12 (4.1%), central line associate bloodstream infection (clabsi) 5 (1.7%) with an infection rate of 0.95 per 1,000 catheter days, exit site infection 9 (3.1%) with a rate of 1.46 per 1,000 catheter days, catheter dislodgment 11 (3.8%), and occlusion 7 (2.4%)
[RISK] => found associate in reasons for failures were upper extremity deep venous thrombosis (uedvt) 12 (4.1%), central line associate bloodstream infection (clabsi) 5 (1.7%) with an infection rate of 0.95 per 1,000 catheter days, exit site infection 9 (3.1%) with a rate of 1.46 per 1,000 catheter days, catheter dislodgment 11 (3.8%), and occlusion 7 (2.4%)
# 35034480 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in conclusions: picc-ports are safe venous access devices that should be considered as an alternative option to traditional arm-ports and chest-ports when planning chemotherapy or other long-term intermittent intravenous treatments
## -> Scan Factor Cancer
[TARGET] => found cancer in a previous report on breast cancer patients demonstrated the safety and efficacy of these devices, with a very low failure rate
[RISK] => found low in a previous report on breast cancer patients demonstrated the safety and efficacy of these devices, with a very low failure rate
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in background: picc-ports may be defined as totally implantable central venous devices inserted in the upper limb using the current state-of-the-art techniques of picc insertion (ultrasound-guided venipuncture of deep veins of the arm, micro-puncture kits, proper location of the tip preferably by intracavitary ecg), with placement of the reservoir at the middle third of the arm
## -> Scan Factor PICC infection
[TARGET] => found infection in device failure occurred in 52 cases (1.2%), the main causes being local infection (n = 7; 0.16%) and crbsi (n = 19; 0.42%)
# 33893843 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
[RISK] => found risk in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
[RISK] => found high in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
[RISK] => found increase in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in plasminogen activator inhibitor-1 gene promoter 4g/5g polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study
[RISK] => found risk in plasminogen activator inhibitor-1 gene promoter 4g/5g polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study
[TARGET] => found cancer in purpose: this study investigated the influence of plasminogen activator inhibitor-1 (pai-1) gene polymorphisms and other contributing clinical factors on peripherally inserted central catheter-related venous thrombosis (picc-rvt) in chinese patients with lung cancer
[RISK] => found factor in purpose: this study investigated the influence of plasminogen activator inhibitor-1 (pai-1) gene polymorphisms and other contributing clinical factors on peripherally inserted central catheter-related venous thrombosis (picc-rvt) in chinese patients with lung cancer
[TARGET] => found cancer in conclusion: our finding suggested that there is no statistically significant influence of the pai-1 4g/5g gene variant on picc-rvt in chinese patients with lung cancer
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found fibrinogen in a higher fibrinogen level (or 1.194, 95% ci 1.004-1.420, p = 0.045) and a higher caprini score (or 1.698, 95% ci 1.103-2.614, p = 0.016) were statistically significant risk factors for picc-rvt
[RISK] => found risk in a higher fibrinogen level (or 1.194, 95% ci 1.004-1.420, p = 0.045) and a higher caprini score (or 1.698, 95% ci 1.103-2.614, p = 0.016) were statistically significant risk factors for picc-rvt
[RISK] => found factor in a higher fibrinogen level (or 1.194, 95% ci 1.004-1.420, p = 0.045) and a higher caprini score (or 1.698, 95% ci 1.103-2.614, p = 0.016) were statistically significant risk factors for picc-rvt
[RISK] => found high in a higher fibrinogen level (or 1.194, 95% ci 1.004-1.420, p = 0.045) and a higher caprini score (or 1.698, 95% ci 1.103-2.614, p = 0.016) were statistically significant risk factors for picc-rvt
[TARGET] => found fibrinogen in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
[RISK] => found risk in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
[RISK] => found high in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
[RISK] => found increase in however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy
# 34673343 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in after a median follow-up of 334 [130-798] days, there were no differences in the rates of local (0.22 vs 0.21; p = 0.904) or blood-stream infections (0.13 vs 0.21; p = 0.405)
[RISK] => found low in after a median follow-up of 334 [130-798] days, there were no differences in the rates of local (0.22 vs 0.21; p = 0.904) or blood-stream infections (0.13 vs 0.21; p = 0.405)
## -> Scan Factor Hypertension
[TARGET] => found hypertension in complications associated with peripherally inserted central catheters and hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids
[RISK] => found associate in complications associated with peripherally inserted central catheters and hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids
[TARGET] => found hypertension in evidence regarding the comparison between peripherally inserted central catheters (picc) or tunneled central catheters in pulmonary hypertension (ph) is scarce
# 36726149 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in efficacy and safety of rivaroxaban for the treatment of picc-related upper extremity deep vein thrombosis in cancer patients: a retrospective study
[TARGET] => found cancer in background: the optimal duration and choice of anticoagulant for the treatment of peripherally inserted central catheters (picc)-related upper extremity deep vein thrombosis (uedvt) in cancer patients are still undetermined
[TARGET] => found cancer in objectives: the aim of this study was to assess the efficacy and safety of rivaroxaban for the treatment of picc-related uedvt in cancer patients
[TARGET] => found cancer in methods: we conducted a retrospective cohort study including consecutive cancer patients for the management of acute symptomatic picc-related uedvt
[TARGET] => found cancer in conclusion: our study supported the efficacy of rivaroxaban for treating picc-related uedvt in cancer patients
[TARGET] => found cancer in considering the risk-benefit ratio, further well-designed trials are required to optimize the drug selection and duration for the treatment of picc-related uedvt in cancer patients
[RISK] => found risk in considering the risk-benefit ratio, further well-designed trials are required to optimize the drug selection and duration for the treatment of picc-related uedvt in cancer patients
## -> Scan Factor Age
[TARGET] => found  age  in results: a total of 217 patients were included in the final analysis with a median age of 56 years old, 41.5% of whom had metastases
[TARGET] => found old in results: a total of 217 patients were included in the final analysis with a median age of 56 years old, 41.5% of whom had metastases
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in background: the optimal duration and choice of anticoagulant for the treatment of peripherally inserted central catheters (picc)-related upper extremity deep vein thrombosis (uedvt) in cancer patients are still undetermined
# 24018351 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in a randomised, controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using b-mode ultrasound with modified seldinger technique versus blind puncture
[TARGET] => found chemotherapy in methods: one hundred chemotherapy patients were recruited to participate in a randomised, controlled trial in guangzhou, china
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
# 31948240 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients
[RISK] => found impact in permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients
[RISK] => found low in permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients
## -> Scan Factor Cancer
[TARGET] => found cancer in venous access in cancer patients
[TARGET] => found cancer in the most commonly used permanent venous access devices in cancer patients are the port, picc port and picc catheter (peripherally inserted central catheter)
[TARGET] => found cancer in it is always necessary to consider the type of venous access needed for each individual cancer patient
[TARGET] => found cancer in permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients
[RISK] => found impact in permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients
[RISK] => found low in permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
## -> Scan Factor PICC infection
[TARGET] => found infection in a trend towards the treatment of catheter infections is certainly to maintain the venous access without compromising the patients health
# 32572092 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in consecutive oncology cases in 341 who initially naive intended to be inserted central catheter for chemotherapy, were recruited to our dedicated intravenous lab
## -> Scan Factor Cancer
[TARGET] => found cancer in a longitudinal observational retrospective study on risk factors and predictive model of picc associated thrombosis in cancer patients
[RISK] => found risk in a longitudinal observational retrospective study on risk factors and predictive model of picc associated thrombosis in cancer patients
[RISK] => found factor in a longitudinal observational retrospective study on risk factors and predictive model of picc associated thrombosis in cancer patients
[RISK] => found associate in a longitudinal observational retrospective study on risk factors and predictive model of picc associated thrombosis in cancer patients
## -> Scan Factor Gender
[TARGET] => found sex in tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced
[RISK] => found risk in tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced
## -> Scan Factor BMI
[TARGET] => found bmi in tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced
[RISK] => found risk in tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced
## -> Scan Factor Smoking
[TARGET] => found smoking in tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced
[RISK] => found risk in tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced
## -> Scan Factor Age
# 26202391 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12])
[RISK] => found high in multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12])
[TARGET] => found chemotherapy in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found risk in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found associate in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found increase in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[TARGET] => found chemotherapy in clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections
[RISK] => found associate in clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections
## -> Scan Factor Gender
[TARGET] => found male in results: nine hundred and twenty-three piccs were placed in 644 unique patients, mostly male (68.3%) with a median age of 58 years
## -> Scan Factor Age
[TARGET] => found  age  in results: nine hundred and twenty-three piccs were placed in 644 unique patients, mostly male (68.3%) with a median age of 58 years
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in materials and methods: medical charts of every in-patient that underwent a picc insertion in our hospital between january 2010 and october 2013 were reviewed
## -> Scan Factor PICC infection
[TARGET] => found infection in peripherally inserted central catheter-related infections in a cohort of hospitalized adult patients
[TARGET] => found infection in all picc-related infections were recorded and categorized as catheter-related bloodstream infections (cr-bsi), exit-site infections, and septic thrombophlebitis
[TARGET] => found infection in 31 (3.4%) picc-related infections occurred during the study period corresponding to an infection rate of 1.64 per 1000 catheter-days
[TARGET] => found infection in we observed 27 (87.1%) cr-bsi, corresponding to a rate of 1.43 per 1000 catheter-days, 3 (9.7%) septic thrombophlebitis, and 1 (3.2%) exit-site infection
[TARGET] => found infection in multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12])
[RISK] => found high in multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12])
[TARGET] => found infection in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found risk in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found associate in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found increase in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[TARGET] => found infection in clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections
[RISK] => found associate in clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections
[TARGET] => found infection in a careful assessment of these risk factors may be important for future success in preventing picc-related infections
[RISK] => found risk in a careful assessment of these risk factors may be important for future success in preventing picc-related infections
[RISK] => found factor in a careful assessment of these risk factors may be important for future success in preventing picc-related infections
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anti-coagulant in multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12])
[RISK] => found high in multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12])
[TARGET] => found anti-coagulant in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found risk in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found associate in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[RISK] => found increase in conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections
[TARGET] => found anti-coagulant in clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections
[RISK] => found associate in clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections
# 24142565 ---------
## -> Scan Factor Age
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in eighty-six percent of hospitalists reported having placed a picc solely for venous access (vs specific indications such as long-term antibiotics or parenteral nutrition)
# 35943390 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in methods: a retrospective cohort study was designed and included adult patients with solid organ cancers who were admitted to a general medicine ward or intensive care unit and received a picc
[TARGET] => found icu in the most common indications for picc use were antibiotics (34.5%) and difficult access or blood draws (21.6%); chemotherapy was the primary indication in only 15.7% of patients
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in the most common indications for picc use were antibiotics (34.5%) and difficult access or blood draws (21.6%); chemotherapy was the primary indication in only 15.7% of patients
[TARGET] => found chemotherapy in conclusions: piccs were associated with significant complications in hospitalized patients who had solid malignancies and were often used for reasons other than chemotherapy
[RISK] => found associate in conclusions: piccs were associated with significant complications in hospitalized patients who had solid malignancies and were often used for reasons other than chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in methods: a retrospective cohort study was designed and included adult patients with solid organ cancers who were admitted to a general medicine ward or intensive care unit and received a picc
[TARGET] => found cancer in this study was performed across 50 michigan hospitals and included 3235 patients with solid tumor cancers and who had a picc
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in notably, 17.5% of patients had another central venous catheter at the time of picc insertion
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: data included 3235 hospitalized patients with solid tumors who had piccs placed for 51,047 catheter days
## -> Scan Factor PICC infection
[TARGET] => found infection in major complications were defined as central line-associated bloodstream infection, deep vein thrombosis, pulmonary embolism, and catheter occlusion
[RISK] => found associate in major complications were defined as central line-associated bloodstream infection, deep vein thrombosis, pulmonary embolism, and catheter occlusion
[TARGET] => found infection in a major picc-related complication occurred in 491 patients (15.2%); catheter occlusion was the most prevalent complication (n = 322; 10.0%) followed by deep vein thrombosis (n = 116; 3.6%), central line-associated bloodstream infection (n = 82; 2.5%), and pulmonary embolism (n = 20; 0.6%)
[RISK] => found associate in a major picc-related complication occurred in 491 patients (15.2%); catheter occlusion was the most prevalent complication (n = 322; 10.0%) followed by deep vein thrombosis (n = 116; 3.6%), central line-associated bloodstream infection (n = 82; 2.5%), and pulmonary embolism (n = 20; 0.6%)
[RISK] => found low in a major picc-related complication occurred in 491 patients (15.2%); catheter occlusion was the most prevalent complication (n = 322; 10.0%) followed by deep vein thrombosis (n = 116; 3.6%), central line-associated bloodstream infection (n = 82; 2.5%), and pulmonary embolism (n = 20; 0.6%)
[TARGET] => found infection in overall, 15.2% of patients experienced a complication, including central line-associated bloodstream infections, deep vein thrombosis, pulmonary embolism, or catheter occlusion
[RISK] => found associate in overall, 15.2% of patients experienced a complication, including central line-associated bloodstream infections, deep vein thrombosis, pulmonary embolism, or catheter occlusion
# 35763062 ---------
## -> Scan Factor Age
[TARGET] => found old in lowering platelet count threshold to 10,000/µl for peripherally inserted central catheter placement safely conserves blood products
[RISK] => found low in lowering platelet count threshold to 10,000/µl for peripherally inserted central catheter placement safely conserves blood products
[TARGET] => found old in we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events
[RISK] => found impact in we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events
[RISK] => found low in we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events
[TARGET] => found old in the study population included patients with platelet counts ≥ 10,000/µl and < 50,000/µl undergoing picc placement in 2018 and 2019 when the minimum platelet thresholds were 50,000/µl and 10,000/µl, respectively
[TARGET] => found old in thirty-five patients using the 10,000/µl (10 k) platelet threshold and 46 patients using the 50,000/µl (50 k) platelet threshold were enrolled
[TARGET] => found old in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
[RISK] => found low in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
[RISK] => found less in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in the primary outcome was blood product utilization and the secondary outcome was picc insertion-related bleeding complications
[TARGET] => found picc insertion in the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001)
[RISK] => found more in the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001)
[RISK] => found group in the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001)
[TARGET] => found picc insertion in immediately following picc insertion, minor bleeding occurred in five patients (two [4.3%] and three [8.6%] in the 50 k and 10 k groups, respectively)
[RISK] => found low in immediately following picc insertion, minor bleeding occurred in five patients (two [4.3%] and three [8.6%] in the 50 k and 10 k groups, respectively)
[RISK] => found group in immediately following picc insertion, minor bleeding occurred in five patients (two [4.3%] and three [8.6%] in the 50 k and 10 k groups, respectively)
[TARGET] => found picc insertion in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
[RISK] => found low in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
[RISK] => found less in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in lowering platelet count threshold to 10,000/µl for peripherally inserted central catheter placement safely conserves blood products
[RISK] => found low in lowering platelet count threshold to 10,000/µl for peripherally inserted central catheter placement safely conserves blood products
[TARGET] => found platelet in despite the low risk of peripherally inserted central catheter (picc) insertion-related bleeding, the practice of administering prophylactic platelets varies greatly
[RISK] => found risk in despite the low risk of peripherally inserted central catheter (picc) insertion-related bleeding, the practice of administering prophylactic platelets varies greatly
[RISK] => found low in despite the low risk of peripherally inserted central catheter (picc) insertion-related bleeding, the practice of administering prophylactic platelets varies greatly
[TARGET] => found platelet in we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events
[RISK] => found impact in we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events
[RISK] => found low in we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events
[TARGET] => found platelet in the study population included patients with platelet counts ≥ 10,000/µl and < 50,000/µl undergoing picc placement in 2018 and 2019 when the minimum platelet thresholds were 50,000/µl and 10,000/µl, respectively
[TARGET] => found platelet in thirty-five patients using the 10,000/µl (10 k) platelet threshold and 46 patients using the 50,000/µl (50 k) platelet threshold were enrolled
[TARGET] => found platelet in the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001)
[RISK] => found more in the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001)
[RISK] => found group in the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001)
[TARGET] => found platelet in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
[RISK] => found low in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
[RISK] => found less in lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding
# 27818170 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in methods: we implemented a prospective study between jan 1, 2013, and sept 12, 2015, in patients (age ≥18 years) admitted to a general medicine ward or intensive care unit who received a picc for any reason during clinical care in 47 hospitals in michigan, usa, with a maximum follow-up of 70 days
[RISK] => found low in methods: we implemented a prospective study between jan 1, 2013, and sept 12, 2015, in patients (age ≥18 years) admitted to a general medicine ward or intensive care unit who received a picc for any reason during clinical care in 47 hospitals in michigan, usa, with a maximum follow-up of 70 days
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found blood cell in association between delivery methods for red blood cell transfusion and the risk of venous thromboembolism: a longitudinal study
[RISK] => found risk in association between delivery methods for red blood cell transfusion and the risk of venous thromboembolism: a longitudinal study
[TARGET] => found blood cell in background: mechanisms of red blood cell delivery and their contribution to the incidence of venous thromboembolism are not well understood in the clinical setting
[TARGET] => found blood cell in we assessed whether red blood cell transfusion through peripherally inserted central catheters (piccs) affects the risk of venous thromboembolism compared with transfusion through non-picc devices
[RISK] => found risk in we assessed whether red blood cell transfusion through peripherally inserted central catheters (piccs) affects the risk of venous thromboembolism compared with transfusion through non-picc devices
[TARGET] => found blood cell in the exposure of interest was route of red blood cell transfusion
[TARGET] => found blood cell in of 788 patients who received a red blood cell transfusion through a multi-lumen picc, 61 had venous thromboembolism
[TARGET] => found blood cell in for every red blood cell unit transfused through a picc, there was a significantly increased risk of venous thromboembolism (adjusted hr 1·24, 95% ci 1·01-1·52; p=0·037)
[RISK] => found risk in for every red blood cell unit transfused through a picc, there was a significantly increased risk of venous thromboembolism (adjusted hr 1·24, 95% ci 1·01-1·52; p=0·037)
[RISK] => found increase in for every red blood cell unit transfused through a picc, there was a significantly increased risk of venous thromboembolism (adjusted hr 1·24, 95% ci 1·01-1·52; p=0·037)
[TARGET] => found blood cell in interpretation: red blood cell delivery through a multi-lumen picc is associated with a greater risk of thrombosis than transfusion through a peripheral intravenous catheter
[RISK] => found risk in interpretation: red blood cell delivery through a multi-lumen picc is associated with a greater risk of thrombosis than transfusion through a peripheral intravenous catheter
[RISK] => found associate in interpretation: red blood cell delivery through a multi-lumen picc is associated with a greater risk of thrombosis than transfusion through a peripheral intravenous catheter
[TARGET] => found blood cell in careful monitoring for venous thromboembolism when transfusing red blood cells through multi-lumen piccs seems necessary
# 30673943 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in patients treated with picc removal alone were more likely to have hematologic malignancy, receive chemotherapy, develop thrombocytopenia, and have brachial vein thrombosis
[RISK] => found more in patients treated with picc removal alone were more likely to have hematologic malignancy, receive chemotherapy, develop thrombocytopenia, and have brachial vein thrombosis
## -> Scan Factor Cancer
[TARGET] => found hematologic malignancy in patients treated with picc removal alone were more likely to have hematologic malignancy, receive chemotherapy, develop thrombocytopenia, and have brachial vein thrombosis
[RISK] => found more in patients treated with picc removal alone were more likely to have hematologic malignancy, receive chemotherapy, develop thrombocytopenia, and have brachial vein thrombosis
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Anticoagulants therapy
# 25697969 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found old in results: the incidence of picc-dvt varied between 2% and 75% according to study population, testing modality and threshold for diagnosis
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in centrally positioned, otherwise functional and clinically necessary piccs need not be removed despite concomitant dvt
## -> Scan Factor Anticoagulants therapy
# 36853924 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in methods: this study was carried out in the patient, emergency room, and intensive care units through the evaluation of electronic medical records
## -> Scan Factor Cancer
[TARGET] => found cancer in clinical study of complications of a peripherally inserted central catheter in cancer patients
[TARGET] => found cancer in aim: to evaluate complications after picc use in cancer patients
[TARGET] => found cancer in this study demonstrated the effectiveness of picc and that patients with haematological cancer are more prone to multiple picc passages and more mechanical complications and infections
[RISK] => found more in this study demonstrated the effectiveness of picc and that patients with haematological cancer are more prone to multiple picc passages and more mechanical complications and infections
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the most common complications were mechanical complications (61.2%), infection (38%), and thrombosis (57.1%)
[TARGET] => found infection in this study demonstrated the effectiveness of picc and that patients with haematological cancer are more prone to multiple picc passages and more mechanical complications and infections
[RISK] => found more in this study demonstrated the effectiveness of picc and that patients with haematological cancer are more prone to multiple picc passages and more mechanical complications and infections
# 33860712 ---------
## -> Scan Factor Age
[TARGET] => found old in the incidences of picc-uevt were 4.5% for d-dimer above the age-adjusted threshold and 1.5% for below the threshold (p = 0.001)
[RISK] => found low in the incidences of picc-uevt were 4.5% for d-dimer above the age-adjusted threshold and 1.5% for below the threshold (p = 0.001)
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in method: a retrospective study of adult patients with picc insertion was performed
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in validation of michigan risk score and d-dimer to predict peripherally inserted central catheter-related thrombosis: a study of 206,132 catheter days
[RISK] => found risk in validation of michigan risk score and d-dimer to predict peripherally inserted central catheter-related thrombosis: a study of 206,132 catheter days
[TARGET] => found catheter day in results: two thousand one hundred sixty-three patients were included for a total of 206,132 catheter days
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
# 26117624 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in the same vein entry site was used for placement of the ivcf followed by picc insertion
[RISK] => found low in the same vein entry site was used for placement of the ivcf followed by picc insertion
[TARGET] => found picc insertion in conclusion: simultaneous ivcf and picc insertion using the same upper extremity venous access was feasible and safe in our series
# 25997503 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in univariate and multivariate analysis demonstrated a history of transplant, and the indication of total parenteral nutrition was associated with thrombosis (p<0.001)
[RISK] => found associate in univariate and multivariate analysis demonstrated a history of transplant, and the indication of total parenteral nutrition was associated with thrombosis (p<0.001)
# 32709498 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in peripherally inserted central catheter lines for intensive care unit and onco-hematologic patients: a systematic review and meta-analysis
[TARGET] => found intensive care unit in objective: to compare central line associated bloodstream infection (clabsi) and catheter-related thrombosis rates in intensive care unit (icu) and onco-hematologic patients with picc lines and cvcs
[RISK] => found associate in objective: to compare central line associated bloodstream infection (clabsi) and catheter-related thrombosis rates in intensive care unit (icu) and onco-hematologic patients with picc lines and cvcs
## -> Scan Factor PICC infection
[TARGET] => found infection in objective: to compare central line associated bloodstream infection (clabsi) and catheter-related thrombosis rates in intensive care unit (icu) and onco-hematologic patients with picc lines and cvcs
[RISK] => found associate in objective: to compare central line associated bloodstream infection (clabsi) and catheter-related thrombosis rates in intensive care unit (icu) and onco-hematologic patients with picc lines and cvcs
# 25376324 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
# 34459038 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found dual-lumen in dual-lumen power injectable peripherally inserted central catheters in allogeneic hematopoietic stem cell transplantation: a prospective observational study
[TARGET] => found dual-lumen in aims and objectives: to explore whether dual-lumen power injectable peripherally inserted central catheters (piccs) could be effectively and safely applied in allogeneic hematopoietic stem cell transplantation (allo-hsct) and for serum cyclosporine level monitoring
[TARGET] => found dual-lumen in relevance to clinical practice: the dual-lumen power injectable piccs provided a reliable access for blood sample collection, decreasing the number of blind percutaneous venous punctures in allo-hsct
## -> Scan Factor Power injectable PICC
[TARGET] => found power injectable in dual-lumen power injectable peripherally inserted central catheters in allogeneic hematopoietic stem cell transplantation: a prospective observational study
[TARGET] => found power injectable in aims and objectives: to explore whether dual-lumen power injectable peripherally inserted central catheters (piccs) could be effectively and safely applied in allogeneic hematopoietic stem cell transplantation (allo-hsct) and for serum cyclosporine level monitoring
[TARGET] => found power injectable in methods: we prospectively evaluated the applications and complications of power injectable piccs in 52 consecutive allo-hsct recipients
[TARGET] => found power injectable in we also compared the cyclosporine levels in 188 paired blood samples, simultaneously obtained via power injectable piccs and percutaneous venous puncture, to investigate whether power injectable picc is a feasible route for cyclosporine concentration monitoring in allo-hsct
[TARGET] => found power injectable in no power injectable picc-related thrombotic adverse events were identified; 90.4% (47/52) of cases with power injectable picc removal occurred because of lack of medical utility, suggesting that power injectable picc-related complications were manageable
[TARGET] => found power injectable in conclusion: the power injectable picc is a feasible venous access device for allo-hsct
[TARGET] => found power injectable in relevance to clinical practice: the dual-lumen power injectable piccs provided a reliable access for blood sample collection, decreasing the number of blind percutaneous venous punctures in allo-hsct
## -> Scan Factor Age
## -> Scan Factor Transplantation
[TARGET] => found transplantation in dual-lumen power injectable peripherally inserted central catheters in allogeneic hematopoietic stem cell transplantation: a prospective observational study
[TARGET] => found transplantation in aims and objectives: to explore whether dual-lumen power injectable peripherally inserted central catheters (piccs) could be effectively and safely applied in allogeneic hematopoietic stem cell transplantation (allo-hsct) and for serum cyclosporine level monitoring
## -> Scan Factor PICC infection
[TARGET] => found infection in the insertion-site blood oozing and central line-associated bloodstream infection rates were 36.5% (19/52) and 26.9% (14/52), respectively, indicating the feasibility of these piccs for various applications in allo-hsct
[RISK] => found associate in the insertion-site blood oozing and central line-associated bloodstream infection rates were 36.5% (19/52) and 26.9% (14/52), respectively, indicating the feasibility of these piccs for various applications in allo-hsct
# 34343193 ---------
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
[RISK] => found associate in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
[RISK] => found high in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
[RISK] => found low in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
## -> Scan Factor PICC infection
[TARGET] => found infection in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
[RISK] => found associate in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
[RISK] => found high in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
[RISK] => found low in the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)
# 34226216 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in this pattern continued when only those with malignancy were included in the analysis, those with cancer had twice the risk of thrombosis with a cvr greater than 45%
[RISK] => found risk in this pattern continued when only those with malignancy were included in the analysis, those with cancer had twice the risk of thrombosis with a cvr greater than 45%
[TARGET] => found cancer in these results suggest that in individuals with cancer, the use of a cvr ≤45% should be considered to minimise risk of thrombosis
[RISK] => found risk in these results suggest that in individuals with cancer, the use of a cvr ≤45% should be considered to minimise risk of thrombosis
## -> Scan Factor Large catheter
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in participants: adults who had undergone picc insertion
[TARGET] => found picc insertion in results: 2438 picc insertions were included with 39 cases of thrombosis (1.6%; 95% ci 1.14% to 2.19%)
[TARGET] => found picc insertion in conclusions: adherence to cvr cut-offs are an important component of picc insertion clinical decision making to reduce the risk of thrombosis
[RISK] => found risk in conclusions: adherence to cvr cut-offs are an important component of picc insertion clinical decision making to reduce the risk of thrombosis
## -> Scan Factor PICC infection
[TARGET] => found infection in neither the 33% or 45% cvr cut-off produced statistically significant results in those with infection or other non-malignant conditions
# 31556001 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in a randomized trial of complications of peripherally and centrally inserted central lines in the neuro-intensive care unit: results of the nspvc trial
[TARGET] => found intensive care unit in objective: the objective of this study was to compare the relative number of complications from peripherally inserted central venous catheters (picc) and centrally inserted central venous catheters (cvc) in the neuroscience intensive care unit (nsicu)
[TARGET] => found icu in objective: the objective of this study was to compare the relative number of complications from peripherally inserted central venous catheters (picc) and centrally inserted central venous catheters (cvc) in the neuroscience intensive care unit (nsicu)
[TARGET] => found icu in methods: this study was carried out in a 32-bed nsicu in a large academic hospital in the usa from july 2015 until january 2017
[TARGET] => found icu in conclusions: piccs and cvcs have similar numbers of complications when placed in patients admitted to the nsicu
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was all complications as well as combined numbers of large vein thrombosis, central-line-associated blood stream infections, and insertional trauma
[RISK] => found associate in the primary outcome was all complications as well as combined numbers of large vein thrombosis, central-line-associated blood stream infections, and insertional trauma
[TARGET] => found infection in the combined number of large vein thrombosis, central-line-associated blood stream infection, and insertional trauma was 4/72 in the picc arm and 1/80 in the cvc group (or 4.6 (95% ci 0.5-42.6) p = 0.14)
[RISK] => found associate in the combined number of large vein thrombosis, central-line-associated blood stream infection, and insertional trauma was 4/72 in the picc arm and 1/80 in the cvc group (or 4.6 (95% ci 0.5-42.6) p = 0.14)
[RISK] => found group in the combined number of large vein thrombosis, central-line-associated blood stream infection, and insertional trauma was 4/72 in the picc arm and 1/80 in the cvc group (or 4.6 (95% ci 0.5-42.6) p = 0.14)
# 34137321 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in method: we have retrospectively investigated the safety and efficacy of subcutaneously anchored securement (sas) for peripherally inserted central catheters (picc) in cancer patients
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in the total number of catheter days was 93078
[TARGET] => found catheter day in in 16 patients, the picc was removed because of catheter-related bloodstream infection (crbsi): the overall incidence of crbsi was 0.17 per 1000 catheter days
## -> Scan Factor PICC infection
[TARGET] => found infection in in 16 patients, the picc was removed because of catheter-related bloodstream infection (crbsi): the overall incidence of crbsi was 0.17 per 1000 catheter days
# 36681296 ---------
# 34729630 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in reduction of perioperative venous thrombus formation by antithrombotic peripherally inserted central catheter in esophageal cancer
[TARGET] => found cancer in purpose: although a central venous catheter (cvc) is often needed perioperatively for intraoperative and nutritional management of esophageal cancer (ec), the catheter placement impacts the risk of venous thrombosis
[RISK] => found risk in purpose: although a central venous catheter (cvc) is often needed perioperatively for intraoperative and nutritional management of esophageal cancer (ec), the catheter placement impacts the risk of venous thrombosis
[RISK] => found impact in purpose: although a central venous catheter (cvc) is often needed perioperatively for intraoperative and nutritional management of esophageal cancer (ec), the catheter placement impacts the risk of venous thrombosis
## -> Scan Factor Age
## -> Scan Factor Surgery_type of surgery
# 33244268 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the influence of venous characteristics on peripherally inserted central catheter-related symptomatic venous thrombosis in cancer patients
[TARGET] => found cancer in this study aimed to identify effects of venous characteristics on symptomatic picc-related venous thrombosis in cancer patients and explore the relationship between venous characteristics and blood flow velocity
[RISK] => found low in this study aimed to identify effects of venous characteristics on symptomatic picc-related venous thrombosis in cancer patients and explore the relationship between venous characteristics and blood flow velocity
[TARGET] => found cancer in results: a total of 2933 cancer patients were enrolled in this study; of these patients, 68 experienced symptomatic venous thrombosis
## -> Scan Factor BMI
[TARGET] => found body mass index in in the bivariate analysis, body mass index (bmi), history of venous thrombosis, triglycerides, tumor category, vessel diameter, vessel depth and arm circumference were associated with thrombosis
[RISK] => found associate in in the bivariate analysis, body mass index (bmi), history of venous thrombosis, triglycerides, tumor category, vessel diameter, vessel depth and arm circumference were associated with thrombosis
## -> Scan Factor PICC insertion procedure
[TARGET] => found vein depth in a vein depth of greater than 1.07cm or less than 0.57cm was associated with a higher incidence of picc-related venous thrombosis, and the greater the arm circumference and vessel diameter, the greater the risk of venous thrombosis
[RISK] => found risk in a vein depth of greater than 1.07cm or less than 0.57cm was associated with a higher incidence of picc-related venous thrombosis, and the greater the arm circumference and vessel diameter, the greater the risk of venous thrombosis
[RISK] => found associate in a vein depth of greater than 1.07cm or less than 0.57cm was associated with a higher incidence of picc-related venous thrombosis, and the greater the arm circumference and vessel diameter, the greater the risk of venous thrombosis
[RISK] => found high in a vein depth of greater than 1.07cm or less than 0.57cm was associated with a higher incidence of picc-related venous thrombosis, and the greater the arm circumference and vessel diameter, the greater the risk of venous thrombosis
[RISK] => found less in a vein depth of greater than 1.07cm or less than 0.57cm was associated with a higher incidence of picc-related venous thrombosis, and the greater the arm circumference and vessel diameter, the greater the risk of venous thrombosis
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found triglycerides in in the bivariate analysis, body mass index (bmi), history of venous thrombosis, triglycerides, tumor category, vessel diameter, vessel depth and arm circumference were associated with thrombosis
[RISK] => found associate in in the bivariate analysis, body mass index (bmi), history of venous thrombosis, triglycerides, tumor category, vessel diameter, vessel depth and arm circumference were associated with thrombosis
## -> Scan Factor Slower blood flow velocity
[TARGET] => found blood flow velocity in this study aimed to identify effects of venous characteristics on symptomatic picc-related venous thrombosis in cancer patients and explore the relationship between venous characteristics and blood flow velocity
[RISK] => found low in this study aimed to identify effects of venous characteristics on symptomatic picc-related venous thrombosis in cancer patients and explore the relationship between venous characteristics and blood flow velocity
[TARGET] => found blood flow velocity in in october 2017, 169 patients with piccs were enrolled prospectively, and the relationships between blood flow velocity and venous characteristics were recorded and analyzed
[RISK] => found low in in october 2017, 169 patients with piccs were enrolled prospectively, and the relationships between blood flow velocity and venous characteristics were recorded and analyzed
[TARGET] => found blood flow velocity in blood flow velocity was positively correlated with vessel depth and arm circumference but not with vessel diameter
[RISK] => found correlate in blood flow velocity was positively correlated with vessel depth and arm circumference but not with vessel diameter
[RISK] => found low in blood flow velocity was positively correlated with vessel depth and arm circumference but not with vessel diameter
# 33157980 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in relationship between abo blood group and risk of venous thrombosis in cancer patients with peripherally inserted central catheters: a protocol for systematic review and meta-analysis
[RISK] => found risk in relationship between abo blood group and risk of venous thrombosis in cancer patients with peripherally inserted central catheters: a protocol for systematic review and meta-analysis
[RISK] => found group in relationship between abo blood group and risk of venous thrombosis in cancer patients with peripherally inserted central catheters: a protocol for systematic review and meta-analysis
[TARGET] => found cancer in in order to provide basis for individual prevention and accurate treatment of vte, the purpose of this study was to explore the relationship between abo blood group and the risk of vte in cancer patients associated with picc through meta-analysis
[RISK] => found risk in in order to provide basis for individual prevention and accurate treatment of vte, the purpose of this study was to explore the relationship between abo blood group and the risk of vte in cancer patients associated with picc through meta-analysis
[RISK] => found associate in in order to provide basis for individual prevention and accurate treatment of vte, the purpose of this study was to explore the relationship between abo blood group and the risk of vte in cancer patients associated with picc through meta-analysis
[RISK] => found group in in order to provide basis for individual prevention and accurate treatment of vte, the purpose of this study was to explore the relationship between abo blood group and the risk of vte in cancer patients associated with picc through meta-analysis
[TARGET] => found cancer in methods: electronic databases, including embase, cochrane library, pubmed, chinese databases sinomed, chinese national knowledge infrastructure (cnki), chinese scientific journals database (vip), and wanfang data, were searched for case-control studies of abo blood group and picc-related vte in cancer patients
[RISK] => found group in methods: electronic databases, including embase, cochrane library, pubmed, chinese databases sinomed, chinese national knowledge infrastructure (cnki), chinese scientific journals database (vip), and wanfang data, were searched for case-control studies of abo blood group and picc-related vte in cancer patients
[TARGET] => found cancer in conclusion: this study provided evidence to support the relationship between abo blood group and the risk of picc-related vte in cancer patients
[RISK] => found risk in conclusion: this study provided evidence to support the relationship between abo blood group and the risk of picc-related vte in cancer patients
[RISK] => found group in conclusion: this study provided evidence to support the relationship between abo blood group and the risk of picc-related vte in cancer patients
## -> Scan Factor Age
# 32880203 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in association between abo blood group and venous thrombosis related to the peripherally inserted central catheters in cancer patients
[RISK] => found group in association between abo blood group and venous thrombosis related to the peripherally inserted central catheters in cancer patients
[TARGET] => found cancer in objective: to evaluate the potential relation between the abo blood group and the risk of venous thrombosis in cancer patients with peripherally inserted central catheters (piccs)
[RISK] => found risk in objective: to evaluate the potential relation between the abo blood group and the risk of venous thrombosis in cancer patients with peripherally inserted central catheters (piccs)
[RISK] => found group in objective: to evaluate the potential relation between the abo blood group and the risk of venous thrombosis in cancer patients with peripherally inserted central catheters (piccs)
[TARGET] => found cancer in methods: the patients who underwent picc catheterization in beijing cancer hospital from january 2018 to october 2019 were retrospectively analyzed
## -> Scan Factor Non-O blood type_ group B
[TARGET] => found blood type in the incidence of symptomatic thrombosis was lower in patients with blood type o when compared with that in patients with blood types other than o
[RISK] => found low in the incidence of symptomatic thrombosis was lower in patients with blood type o when compared with that in patients with blood types other than o
[TARGET] => found blood type in after multivariable adjustment, insertion attempts and the non-o blood type were observed to remain associated with thrombosis
[RISK] => found associate in after multivariable adjustment, insertion attempts and the non-o blood type were observed to remain associated with thrombosis
[TARGET] => found blood type in conclusion: the risk of picc-related thrombosis in patients with non-o blood type is significantly higher than that in patients with blood type o
[RISK] => found risk in conclusion: the risk of picc-related thrombosis in patients with non-o blood type is significantly higher than that in patients with blood type o
[RISK] => found high in conclusion: the risk of picc-related thrombosis in patients with non-o blood type is significantly higher than that in patients with blood type o
# 26025158 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in objective: to assess the safety of peripherally inserted central venous catheter (picc) placement in patients with altered and uncorrected coagulation parameters or receiving antiplatelet therapy
[TARGET] => found platelet in materials and methods: medical charts of all patients with major primary and secondary hemostasis disorders, combined hemostasis disorders or on antiplatelet therapy and who had undergone non-tunneled picc placement from december 2009 to december 2013, were retrospectively reviewed
[TARGET] => found platelet in a hemostatic disorder was defined as a platelet count (pc)≤50×10(9)/l, an international normalized ratio (inr) ≥ 2, or an activated partial thromboplastin time (aptt)≥66s, alone or in combination
[TARGET] => found platelet in underlying hemostasis disorders were not corrected and antiplatelet therapy was not interrupted before picc placement in any patient
[TARGET] => found platelet in eighty-nine (23%) piccs were placed in patients who were receiving antiplatelet therapy (aspirin, clopidogrel, rivaroxaban)
[TARGET] => found platelet in conclusion: in patients with severe primary and secondary hemostasis disorders, combined hemostasis disorders or on antiplatelet therapy, picc placement is a feasible and safe procedure and does not require correction of coagulation parameters or discontinuation of antiplatelet therapy
# 30560363 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
[RISK] => found risk in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
[RISK] => found factor in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
[RISK] => found correlation in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
## -> Scan Factor Gender
[TARGET] => found gender in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
[RISK] => found risk in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
[RISK] => found factor in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
[RISK] => found correlation in other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi
## -> Scan Factor Age
[TARGET] => found  age  in we compared 302 of 327 consecutive recipients (mean age [± sd], 68.0 ± 15.9 years; men, 134; women, 168) of tunneled piccs (october 2017 to may 2018) with 309 of 328 consecutive recipients (mean age, 68.7 ± 14.6 years; men, 142; women, 167) of conventional piccs (april 2016 to september 2017)
## -> Scan Factor PICC infection
[TARGET] => found infection in objective: to evaluate the impact of subcutaneous tunneling on peripherally inserted central catheter (picc) placement in terms of central line-associated bloodstream infections (clabsis)
[RISK] => found impact in objective: to evaluate the impact of subcutaneous tunneling on peripherally inserted central catheter (picc) placement in terms of central line-associated bloodstream infections (clabsis)
[RISK] => found associate in objective: to evaluate the impact of subcutaneous tunneling on peripherally inserted central catheter (picc) placement in terms of central line-associated bloodstream infections (clabsis)
[TARGET] => found infection in in each group, procedure times and rates of complications, including clabsi, entry-site infection, dislocation, thrombophlebitis, and occlusion, were examined
[RISK] => found group in in each group, procedure times and rates of complications, including clabsi, entry-site infection, dislocation, thrombophlebitis, and occlusion, were examined
[TARGET] => found infection in key points: • subcutaneous tunnels created to place peripherally inserted central catheters significantly reduced catheter-associated bloodstream infections
[RISK] => found associate in key points: • subcutaneous tunnels created to place peripherally inserted central catheters significantly reduced catheter-associated bloodstream infections
# 24137199 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in three cancer patients aged 30-50 years old, two females and one male, were subjected to chemotherapy
[TARGET] => found chemotherapy in on the first day of chemotherapy, a picc was inserted into the right basilic vein with its tip in the superior vena cava
[TARGET] => found chemotherapy in on the third day of chemotherapy, pain, swelling and skin flushing started
[TARGET] => found chemotherapy in on days 20-28 of chemotherapy, the thrombus in the axillary and brachial veins disappeared in the three patients
## -> Scan Factor Cancer
[TARGET] => found cancer in the complete recanalization of picc-related venous thrombosis in cancer patients: a series of case reports
[TARGET] => found cancer in in this study, cancer patients with venous thrombosis associated with the use of peripherally inserted central catheters (piccs) underwent complete recanalization by the administration of panax notoginseng saponins (pns), which vary from heparin or urokinase in that they do not have the same risks associated with thrombolysis, including bleeding
[RISK] => found risk in in this study, cancer patients with venous thrombosis associated with the use of peripherally inserted central catheters (piccs) underwent complete recanalization by the administration of panax notoginseng saponins (pns), which vary from heparin or urokinase in that they do not have the same risks associated with thrombolysis, including bleeding
[RISK] => found associate in in this study, cancer patients with venous thrombosis associated with the use of peripherally inserted central catheters (piccs) underwent complete recanalization by the administration of panax notoginseng saponins (pns), which vary from heparin or urokinase in that they do not have the same risks associated with thrombolysis, including bleeding
[TARGET] => found cancer in to the best of our knowledge, this is the first study concerning the treatment of cancers with pns to be reported in the literature
[TARGET] => found cancer in three cancer patients aged 30-50 years old, two females and one male, were subjected to chemotherapy
[TARGET] => found cancer in the results suggest that pns are a feasible and effective treatment option for many types of cancer, but have a broader clinical impact on cancer patients with picc-related venous thrombosis
[RISK] => found impact in the results suggest that pns are a feasible and effective treatment option for many types of cancer, but have a broader clinical impact on cancer patients with picc-related venous thrombosis
[TARGET] => found cancer in therefore, this study is an original case report of particular interest to cancer patients with picc-related venous thrombosis
## -> Scan Factor Gender
[TARGET] => found male in three cancer patients aged 30-50 years old, two females and one male, were subjected to chemotherapy
[TARGET] => found female in three cancer patients aged 30-50 years old, two females and one male, were subjected to chemotherapy
## -> Scan Factor Age
[TARGET] => found old in three cancer patients aged 30-50 years old, two females and one male, were subjected to chemotherapy
# 29974358 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review
[TARGET] => found chemotherapy in importance: systemic chemotherapy can be administered either through a peripheral vein (iv), or centrally through peripherally inserted central catheter (picc), totally implanted vascular access devices (ports) or tunnelled cuffed catheters
[TARGET] => found chemotherapy in despite the widespread use of systemic chemotherapy in patients with breast cancer, the optimal choice of vascular access is unknown
[TARGET] => found chemotherapy in objective: this systematic review evaluated complication rates and patient satisfaction with different access strategies for administering neo/adjuvant chemotherapy for breast cancer
## -> Scan Factor Cancer
[TARGET] => found cancer in optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review
[TARGET] => found cancer in despite the widespread use of systemic chemotherapy in patients with breast cancer, the optimal choice of vascular access is unknown
[TARGET] => found cancer in objective: this systematic review evaluated complication rates and patient satisfaction with different access strategies for administering neo/adjuvant chemotherapy for breast cancer
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in median complication rates were infection: 6.0% picc (2 studies) versus 2.1% port (8 studies); thrombosis: 8.9% picc (2 studies) versus 2.6% port (9 studies); extravasation: 0 picc (1 study) versus 0.4% port (4 studies) and mechanical issues: picc 3.8% (1 study) versus 1.8% port (9 studies)
# 34096375 ---------
## -> Scan Factor Gender
[TARGET] => found gender in the data collected includes gender, egfr value at the date of insertion, accessed vein and side, ongoing or subsequent dialysis within 1 year, and death within 1 year of the insertion date
[TARGET] => found male in material and methods: a retrospective study of 2825 adult patients (male 51.2%, female 48.8%) who had a picc insertion from january 2017 to december 2019
[TARGET] => found female in material and methods: a retrospective study of 2825 adult patients (male 51.2%, female 48.8%) who had a picc insertion from january 2017 to december 2019
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in material and methods: a retrospective study of 2825 adult patients (male 51.2%, female 48.8%) who had a picc insertion from january 2017 to december 2019
[TARGET] => found picc insertion in result: picc insertion was done in patients with egfr⩽45 ml/min/1.73 m(2) in 26.7% (724/2709) of the sample
[TARGET] => found picc insertion in the overall death rate for the year post picc insertion was 38.7% (1094/2825), which was significantly higher in low egfr patients (413/724, 57%) compared to patients with egfr>45 ml/min/1.73 m(2) (632/1985, 31.8%) (p-value < 0.0001, odds ratio 2.84 (95% confidence interval 2.38-3.38))
[RISK] => found high in the overall death rate for the year post picc insertion was 38.7% (1094/2825), which was significantly higher in low egfr patients (413/724, 57%) compared to patients with egfr>45 ml/min/1.73 m(2) (632/1985, 31.8%) (p-value < 0.0001, odds ratio 2.84 (95% confidence interval 2.38-3.38))
[RISK] => found low in the overall death rate for the year post picc insertion was 38.7% (1094/2825), which was significantly higher in low egfr patients (413/724, 57%) compared to patients with egfr>45 ml/min/1.73 m(2) (632/1985, 31.8%) (p-value < 0.0001, odds ratio 2.84 (95% confidence interval 2.38-3.38))
[TARGET] => found picc insertion in the rate of dialysis initiated in the year post picc insertion was 5.9% (98/1657)
[TARGET] => found picc insertion in conclusion: picc insertion in patients with ckd is practiced frequently
# 31764785 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant)
[RISK] => found low in peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant)
[RISK] => found group in peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant)
[TARGET] => found chemotherapy in there were significant differences in the rivaroxaban group and the lmwh group compared to the control group (p = .010 and p = .009, respectively), but no significant difference was observed between the rivaroxaban group and the lmwh group (p = .743).anticoagulants such as rivaroxaban and lmwh may reduce the incidence of picc-related uevt in patients receiving chemotherapy
[RISK] => found group in there were significant differences in the rivaroxaban group and the lmwh group compared to the control group (p = .010 and p = .009, respectively), but no significant difference was observed between the rivaroxaban group and the lmwh group (p = .743).anticoagulants such as rivaroxaban and lmwh may reduce the incidence of picc-related uevt in patients receiving chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in the anticoagulants rivaroxaban and low molecular weight heparin prevent picc-related upper extremity venous thrombosis in cancer patients
[RISK] => found low in the anticoagulants rivaroxaban and low molecular weight heparin prevent picc-related upper extremity venous thrombosis in cancer patients
[TARGET] => found cancer in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found associate in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found low in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
## -> Scan Factor Gender
[TARGET] => found sex in uevt incidence and other complications during picc use were observed and recorded.the rivaroxaban, lmwh, and control groups included 138 (79 males; 54.9 ± 11.0 years), 144 (76 males; 56.0 ± 10.9 years), and 141 (71 males; 53.3 ± 10.9 years) patients, (p = .402 and p = .623 for age and sex respectively)
[RISK] => found group in uevt incidence and other complications during picc use were observed and recorded.the rivaroxaban, lmwh, and control groups included 138 (79 males; 54.9 ± 11.0 years), 144 (76 males; 56.0 ± 10.9 years), and 141 (71 males; 53.3 ± 10.9 years) patients, (p = .402 and p = .623 for age and sex respectively)
## -> Scan Factor BMI
[TARGET] => found body mass index in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found associate in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found low in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
## -> Scan Factor Smoking
[TARGET] => found smoking in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found associate in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found low in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
## -> Scan Factor Age
[TARGET] => found  age  in uevt incidence and other complications during picc use were observed and recorded.the rivaroxaban, lmwh, and control groups included 138 (79 males; 54.9 ± 11.0 years), 144 (76 males; 56.0 ± 10.9 years), and 141 (71 males; 53.3 ± 10.9 years) patients, (p = .402 and p = .623 for age and sex respectively)
[RISK] => found group in uevt incidence and other complications during picc use were observed and recorded.the rivaroxaban, lmwh, and control groups included 138 (79 males; 54.9 ± 11.0 years), 144 (76 males; 56.0 ± 10.9 years), and 141 (71 males; 53.3 ± 10.9 years) patients, (p = .402 and p = .623 for age and sex respectively)
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found associate in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
[RISK] => found low in there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in the anticoagulants rivaroxaban and low molecular weight heparin prevent picc-related upper extremity venous thrombosis in cancer patients
[RISK] => found low in the anticoagulants rivaroxaban and low molecular weight heparin prevent picc-related upper extremity venous thrombosis in cancer patients
[TARGET] => found anticoagulant in peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant)
[RISK] => found low in peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant)
[RISK] => found group in peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant)
[TARGET] => found anticoagulant in there were significant differences in the rivaroxaban group and the lmwh group compared to the control group (p = .010 and p = .009, respectively), but no significant difference was observed between the rivaroxaban group and the lmwh group (p = .743).anticoagulants such as rivaroxaban and lmwh may reduce the incidence of picc-related uevt in patients receiving chemotherapy
[RISK] => found group in there were significant differences in the rivaroxaban group and the lmwh group compared to the control group (p = .010 and p = .009, respectively), but no significant difference was observed between the rivaroxaban group and the lmwh group (p = .743).anticoagulants such as rivaroxaban and lmwh may reduce the incidence of picc-related uevt in patients receiving chemotherapy
# 35287828 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the role of body mass index in the development of thromboembolic events among cancer patients with piccs: a systematic review
[TARGET] => found cancer in the aim of this systematic review is to analyze the available scientific literature in order to determine whether bmi could represent a risk factor in the development of thromboembolic event among cancer patients with piccs
[RISK] => found risk in the aim of this systematic review is to analyze the available scientific literature in order to determine whether bmi could represent a risk factor in the development of thromboembolic event among cancer patients with piccs
[RISK] => found factor in the aim of this systematic review is to analyze the available scientific literature in order to determine whether bmi could represent a risk factor in the development of thromboembolic event among cancer patients with piccs
[TARGET] => found cancer in the primary endpoint was the relative risk (rr) of picc-related thrombosis of overweight/obese vs normal weight/underweight (i.e., bmi ≥25 vs <25 kg/m(2)) in cancer patients
[RISK] => found risk in the primary endpoint was the relative risk (rr) of picc-related thrombosis of overweight/obese vs normal weight/underweight (i.e., bmi ≥25 vs <25 kg/m(2)) in cancer patients
[TARGET] => found cancer in underweight condition could also play a role in thrombosis development, especially in nasopharyngeal and digestive system cancer
## -> Scan Factor BMI
[TARGET] => found body mass index in the role of body mass index in the development of thromboembolic events among cancer patients with piccs: a systematic review
[TARGET] => found body mass index in among the identification of independent risk factors, the role of body mass index (bmi) ≥25 kg/m(2) is now emerging in literature with conflicting results
[RISK] => found risk in among the identification of independent risk factors, the role of body mass index (bmi) ≥25 kg/m(2) is now emerging in literature with conflicting results
[RISK] => found factor in among the identification of independent risk factors, the role of body mass index (bmi) ≥25 kg/m(2) is now emerging in literature with conflicting results
## -> Scan Factor Age
[TARGET] => found old in conclusion: this review showed a two-fold risk of thrombosis in overweight/obese compared to normal weight/underweight oncological patients with piccs
[RISK] => found risk in conclusion: this review showed a two-fold risk of thrombosis in overweight/obese compared to normal weight/underweight oncological patients with piccs
# 28218366 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days
[TARGET] => found cancer in purpose: to evaluate incidence and risk factors of peripherally inserted central catheter (picc)-related complications in cancer patients
[RISK] => found risk in purpose: to evaluate incidence and risk factors of peripherally inserted central catheter (picc)-related complications in cancer patients
[RISK] => found factor in purpose: to evaluate incidence and risk factors of peripherally inserted central catheter (picc)-related complications in cancer patients
[TARGET] => found cancer in methods: a prospective, multicenter, cohort study of cancer patients with picc insertion was performed from february 1, 2013 to april 24, 2014
[TARGET] => found cancer in results: there were 477 cancer patients included, for a total of 50,841 catheter-days
[TARGET] => found cancer in conclusions: cancer patients with bmi greater than 25 were more likely to have picc complications
[RISK] => found more in conclusions: cancer patients with bmi greater than 25 were more likely to have picc complications
## -> Scan Factor Gender
## -> Scan Factor BMI
[TARGET] => found body mass index in in multivariable analysis, body mass index (bmi) >25 (odds ratio, 2.09; 95% confidence interval, 1.26-3.47, p = 0.004) was shown to be a significant risk factor for picc complications
[RISK] => found risk in in multivariable analysis, body mass index (bmi) >25 (odds ratio, 2.09; 95% confidence interval, 1.26-3.47, p = 0.004) was shown to be a significant risk factor for picc complications
[RISK] => found factor in in multivariable analysis, body mass index (bmi) >25 (odds ratio, 2.09; 95% confidence interval, 1.26-3.47, p = 0.004) was shown to be a significant risk factor for picc complications
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: a prospective, multicenter, cohort study of cancer patients with picc insertion was performed from february 1, 2013 to april 24, 2014
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days
[TARGET] => found catheter day in eighty-one patients (17.0%) developed picc-related complications, with an incidence of 1.59 per 1000 catheter days
[TARGET] => found catheter day in nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (uedvt) and central line associated bloodstream infection (clabsi) was shown in six (1.3%) piccs with an infection rate 0.12 per 1000 catheter days
[RISK] => found associate in nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (uedvt) and central line associated bloodstream infection (clabsi) was shown in six (1.3%) piccs with an infection rate 0.12 per 1000 catheter days
## -> Scan Factor PICC infection
[TARGET] => found infection in nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (uedvt) and central line associated bloodstream infection (clabsi) was shown in six (1.3%) piccs with an infection rate 0.12 per 1000 catheter days
[RISK] => found associate in nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (uedvt) and central line associated bloodstream infection (clabsi) was shown in six (1.3%) piccs with an infection rate 0.12 per 1000 catheter days
# 35645580 ---------
## -> Scan Factor Diabete
[TARGET] => found diabetes in in univariate and multivariate analyses, diabetes mellitus was associated with catheter-related infection
[RISK] => found associate in in univariate and multivariate analyses, diabetes mellitus was associated with catheter-related infection
[TARGET] => found diabetes in in univariate and multivariate analyses, diabetes mellitus and fluoroscopy-guided insertion were associated with favorable catheter survival
[RISK] => found associate in in univariate and multivariate analyses, diabetes mellitus and fluoroscopy-guided insertion were associated with favorable catheter survival
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in conclusion: the results of our study showed high success and low complication rates for picc insertion by nephrologists
[RISK] => found high in conclusion: the results of our study showed high success and low complication rates for picc insertion by nephrologists
[RISK] => found low in conclusion: the results of our study showed high success and low complication rates for picc insertion by nephrologists
## -> Scan Factor PICC infection
[TARGET] => found infection in the reasons for catheter removal were classified as accidental removal; treatment termination; catheter occlusion; vessel thrombosis; catheter-related infection, or patient death
[TARGET] => found infection in overall catheter complications were defined as catheter occlusion, vessel thrombosis, or catheter-related infection
[TARGET] => found infection in in univariate and multivariate analyses, diabetes mellitus was associated with catheter-related infection
[RISK] => found associate in in univariate and multivariate analyses, diabetes mellitus was associated with catheter-related infection
# 28978332 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in methods: this single-centre pilot rct included 124 admitted medical/surgical/cancer patients aged ≥ 16 years with a picc
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was picc failure, a composite of picc removal for local infection, catheter-associated bloodstream infection, dislodgement, occlusion, and/or catheter fracture
[RISK] => found associate in the primary outcome was picc failure, a composite of picc removal for local infection, catheter-associated bloodstream infection, dislodgement, occlusion, and/or catheter fracture
# 26312402 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in measurements: information on indication for picc use, device characteristics (e.g., lumens, gauge), and participant data (comorbidities, medications) were obtained from medical records
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in measurements: information on indication for picc use, device characteristics (e.g., lumens, gauge), and participant data (comorbidities, medications) were obtained from medical records
## -> Scan Factor PICC infection
[TARGET] => found infection in major (central line-associated bloodstream infection, venous thromboembolism, catheter dislodgement) and minor (migration, dressing disruption, lumen occlusion, exit site infection) complications and process measures (flushing of picc, assessment of necessity) were recorded
[RISK] => found associate in major (central line-associated bloodstream infection, venous thromboembolism, catheter dislodgement) and minor (migration, dressing disruption, lumen occlusion, exit site infection) complications and process measures (flushing of picc, assessment of necessity) were recorded
# 26842716 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
# 28936124 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in statistically significant risk factors for developing prdvt in multivariate analysis included more than one attempt for insertion (or 2.61, 95%ci: 1.12-6.05) and the use of fluoropyrimidine containing chemotherapy (or 4.27, 95%ci 1.3-14.07)
[RISK] => found risk in statistically significant risk factors for developing prdvt in multivariate analysis included more than one attempt for insertion (or 2.61, 95%ci: 1.12-6.05) and the use of fluoropyrimidine containing chemotherapy (or 4.27, 95%ci 1.3-14.07)
[RISK] => found factor in statistically significant risk factors for developing prdvt in multivariate analysis included more than one attempt for insertion (or 2.61, 95%ci: 1.12-6.05) and the use of fluoropyrimidine containing chemotherapy (or 4.27, 95%ci 1.3-14.07)
[RISK] => found more in statistically significant risk factors for developing prdvt in multivariate analysis included more than one attempt for insertion (or 2.61, 95%ci: 1.12-6.05) and the use of fluoropyrimidine containing chemotherapy (or 4.27, 95%ci 1.3-14.07)
[TARGET] => found chemotherapy in when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis
[RISK] => found risk in when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis
[RISK] => found factor in when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis
[TARGET] => found chemotherapy in fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte
[RISK] => found associate in fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte
[RISK] => found more in fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte
## -> Scan Factor Cancer
[TARGET] => found cancer in the risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients
[RISK] => found risk in the risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients
[RISK] => found associate in the risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients
[TARGET] => found cancer in piccs are increasingly utilised in the management of cancer patients, a group which carries both additional risks for vascular thromboembolism as well as for complex morbidity
[RISK] => found risk in piccs are increasingly utilised in the management of cancer patients, a group which carries both additional risks for vascular thromboembolism as well as for complex morbidity
[RISK] => found group in piccs are increasingly utilised in the management of cancer patients, a group which carries both additional risks for vascular thromboembolism as well as for complex morbidity
[TARGET] => found cancer in we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors
[RISK] => found risk in we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors
[RISK] => found factor in we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors
[TARGET] => found cancer in conclusions: this is a large study of vte following picc insertion in cancer patients which also looks at the rate of distant vte
[RISK] => found low in conclusions: this is a large study of vte following picc insertion in cancer patients which also looks at the rate of distant vte
## -> Scan Factor Gender
[TARGET] => found gender in male gender was the only significant risk factor for distant vte
[RISK] => found risk in male gender was the only significant risk factor for distant vte
[RISK] => found factor in male gender was the only significant risk factor for distant vte
[TARGET] => found gender in when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis
[RISK] => found risk in when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis
[RISK] => found factor in when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors
[RISK] => found risk in we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors
[RISK] => found factor in we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors
[TARGET] => found picc insertion in methods: in this clinical audit, the records of patients referred for picc insertion in our centre in the period between 1/1/2011 and 1/4/2014 were retrospectively reviewed
[TARGET] => found picc insertion in the kaplan meier method was used to study time from picc insertion to prdvt/vte
[TARGET] => found picc insertion in conclusions: this is a large study of vte following picc insertion in cancer patients which also looks at the rate of distant vte
[RISK] => found low in conclusions: this is a large study of vte following picc insertion in cancer patients which also looks at the rate of distant vte
[TARGET] => found picc insertion in fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte
[RISK] => found associate in fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte
[RISK] => found more in fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte
# 30594171 ---------
## -> Scan Factor Cancer
[TARGET] => found carcinoma in symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis
[RISK] => found associate in symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis
[TARGET] => found carcinoma in background: despite increasing use, symptomatic venous thromboembolism (vte) associated with peripherally inserted central catheter (picc) is a common complication in nonmetastatic nasopharyngeal carcinoma (npc) patients
[RISK] => found associate in background: despite increasing use, symptomatic venous thromboembolism (vte) associated with peripherally inserted central catheter (picc) is a common complication in nonmetastatic nasopharyngeal carcinoma (npc) patients
## -> Scan Factor Gender
[TARGET] => found gender in methods: a total of 3012 nonmetastatic npc patients were enrolled in this retrospective study, and we applied cox regression and log-rank tests to assess the association between picc-vte and survival using the propensity score method (psm) to adjust for gender, age, radiotherapy technique, tumor stage, node stage, uicc clinical stage and pre-treatment ebv dna
## -> Scan Factor Age
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in subgroup analyses indicated that no significant survival difference was found between picc-related superficial venous thrombosis and deep vein thrombosis, nor did different anticoagulant treatment methods
[RISK] => found group in subgroup analyses indicated that no significant survival difference was found between picc-related superficial venous thrombosis and deep vein thrombosis, nor did different anticoagulant treatment methods
# 31721153 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in both peripherally inserted central catheters (picc) and totally implanted chest ports (port) are commonly used for the delivery of chemotherapy
[TARGET] => found chemotherapy in our findings are relevant to anaesthetists, oncologists and vascular access clinicians and should be considered when choosing vascular access device prior to chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in cost analysis comparison between peripherally inserted central catheters and implanted chest ports in patients with cancer-a health economic evaluation of the piccport trial
[TARGET] => found cancer in background: a reliable central venous access device is a cornerstone in the treatment of cancer
[TARGET] => found cancer in method: we conducted a randomized controlled trial including 399 patients with cancer and performed a health economic evaluation investigating the cost related to piccs and ports using several clinically relevant dimensions from a healthcare perspective
[TARGET] => found cancer in conclusion: we have demonstrated that the cost from a healthcare perspective is higher in cancer patients receiving a picc than to those with a port
[RISK] => found high in conclusion: we have demonstrated that the cost from a healthcare perspective is higher in cancer patients receiving a picc than to those with a port
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in both types of catheter can cause adverse events such as catheter-related deep venous thrombosis (cr-dvt), infection and mechanical complications
# 37046808 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study
[RISK] => found risk in intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study
[RISK] => found low in intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study
[TARGET] => found chemotherapy in in a 10-year period, 336 cvc were inserted in the bbv (n = 115), ijv (n = 111), and scv (n = 110) in 336 patients suffering from aml (n = 201) and all (n = 135) and undergoing induction chemotherapy
[TARGET] => found chemotherapy in picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi
[RISK] => found risk in picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi
[RISK] => found low in picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi
## -> Scan Factor Cancer
[TARGET] => found leukemia in intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study
[RISK] => found risk in intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study
[RISK] => found low in intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study
[TARGET] => found leukemia in a bbv approach [peripherally inserted central catheter (picc)] is increasingly used for short- to intermediate-term cvcs for acute leukemias undergoing cytotoxic intensive regimens
[TARGET] => found leukemia in in this retrospective study, the catheterization of the bbv, ijv, and scv in patients with previously untreated acute leukemia was assessed
[TARGET] => found leukemia in picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi
[RISK] => found risk in picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi
[RISK] => found low in picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was the composite incidence of catheter-related symptomatic deep-vein thrombosis (sdvt) and bloodstream infection (bsi) from catheterization up to 30 days later
# 31445252 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in machine learning approaches for risk assessment of peripherally inserted central catheter-related vein thrombosis in hospitalized patients with cancer
[RISK] => found risk in machine learning approaches for risk assessment of peripherally inserted central catheter-related vein thrombosis in hospitalized patients with cancer
[TARGET] => found cancer in design: we conducted a prospective cohort study of 348 cancer patients with piccs who were admitted to the department of oncology of west china hospital, over a 1-year period, between february 1, 2016, and february 31, 2017
[TARGET] => found cancer in conclusions: our research confirmed that ml approaches are powerful tools to identify cancer patients with a high risk of picc-related thrombosis, which outperform the currently used criteria (seeley)
[RISK] => found risk in conclusions: our research confirmed that ml approaches are powerful tools to identify cancer patients with a high risk of picc-related thrombosis, which outperform the currently used criteria (seeley)
[RISK] => found high in conclusions: our research confirmed that ml approaches are powerful tools to identify cancer patients with a high risk of picc-related thrombosis, which outperform the currently used criteria (seeley)
[TARGET] => found cancer in from our research, more-precise assessments can be performed in cancer patients with piccs to help decide the prophylaxis and effectively lower the incidence of picc-related thrombosis
[RISK] => found more in from our research, more-precise assessments can be performed in cancer patients with piccs to help decide the prophylaxis and effectively lower the incidence of picc-related thrombosis
[RISK] => found low in from our research, more-precise assessments can be performed in cancer patients with piccs to help decide the prophylaxis and effectively lower the incidence of picc-related thrombosis
# 24781722 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter
[RISK] => found risk in thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter
[RISK] => found factor in thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter
[TARGET] => found chemotherapy in objective: to evaluate risk factors for venous thrombosis in patients undergoing chemotherapy via peripherally inserted central catheter (picc)
[RISK] => found risk in objective: to evaluate risk factors for venous thrombosis in patients undergoing chemotherapy via peripherally inserted central catheter (picc)
[RISK] => found factor in objective: to evaluate risk factors for venous thrombosis in patients undergoing chemotherapy via peripherally inserted central catheter (picc)
[TARGET] => found chemotherapy in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
[RISK] => found risk in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
[RISK] => found factor in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
## -> Scan Factor Gender
[TARGET] => found sex in methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients
## -> Scan Factor BMI
[TARGET] => found body mass index in methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients
[TARGET] => found bmi in methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients
[TARGET] => found bmi in age >60 years, bmi >25 kg/m(2) and wbc >11.4 × 10(9)/l were identified as independent risk factors for thrombosis
[RISK] => found risk in age >60 years, bmi >25 kg/m(2) and wbc >11.4 × 10(9)/l were identified as independent risk factors for thrombosis
[RISK] => found factor in age >60 years, bmi >25 kg/m(2) and wbc >11.4 × 10(9)/l were identified as independent risk factors for thrombosis
[TARGET] => found bmi in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
[RISK] => found risk in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
[RISK] => found factor in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
## -> Scan Factor Smoking
[TARGET] => found smoking in methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients
## -> Scan Factor Age
[TARGET] => found  age  in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
[RISK] => found risk in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
[RISK] => found factor in conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy
## -> Scan Factor History Of Thrombosis
[TARGET] => found history of thrombo in methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients
[TARGET] => found blood cell in methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients
# 30384035 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in we report the rate of vte in intensive care unit (icu) medical patients receiving picc, cvc, both, or neither
[TARGET] => found icu in we report the rate of vte in intensive care unit (icu) medical patients receiving picc, cvc, both, or neither
[TARGET] => found icu in methods: we conducted a single-center, retrospective cohort study of medical-icu patients between november 2007 and november 2013 grouped by receipt of cvc, picc, both, or neither
[RISK] => found group in methods: we conducted a single-center, retrospective cohort study of medical-icu patients between november 2007 and november 2013 grouped by receipt of cvc, picc, both, or neither
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in cox modeling was used to analyze this population and adjust for comorbidities which could contribute to vte
# 26113804 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in post-thrombotic complication rates, particularly infection, were higher in the picc group compared to the ltstc group (p = 0.597)
[RISK] => found high in post-thrombotic complication rates, particularly infection, were higher in the picc group compared to the ltstc group (p = 0.597)
[RISK] => found group in post-thrombotic complication rates, particularly infection, were higher in the picc group compared to the ltstc group (p = 0.597)
# 28740162 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in karnofsky performance scores, d-dimer and blood platelet levels and previous chemotherapy were principal components
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in we retrospectively reviewed a database of 320 consecutive patients who underwent picc insertion between december 2014 and december 2015 at the first affiliated hospital of xi'an jiaotong university to explore the potential associations between risk factors and picc-associated thrombosis
[RISK] => found risk in we retrospectively reviewed a database of 320 consecutive patients who underwent picc insertion between december 2014 and december 2015 at the first affiliated hospital of xi'an jiaotong university to explore the potential associations between risk factors and picc-associated thrombosis
[RISK] => found factor in we retrospectively reviewed a database of 320 consecutive patients who underwent picc insertion between december 2014 and december 2015 at the first affiliated hospital of xi'an jiaotong university to explore the potential associations between risk factors and picc-associated thrombosis
[RISK] => found associate in we retrospectively reviewed a database of 320 consecutive patients who underwent picc insertion between december 2014 and december 2015 at the first affiliated hospital of xi'an jiaotong university to explore the potential associations between risk factors and picc-associated thrombosis
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found performance score in karnofsky performance scores, d-dimer and blood platelet levels and previous chemotherapy were principal components
[TARGET] => found karnofsky in karnofsky performance scores, d-dimer and blood platelet levels and previous chemotherapy were principal components
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in karnofsky performance scores, d-dimer and blood platelet levels and previous chemotherapy were principal components
# 24911379 ---------
## -> Scan Factor Gender
[TARGET] => found gender in age- and gender-matched controls were randomly selected among patients who underwent picc placement without documented complications during this time
## -> Scan Factor BMI
[TARGET] => found body mass index in in multivariable logistic regression analyses, malnutrition and after-hours placement were significantly associated with increased risk of complications, as was body mass index (bmi) >30 after adjusting for anticoagulation and time of placement
[RISK] => found risk in in multivariable logistic regression analyses, malnutrition and after-hours placement were significantly associated with increased risk of complications, as was body mass index (bmi) >30 after adjusting for anticoagulation and time of placement
[RISK] => found associate in in multivariable logistic regression analyses, malnutrition and after-hours placement were significantly associated with increased risk of complications, as was body mass index (bmi) >30 after adjusting for anticoagulation and time of placement
[RISK] => found increase in in multivariable logistic regression analyses, malnutrition and after-hours placement were significantly associated with increased risk of complications, as was body mass index (bmi) >30 after adjusting for anticoagulation and time of placement
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in in our multivariable logistic regression analyses, use of anticoagulation/antiplatelet agents was associated with decreased risk of all-cause complications, nonmechanical complications, and catheter-associated thrombosis
[RISK] => found risk in in our multivariable logistic regression analyses, use of anticoagulation/antiplatelet agents was associated with decreased risk of all-cause complications, nonmechanical complications, and catheter-associated thrombosis
[RISK] => found associate in in our multivariable logistic regression analyses, use of anticoagulation/antiplatelet agents was associated with decreased risk of all-cause complications, nonmechanical complications, and catheter-associated thrombosis
[RISK] => found decrease in in our multivariable logistic regression analyses, use of anticoagulation/antiplatelet agents was associated with decreased risk of all-cause complications, nonmechanical complications, and catheter-associated thrombosis
[TARGET] => found platelet in use of anticoagulation/antiplatelet agents and avoiding after-hours placement may reduce complications and enhance patient safety
## -> Scan Factor PICC infection
[TARGET] => found infection in complications included catheter-associated thrombosis (3%), mechanical complications (4%), catheter-associated bloodstream infections (2%), and cellulitis (1%)
[RISK] => found associate in complications included catheter-associated thrombosis (3%), mechanical complications (4%), catheter-associated bloodstream infections (2%), and cellulitis (1%)
# 31981040 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in management of anticoagulant therapy according to the platelet count
[TARGET] => found platelet in uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l
[RISK] => found low in uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l
[RISK] => found group in uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in management of anticoagulant therapy according to the platelet count
[TARGET] => found anticoagulant in uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l
[RISK] => found low in uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l
[RISK] => found group in uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l
[TARGET] => found anticoagulant in we observed no hemorrhagic or thrombotic complications related to the anticoagulant therapy; length of treatment was comparable between groups 1 and 2 (51 days group 1 vs 50 days group 2)
[RISK] => found group in we observed no hemorrhagic or thrombotic complications related to the anticoagulant therapy; length of treatment was comparable between groups 1 and 2 (51 days group 1 vs 50 days group 2)
# 32128353 ---------
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in piccs were used in elderly inpatients with dementia who required (a) intravenous therapy, supplemental parenteral nutrition, and dysphagia rehabilitation during acute illness; (b) end-of-life care; (c) total parenteral nutrition (tpn); or (d) an alternative to peripheral vascular (pv) access
## -> Scan Factor PICC infection
[TARGET] => found infection in the incidence of catheter-related bloodstream infection was 0.22 per 1,000 picc-days, and that of deep venous thrombosis was 0.66 per 1,000 picc-days
# 35279504 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in risk of vte associated with ports and piccs in cancer patients: a systematic review and meta-analysis
[RISK] => found risk in risk of vte associated with ports and piccs in cancer patients: a systematic review and meta-analysis
[RISK] => found associate in risk of vte associated with ports and piccs in cancer patients: a systematic review and meta-analysis
[TARGET] => found cancer in objective: we aimed to study the incidence of port-related vte and picc-related vte in cancer patients by a meta-analysis
[TARGET] => found cancer in cohort studies and randomized controlled trials (rcts) comparing port-related vte and picc-related vte in cancer patients were included
[TARGET] => found cancer in our meta-analysis of 22 studies suggested that the risk of port-related vte was lower than that of picc-related vte in cancer patients (or = 0.38, 95% ci: 0.25-0.58)
[RISK] => found risk in our meta-analysis of 22 studies suggested that the risk of port-related vte was lower than that of picc-related vte in cancer patients (or = 0.38, 95% ci: 0.25-0.58)
[RISK] => found low in our meta-analysis of 22 studies suggested that the risk of port-related vte was lower than that of picc-related vte in cancer patients (or = 0.38, 95% ci: 0.25-0.58)
[TARGET] => found cancer in conclusions: ports are associated with a lower risk of vte than piccs in cancer patients
[RISK] => found risk in conclusions: ports are associated with a lower risk of vte than piccs in cancer patients
[RISK] => found associate in conclusions: ports are associated with a lower risk of vte than piccs in cancer patients
[RISK] => found low in conclusions: ports are associated with a lower risk of vte than piccs in cancer patients
[TARGET] => found cancer in the risk of vte and benefits should be considered when selecting ports or piccs for cancer patients
[RISK] => found risk in the risk of vte and benefits should be considered when selecting ports or piccs for cancer patients
# 34095299 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
[TARGET] => found chemotherapy in the results demonstrate a statistically significant difference in age, diabetes, hypertension, histology, surgery, chemotherapy, and picc (p < 0.05), compared with control
## -> Scan Factor Diabete
[TARGET] => found diabetes in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
[TARGET] => found diabetes in the results demonstrate a statistically significant difference in age, diabetes, hypertension, histology, surgery, chemotherapy, and picc (p < 0.05), compared with control
[TARGET] => found diabetes in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[RISK] => found risk in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[RISK] => found factor in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[RISK] => found associate in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[TARGET] => found diabetes in the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia
[RISK] => found associate in the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia
## -> Scan Factor Cancer
[TARGET] => found cancer in risk factors for gastric cancer-associated thrombotic diseases in a han chinese population
[RISK] => found risk in risk factors for gastric cancer-associated thrombotic diseases in a han chinese population
[RISK] => found factor in risk factors for gastric cancer-associated thrombotic diseases in a han chinese population
[RISK] => found associate in risk factors for gastric cancer-associated thrombotic diseases in a han chinese population
[TARGET] => found cancer in the aim of the present work was to investigate the risk factors for gastric cancer- (gc-) associated thrombotic diseases in a han chinese population
[RISK] => found risk in the aim of the present work was to investigate the risk factors for gastric cancer- (gc-) associated thrombotic diseases in a han chinese population
[RISK] => found factor in the aim of the present work was to investigate the risk factors for gastric cancer- (gc-) associated thrombotic diseases in a han chinese population
[RISK] => found associate in the aim of the present work was to investigate the risk factors for gastric cancer- (gc-) associated thrombotic diseases in a han chinese population
## -> Scan Factor Gender
[TARGET] => found gender in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
## -> Scan Factor Smoking
[TARGET] => found smoking in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
[TARGET] => found surgery in the results demonstrate a statistically significant difference in age, diabetes, hypertension, histology, surgery, chemotherapy, and picc (p < 0.05), compared with control
[TARGET] => found surgery in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[RISK] => found risk in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[RISK] => found factor in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[RISK] => found associate in age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05)
[TARGET] => found surgery in the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia
[RISK] => found associate in the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia
## -> Scan Factor Menopause_endocrine therapy_hormone use
[TARGET] => found hormone in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
## -> Scan Factor Thrombophilia
[TARGET] => found thrombophilia in the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia
[RISK] => found associate in the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia
## -> Scan Factor Hypertension
[TARGET] => found hypertension in the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected
[TARGET] => found hypertension in the results demonstrate a statistically significant difference in age, diabetes, hypertension, histology, surgery, chemotherapy, and picc (p < 0.05), compared with control
# 36163680 ---------
## -> Scan Factor Age
# 25680892 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found risk in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found factor in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
## -> Scan Factor Diabete
[TARGET] => found diabetes in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found risk in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found factor in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
## -> Scan Factor Gender
## -> Scan Factor BMI
[TARGET] => found obesity in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found risk in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found factor in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
## -> Scan Factor Age
## -> Scan Factor History Of Thrombosis
[TARGET] => found history of thrombo in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found risk in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found factor in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found ecog in identification of patient-related risk factors could lead to early recognition of upper limb deep vein thrombosis in patients with catheters, thereby preventing complications
[RISK] => found risk in identification of patient-related risk factors could lead to early recognition of upper limb deep vein thrombosis in patients with catheters, thereby preventing complications
[RISK] => found factor in identification of patient-related risk factors could lead to early recognition of upper limb deep vein thrombosis in patients with catheters, thereby preventing complications
## -> Scan Factor Thrombophilia
[TARGET] => found thrombophilia in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found risk in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
[RISK] => found factor in multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis
# 34454607 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in the success rate of the first catheterization, the success rate of the catheterization, the timing of the catheterization, the complications and the position of the catheter end were compared between the two groups
[RISK] => found group in the success rate of the first catheterization, the success rate of the catheterization, the timing of the catheterization, the complications and the position of the catheter end were compared between the two groups
# 37736715 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in clinical characteristics of peripherally inserted central catheter-related complications in cancer patients undergoing chemotherapy: a prospective and observational study
[TARGET] => found chemotherapy in the purpose of this study was to investigate the clinical characteristics of picc-related complications in cancer patients undergoing chemotherapy
[TARGET] => found chemotherapy in conclusions: picc-related complications were pretty common in cancer patients undergoing chemotherapy
[TARGET] => found chemotherapy in because more than half of the patients with picc-related complications could be managed with conventional interventions, piccs remain a priority for cancer patients undergoing short-term chemotherapy
[RISK] => found more in because more than half of the patients with picc-related complications could be managed with conventional interventions, piccs remain a priority for cancer patients undergoing short-term chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in clinical characteristics of peripherally inserted central catheter-related complications in cancer patients undergoing chemotherapy: a prospective and observational study
[TARGET] => found cancer in purpose: the incidence of peripherally inserted central catheter (picc)-related complications is higher in cancer patients than in noncancer patients
[RISK] => found high in purpose: the incidence of peripherally inserted central catheter (picc)-related complications is higher in cancer patients than in noncancer patients
[TARGET] => found cancer in the purpose of this study was to investigate the clinical characteristics of picc-related complications in cancer patients undergoing chemotherapy
[TARGET] => found cancer in cancer patients undergoing picc insertion for anticancer treatment were recruited and followed up until the first week after catheter removal
[RISK] => found low in cancer patients undergoing picc insertion for anticancer treatment were recruited and followed up until the first week after catheter removal
[TARGET] => found cancer in conclusions: picc-related complications were pretty common in cancer patients undergoing chemotherapy
[TARGET] => found cancer in because more than half of the patients with picc-related complications could be managed with conventional interventions, piccs remain a priority for cancer patients undergoing short-term chemotherapy
[RISK] => found more in because more than half of the patients with picc-related complications could be managed with conventional interventions, piccs remain a priority for cancer patients undergoing short-term chemotherapy
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in cancer patients undergoing picc insertion for anticancer treatment were recruited and followed up until the first week after catheter removal
[RISK] => found low in cancer patients undergoing picc insertion for anticancer treatment were recruited and followed up until the first week after catheter removal
## -> Scan Factor PICC infection
[TARGET] => found infection in catheter fracture and catheter-related bloodstream infection were classified as the "late onset" group occurring after the second month post-insertion
[RISK] => found group in catheter fracture and catheter-related bloodstream infection were classified as the "late onset" group occurring after the second month post-insertion
[TARGET] => found infection in marsi, catheter dislodgement, occlusion, and insertion site infection were classified as the "persistent onset" group persistently occurring during the whole catheter-dwelling period
[RISK] => found group in marsi, catheter dislodgement, occlusion, and insertion site infection were classified as the "persistent onset" group persistently occurring during the whole catheter-dwelling period
# 27240799 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in background: central line-associated bloodstream infections (clabsis) are a common life-threatening risk factor associated with central venous catheters (cvcs)
[RISK] => found risk in background: central line-associated bloodstream infections (clabsis) are a common life-threatening risk factor associated with central venous catheters (cvcs)
[RISK] => found factor in background: central line-associated bloodstream infections (clabsis) are a common life-threatening risk factor associated with central venous catheters (cvcs)
[RISK] => found associate in background: central line-associated bloodstream infections (clabsis) are a common life-threatening risk factor associated with central venous catheters (cvcs)
# 25616129 ---------
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in during follow up of piccs, catheter infection rate was 0.3/1000 days, vein thrombosis rate 0.4/1000 days, catheter occlusion 0.4/1000 days, and catheter displacement 0.33/1000 days
[RISK] => found low in during follow up of piccs, catheter infection rate was 0.3/1000 days, vein thrombosis rate 0.4/1000 days, catheter occlusion 0.4/1000 days, and catheter displacement 0.33/1000 days
[TARGET] => found infection in for midline catheters infection rate was 1.4/1000 days, vein thrombosis 5.2/1000 days, catheter occlusion 2.6/1000 days, and catheter displacement 2.2/1000 days
# 25634150 ---------
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in joanna briggs institute tools were used to extract data from the final 19 articles with information collated relating to catheter type, patient type, overall complication rate, rates of infection, occlusion, dislodgment, phlebitis, thrombus and rupture
[TARGET] => found infection in although both lines saw similar overall rates upon closer observation, the strengths and weaknesses of both lines are shown.polyurethane picc lines were found to provide lower rates of infection, dislodgment, thrombus and rupture complications.mixed results were found with catheter line occlusions, overall averages showing polyurethane lines slightly higher rates than silicone
[RISK] => found high in although both lines saw similar overall rates upon closer observation, the strengths and weaknesses of both lines are shown.polyurethane picc lines were found to provide lower rates of infection, dislodgment, thrombus and rupture complications.mixed results were found with catheter line occlusions, overall averages showing polyurethane lines slightly higher rates than silicone
[RISK] => found low in although both lines saw similar overall rates upon closer observation, the strengths and weaknesses of both lines are shown.polyurethane picc lines were found to provide lower rates of infection, dislodgment, thrombus and rupture complications.mixed results were found with catheter line occlusions, overall averages showing polyurethane lines slightly higher rates than silicone
# 31005243 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in background: centrally inserted totally implanted vascular access ports (ports) and peripherally inserted central catheters (piccs) are widely used for the administration of chemotherapy
[TARGET] => found chemotherapy in our aim was to study the incidence of catheter-related deep venous thrombosis in patients with cancer receiving chemotherapy through either a picc or a port
[TARGET] => found chemotherapy in this increased risk should be considered when choosing a vascular access device for chemotherapy, especially in patients with solid malignancy
[RISK] => found risk in this increased risk should be considered when choosing a vascular access device for chemotherapy, especially in patients with solid malignancy
[RISK] => found increase in this increased risk should be considered when choosing a vascular access device for chemotherapy, especially in patients with solid malignancy
## -> Scan Factor Cancer
[TARGET] => found cancer in clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial
[RISK] => found impact in clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial
[TARGET] => found cancer in our aim was to study the incidence of catheter-related deep venous thrombosis in patients with cancer receiving chemotherapy through either a picc or a port
[TARGET] => found cancer in methods: adults with non-haematological cancer (mainly breast and colorectal) from two swedish oncology centres were included and followed for up to 1 yr
[RISK] => found low in methods: adults with non-haematological cancer (mainly breast and colorectal) from two swedish oncology centres were included and followed for up to 1 yr
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary end point was the occurrence of a clinically significant catheter-related deep venous thrombosis, and the secondary end point was a composite of adverse events related to the catheter: insertion complication, thrombosis, occlusion, infection, and mechanical problems
# 34488396 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in clinical effect and safety of venous access ports and peripherally inserted central catheters in patients receiving tumor chemotherapy: a systematic review and meta-analysis
[TARGET] => found chemotherapy in background: to evaluate the effects and safety of peripherally inserted central catheters (piccs) and venous access ports (ports) for cancer patients receiving chemotherapy
[TARGET] => found chemotherapy in methods: we searched randomized controlled trials and retrospective cohort studies comparing piccs to ports in cancer patients receiving chemotherapy
[TARGET] => found chemotherapy in discussion: our study suggested that ports had similar clinical effects to piccs in cancer patients receiving chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in background: to evaluate the effects and safety of peripherally inserted central catheters (piccs) and venous access ports (ports) for cancer patients receiving chemotherapy
[TARGET] => found cancer in methods: we searched randomized controlled trials and retrospective cohort studies comparing piccs to ports in cancer patients receiving chemotherapy
[TARGET] => found cancer in discussion: our study suggested that ports had similar clinical effects to piccs in cancer patients receiving chemotherapy
# 36203676 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the aim of this study was to evaluate the benefits of an online multimodal nursing program on the quality of life and psychological resilience of asymptomatic picc-rt patients with ovarian cancer
# 38105233 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte
[RISK] => found risk in logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte
[RISK] => found factor in logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte
## -> Scan Factor Cancer
[TARGET] => found cancer in risk factors of venous thromboembolism in inpatients with colorectal cancer in china
[RISK] => found risk in risk factors of venous thromboembolism in inpatients with colorectal cancer in china
[RISK] => found factor in risk factors of venous thromboembolism in inpatients with colorectal cancer in china
[TARGET] => found cancer in to explore the risk factors for venous thromboembolism (vte) in inpatients with colorectal cancer
[RISK] => found risk in to explore the risk factors for venous thromboembolism (vte) in inpatients with colorectal cancer
[RISK] => found factor in to explore the risk factors for venous thromboembolism (vte) in inpatients with colorectal cancer
[TARGET] => found cancer in the demographic factors, comorbidities, and hematological indices of patients with colorectal cancer treated in our hospital from 2016 to 2021 were collected and recorded
[RISK] => found factor in the demographic factors, comorbidities, and hematological indices of patients with colorectal cancer treated in our hospital from 2016 to 2021 were collected and recorded
[TARGET] => found cancer in clinical parameters are associated with vte in inpatients with colorectal cancer, which will help to guide clinicians to take effective measures to improve the patients' prognosis
[RISK] => found associate in clinical parameters are associated with vte in inpatients with colorectal cancer, which will help to guide clinicians to take effective measures to improve the patients' prognosis
## -> Scan Factor Smoking
[TARGET] => found smoking in comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)
[RISK] => found group in comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)
## -> Scan Factor Age
[TARGET] => found  age  in logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte
[RISK] => found risk in logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte
[RISK] => found factor in logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in the demographic factors, comorbidities, and hematological indices of patients with colorectal cancer treated in our hospital from 2016 to 2021 were collected and recorded
[RISK] => found factor in the demographic factors, comorbidities, and hematological indices of patients with colorectal cancer treated in our hospital from 2016 to 2021 were collected and recorded
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found blood cell in comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)
[RISK] => found group in comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)
## -> Scan Factor PICC infection
[TARGET] => found infection in comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)
[RISK] => found group in comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)
# 36013377 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in central venous access and the risk for thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer
[RISK] => found risk in central venous access and the risk for thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer
[TARGET] => found chemotherapy in thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc)
[RISK] => found risk in thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc)
[RISK] => found high in thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc)
## -> Scan Factor Cancer
[TARGET] => found cancer in central venous access and the risk for thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer
[RISK] => found risk in central venous access and the risk for thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer
[TARGET] => found cancer in thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc)
[RISK] => found risk in thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc)
[RISK] => found high in thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc)
## -> Scan Factor Age
# 28619777 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheter dressing and securement in patients with cancer: the pisces trial
[TARGET] => found cancer in patients with cancer are at highest risk, and this increases morbidity, mortality and costs
[RISK] => found risk in patients with cancer are at highest risk, and this increases morbidity, mortality and costs
[RISK] => found high in patients with cancer are at highest risk, and this increases morbidity, mortality and costs
[RISK] => found increase in patients with cancer are at highest risk, and this increases morbidity, mortality and costs
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in for the dressing hypothesis, we hypothesise chg discs will reduce catheter-associated bloodstream infection (cabsi) compared with no chg disc
[RISK] => found associate in for the dressing hypothesis, we hypothesise chg discs will reduce catheter-associated bloodstream infection (cabsi) compared with no chg disc
[TARGET] => found infection in for the securement hypothesis, we hypothesise that isd will reduce composite picc failure (infection (cabsi/local infection), occlusion, dislodgement or thrombosis), compared with sed
# 37883756 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in objective: to observe the effect of nurse-patient co-management mode on preventing venous thromboembolism (vte) in lung cancer patients with carboplatin and gemcitabine chemotherapy after peripheral venipuncture central venous catheterization (picc)
[TARGET] => found chemotherapy in all patients received a combination chemotherapy of carboplatin and gemcitabine and picc catheterization
[TARGET] => found chemotherapy in conclusion: the nurse-patient co-management model has shown to be effective in reducing the incidence of venous thromboembolism in patients who have undergone picc catheterization while receiving carboplatin and gemcitabine chemotherapy
[TARGET] => found carboplatin in objective: to observe the effect of nurse-patient co-management mode on preventing venous thromboembolism (vte) in lung cancer patients with carboplatin and gemcitabine chemotherapy after peripheral venipuncture central venous catheterization (picc)
[TARGET] => found carboplatin in all patients received a combination chemotherapy of carboplatin and gemcitabine and picc catheterization
[TARGET] => found carboplatin in conclusion: the nurse-patient co-management model has shown to be effective in reducing the incidence of venous thromboembolism in patients who have undergone picc catheterization while receiving carboplatin and gemcitabine chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in a novel model to prevent venous thromboembolism in patients with lung cancer
[TARGET] => found cancer in objective: to observe the effect of nurse-patient co-management mode on preventing venous thromboembolism (vte) in lung cancer patients with carboplatin and gemcitabine chemotherapy after peripheral venipuncture central venous catheterization (picc)
[TARGET] => found cancer in methods: 100 patients with lung cancer admitted to the 2nd affiliated hospital of hainan medical university from april 2020 to april 2022 were selected
[TARGET] => found cancer in patients in the control group were given routine nursing for lung cancer, and patients in the observation group were treated with nurse-patient co-management mode, and nursing intervention lasted for 2 months
[RISK] => found group in patients in the control group were given routine nursing for lung cancer, and patients in the observation group were treated with nurse-patient co-management mode, and nursing intervention lasted for 2 months
## -> Scan Factor Age
# 37366542 ---------
# 35086961 ---------
## -> Scan Factor Gender
[TARGET] => found male in mean patient age was 66.4±19 years and 51.0% were female
[TARGET] => found female in mean patient age was 66.4±19 years and 51.0% were female
## -> Scan Factor Age
[TARGET] => found  age  in mean patient age was 66.4±19 years and 51.0% were female
## -> Scan Factor PICC infection
[TARGET] => found infection in picc-related major (deep vein thrombosis (dvt), central line-associated bloodstream infection (clabsi) and catheter occlusion) and minor complications were collected
[RISK] => found associate in picc-related major (deep vein thrombosis (dvt), central line-associated bloodstream infection (clabsi) and catheter occlusion) and minor complications were collected
# 33908337 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in multivariable cox proportional hazards models with robust sandwich standard error estimates accounting for the clustered nature of data were used to identify factors associated with picc complications in coated versus noncoated devices across general care, intensive care unit (icu), and oncology patients
[RISK] => found factor in multivariable cox proportional hazards models with robust sandwich standard error estimates accounting for the clustered nature of data were used to identify factors associated with picc complications in coated versus noncoated devices across general care, intensive care unit (icu), and oncology patients
[RISK] => found associate in multivariable cox proportional hazards models with robust sandwich standard error estimates accounting for the clustered nature of data were used to identify factors associated with picc complications in coated versus noncoated devices across general care, intensive care unit (icu), and oncology patients
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in objective: to examine the effectiveness of antimicrobial and antithrombogenic materials incorporated into peripherally inserted central catheters (piccs) to prevent bloodstream infection, thrombosis, and catheter occlusion
[TARGET] => found infection in within the entire cohort, 540 (1.3%) developed thrombosis, 745 (1.8%) developed bloodstream infection, and 4,090 (9.6%) developed catheter occlusion
[TARGET] => found infection in adjusting for known risk factors, antimicrobial piccs were not associated with infection reduction (hr, 1.16; 95% ci, 0.82-1.64), and antithrombogenic piccs were not associated with reduction in thrombosis and occlusion (hr, 1.15; 95% ci, 0.92-1.44)
[RISK] => found risk in adjusting for known risk factors, antimicrobial piccs were not associated with infection reduction (hr, 1.16; 95% ci, 0.82-1.64), and antithrombogenic piccs were not associated with reduction in thrombosis and occlusion (hr, 1.15; 95% ci, 0.92-1.44)
[RISK] => found factor in adjusting for known risk factors, antimicrobial piccs were not associated with infection reduction (hr, 1.16; 95% ci, 0.82-1.64), and antithrombogenic piccs were not associated with reduction in thrombosis and occlusion (hr, 1.15; 95% ci, 0.92-1.44)
[RISK] => found associate in adjusting for known risk factors, antimicrobial piccs were not associated with infection reduction (hr, 1.16; 95% ci, 0.82-1.64), and antithrombogenic piccs were not associated with reduction in thrombosis and occlusion (hr, 1.15; 95% ci, 0.92-1.44)
# 37572590 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the clinical topography of peripherally inserted central catheter-related thrombosis in cancer patients: a prospective and longitudinal observational study based on ultrasound scans every two days
[TARGET] => found cancer in aims: to delineate the clinical topography of peripherally inserted central catheter (picc)-related thrombosis in cancer patients
[TARGET] => found cancer in methods: cancer patients scheduled for picc placement were potentially eligible; patients with contraindications to picc placement or existing diseases affecting blood flow were excluded; and those who later withdrew or did not reply to our contact request during the follow-up period were eliminated from this study
[RISK] => found low in methods: cancer patients scheduled for picc placement were potentially eligible; patients with contraindications to picc placement or existing diseases affecting blood flow were excluded; and those who later withdrew or did not reply to our contact request during the follow-up period were eliminated from this study
[TARGET] => found cancer in conclusion: picc-related thrombosis is common and can occur very early post insertion in cancer patients, and most thromboses present atypical symptoms
# 33840246 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in subcutaneous tunneling technique to improve outcomes for patients undergoing chemotherapy with peripherally inserted central catheters: a randomized controlled trial
[TARGET] => found chemotherapy in objective: to compare the value of the subcutaneous tunneling technique versus the normal technique in improving the outcomes of patients undergoing chemotherapy with peripherally inserted central catheters (piccs)
# 25198809 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in aim: the aim of this study is to compare the complication rates of three vascular access devices in patients with solid tumours having infusion chemotherapy
[TARGET] => found chemotherapy in materials and methods: an observational study of 58 central venous catheter (cvc) lines inserted in 55 patients with solid tumours requiring infusional chemotherapy was performed
[TARGET] => found chemotherapy in results: the two cvc groups (ports and non-ports) matched equally in terms of tumour site; all patients with solid tumours were included, haematology patients were excluded and chemotherapy regimens were comparable
[RISK] => found group in results: the two cvc groups (ports and non-ports) matched equally in terms of tumour site; all patients with solid tumours were included, haematology patients were excluded and chemotherapy regimens were comparable
[TARGET] => found chemotherapy in conclusions: in our study, we demonstrated that central venous ports and picc lines in patients undergoing infusional chemotherapy had lower line infection rates than tunnelled catheters, and only ports have been shown to be almost complication-free
[RISK] => found low in conclusions: in our study, we demonstrated that central venous ports and picc lines in patients undergoing infusional chemotherapy had lower line infection rates than tunnelled catheters, and only ports have been shown to be almost complication-free
[TARGET] => found chemotherapy in therefore, we recommend that central venous ports are a safe, acceptable cvc option for infusional chemotherapy for adults with solid tumours
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in a comparison of infections and complications in central venous catheters in adults with solid tumours
[TARGET] => found infection in the study was conducted between january 2011 and august 2013, looking at complication and infection rates as primary outcomes
[TARGET] => found infection in ten out of 19 tunnelled catheters had complications including three displacements and seven were removed due to infection
[TARGET] => found infection in conclusions: in our study, we demonstrated that central venous ports and picc lines in patients undergoing infusional chemotherapy had lower line infection rates than tunnelled catheters, and only ports have been shown to be almost complication-free
[RISK] => found low in conclusions: in our study, we demonstrated that central venous ports and picc lines in patients undergoing infusional chemotherapy had lower line infection rates than tunnelled catheters, and only ports have been shown to be almost complication-free
[TARGET] => found infection in in addition, we found infection rates higher in cvcs s cared for by patient/carers rather than hospital only care, and higher in colorectal patients with stomas
[RISK] => found high in in addition, we found infection rates higher in cvcs s cared for by patient/carers rather than hospital only care, and higher in colorectal patients with stomas
# 25953205 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in after multivariate analysis, two risk factors were significantly associated with the overall occurrence of complications: age more than 70 years [or = 2.89 (1.06-7.89], p = 0.04] and number of lumen at least two [or = 2.64 (1.03-6.75), p = 0.04]
[RISK] => found risk in after multivariate analysis, two risk factors were significantly associated with the overall occurrence of complications: age more than 70 years [or = 2.89 (1.06-7.89], p = 0.04] and number of lumen at least two [or = 2.64 (1.03-6.75), p = 0.04]
[RISK] => found factor in after multivariate analysis, two risk factors were significantly associated with the overall occurrence of complications: age more than 70 years [or = 2.89 (1.06-7.89], p = 0.04] and number of lumen at least two [or = 2.64 (1.03-6.75), p = 0.04]
[RISK] => found associate in after multivariate analysis, two risk factors were significantly associated with the overall occurrence of complications: age more than 70 years [or = 2.89 (1.06-7.89], p = 0.04] and number of lumen at least two [or = 2.64 (1.03-6.75), p = 0.04]
[RISK] => found more in after multivariate analysis, two risk factors were significantly associated with the overall occurrence of complications: age more than 70 years [or = 2.89 (1.06-7.89], p = 0.04] and number of lumen at least two [or = 2.64 (1.03-6.75), p = 0.04]
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in all picc complications were recorded during the patient hospitalization: infection [catheter-related bloodstream infection (crbsi), central line associated bloodstream infection (clabsi), exit-site infection, septic phlebitis], thrombosis, occlusion, mechanical complication (accidental withdrawal, malposition, median nerve irritation)
[RISK] => found associate in all picc complications were recorded during the patient hospitalization: infection [catheter-related bloodstream infection (crbsi), central line associated bloodstream infection (clabsi), exit-site infection, septic phlebitis], thrombosis, occlusion, mechanical complication (accidental withdrawal, malposition, median nerve irritation)
[TARGET] => found position in aeruginosa), two exit-site infections and 10 clabsis), 11 (6%) occlusions, and 12 (7%) mechanical complications (10 accidental withdrawals, one malposition, one median nerve irritation)
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in records of 180 consecutives piccs placed in patients hospitalized in the orthopedic surgery department were reviewed
## -> Scan Factor PICC infection
[TARGET] => found infection in evaluation of picc complications in orthopedic inpatients with bone infection for long-term intravenous antibiotics therapy
[TARGET] => found infection in purpose: the purpose of this study is to evaluate the complications of peripherally inserted central catheters (piccs) in orthopedic patients with chronic bone orthopedic infection
[TARGET] => found infection in all patients had bones infections necessitating a long-term intravenous antibiotics therapy
[TARGET] => found infection in all picc complications were recorded during the patient hospitalization: infection [catheter-related bloodstream infection (crbsi), central line associated bloodstream infection (clabsi), exit-site infection, septic phlebitis], thrombosis, occlusion, mechanical complication (accidental withdrawal, malposition, median nerve irritation)
[RISK] => found associate in all picc complications were recorded during the patient hospitalization: infection [catheter-related bloodstream infection (crbsi), central line associated bloodstream infection (clabsi), exit-site infection, septic phlebitis], thrombosis, occlusion, mechanical complication (accidental withdrawal, malposition, median nerve irritation)
[TARGET] => found infection in thirty-six piccs (20%) were removed due to complications (9.2 complications per 1000 picc-days): 14 (8%) infections (one crbsi (pseudomonas aeruginosa), one septic phlebitis (p
[TARGET] => found infection in aeruginosa), two exit-site infections and 10 clabsis), 11 (6%) occlusions, and 12 (7%) mechanical complications (10 accidental withdrawals, one malposition, one median nerve irritation)
[TARGET] => found infection in conclusions: even in orthopedic patients with chronic orthopedic bone infection, piccs have a low rate of complication
[RISK] => found low in conclusions: even in orthopedic patients with chronic orthopedic bone infection, piccs have a low rate of complication
# 34973357 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found risk in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found factor in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found associate in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[TARGET] => found lumens in the number of catheter lumens is one of the modifiable factors to reduce complications
[RISK] => found factor in the number of catheter lumens is one of the modifiable factors to reduce complications
## -> Scan Factor Diabete
[TARGET] => found diabetes in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found risk in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found factor in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found associate in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[TARGET] => found diabetes in conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes
[RISK] => found risk in conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes
[RISK] => found factor in conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes
## -> Scan Factor BMI
[TARGET] => found obesity in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found risk in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found factor in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[RISK] => found associate in in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care
[TARGET] => found obesity in conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes
[RISK] => found risk in conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes
[RISK] => found factor in conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary endpoint was the composite of picc-associated complications until removal, including occlusion, migration, accidental withdrawal, infection, thrombosis, and hematoma
[RISK] => found associate in the primary endpoint was the composite of picc-associated complications until removal, including occlusion, migration, accidental withdrawal, infection, thrombosis, and hematoma
# 31073442 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found triple lumen in central venous lines (cvl) used in our unit include peripherally inserted central catheters (picc) lines, and antibiotic and heparin coated double or triple lumen lines placed in internal jugular (ij), femoral (fem), or ra positions
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in central venous lines (cvl) used in our unit include peripherally inserted central catheters (picc) lines, and antibiotic and heparin coated double or triple lumen lines placed in internal jugular (ij), femoral (fem), or ra positions
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in purpose  right atrial (ra) or intracardiac lines are commonly used for hemodynamic monitoring in children undergoing cardiac surgery
[TARGET] => found surgery in methods  after approval from the institutional review board, a retrospective review of all patients undergoing cardiac surgery at arkansas children's hospital between the dates of january 1, 2006 and december 31, 2011 was performed
[TARGET] => found surgery in disease severity as assessed by risk-adjusted classification for congenital heart surgery (rachs) score ( p  < 0.046), year of placement ( p  < 0.001), and line type adjusted for thrombolytic (alteplase) use are significantly associated with risk of any cabsi
[RISK] => found risk in disease severity as assessed by risk-adjusted classification for congenital heart surgery (rachs) score ( p  < 0.046), year of placement ( p  < 0.001), and line type adjusted for thrombolytic (alteplase) use are significantly associated with risk of any cabsi
[RISK] => found associate in disease severity as assessed by risk-adjusted classification for congenital heart surgery (rachs) score ( p  < 0.046), year of placement ( p  < 0.001), and line type adjusted for thrombolytic (alteplase) use are significantly associated with risk of any cabsi
## -> Scan Factor PICC infection
[TARGET] => found infection in catheter-associated blood stream infections in intracardiac lines
[RISK] => found associate in catheter-associated blood stream infections in intracardiac lines
[TARGET] => found infection in in some institutions, these lines are used as the preferred long-term access line due to concerns for catheter-associated blood stream infections (cabsi) and catheter-related venous thrombosis with central lines in other locations
[RISK] => found associate in in some institutions, these lines are used as the preferred long-term access line due to concerns for catheter-associated blood stream infections (cabsi) and catheter-related venous thrombosis with central lines in other locations
# 34297997 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in central venous access devices for the delivery of systemic anticancer therapy (cava): a randomised controlled trial
[TARGET] => found cancer in background: hickman-type tunnelled catheters (hickman), peripherally inserted central catheters (piccs), and totally implanted ports (ports) are used to deliver systemic anticancer treatment (sact) via a central vein
[TARGET] => found cancer in methods: we did an open-label, multicentre, randomised controlled trial (cancer and venous access [cava]) of three central venous access devices: piccs versus hickman (non-inferiority; 10% margin); ports versus hickman (superiority; 15% margin); and ports versus piccs (superiority; 15% margin)
[TARGET] => found cancer in randomisation was done using a minimisation algorithm stratifying by centre, body-mass index, type of cancer, device history, and treatment mode
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was complication rate (composite of infection, venous thrombosis, pulmonary embolus, inability to aspirate blood, mechanical failure, and other) assessed until device removal, withdrawal from study, or 1-year follow-up
[RISK] => found low in the primary outcome was complication rate (composite of infection, venous thrombosis, pulmonary embolus, inability to aspirate blood, mechanical failure, and other) assessed until device removal, withdrawal from study, or 1-year follow-up
# 36960818 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found multiple-lumen in nudging to select single-lumen over multiple-lumen peripherally inserted central catheters (piccs) in a large safety net system
[TARGET] => found multilumen in compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis
[RISK] => found associate in compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis
[RISK] => found low in compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis
[TARGET] => found multilumen in despite this, multilumen piccs are still overused
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis
[RISK] => found associate in compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis
[RISK] => found low in compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis
[TARGET] => found infection in clabsi rates had a nonsignificant reduction by 26.7% from 2.44 to 1.79 infections per month (p = .255)
# 34711086 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in methods: in this randomized controlled trial, 120 cancer patients were randomly assigned to the upper portion of the red zone (rz), the green zone (gz) and the lower portion of the yellow zone (yz) groups (at a 1:1:1 ratio)
[RISK] => found low in methods: in this randomized controlled trial, 120 cancer patients were randomly assigned to the upper portion of the red zone (rz), the green zone (gz) and the lower portion of the yellow zone (yz) groups (at a 1:1:1 ratio)
[RISK] => found group in methods: in this randomized controlled trial, 120 cancer patients were randomly assigned to the upper portion of the red zone (rz), the green zone (gz) and the lower portion of the yellow zone (yz) groups (at a 1:1:1 ratio)
[TARGET] => found cancer in the aim was to compare the degree of patient comfort and the incidence of major picc complications among the three insertion zones based on the zim(tm) in a chinese cancer center
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in conclusions: this study found that the lower portion of yz seems to be another suitable picc insertion site for a higher degree of comfort and a lower risk of occlusion and thrombosis, which broadens the choice of picc insertion sites in the upper arm for clinical practice
[RISK] => found risk in conclusions: this study found that the lower portion of yz seems to be another suitable picc insertion site for a higher degree of comfort and a lower risk of occlusion and thrombosis, which broadens the choice of picc insertion sites in the upper arm for clinical practice
[RISK] => found high in conclusions: this study found that the lower portion of yz seems to be another suitable picc insertion site for a higher degree of comfort and a lower risk of occlusion and thrombosis, which broadens the choice of picc insertion sites in the upper arm for clinical practice
[RISK] => found low in conclusions: this study found that the lower portion of yz seems to be another suitable picc insertion site for a higher degree of comfort and a lower risk of occlusion and thrombosis, which broadens the choice of picc insertion sites in the upper arm for clinical practice
# 26519981 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found triple lumen in methods: we performed a retrospective cohort study of 200 piccs (dual/triple lumen) and 200 ciccs (triple/quadruple lumen) placed in medical icu adults at mayo rochester between 2012 and 2013
[TARGET] => found quadruple lumen in methods: we performed a retrospective cohort study of 200 piccs (dual/triple lumen) and 200 ciccs (triple/quadruple lumen) placed in medical icu adults at mayo rochester between 2012 and 2013
## -> Scan Factor ICU
[TARGET] => found intensive care unit in complication rates among peripherally inserted central venous catheters and centrally inserted central catheters in the medical intensive care unit
[TARGET] => found intensive care unit in purpose: there are limited contemporary data describing the rates of catheter-related deep vein thrombosis (crdvt) and central line-associated bloodstream infection for peripherally inserted central venous catheters (piccs) and centrally inserted central venous catheters (ciccs) in the medical intensive care unit (icu)
[RISK] => found associate in purpose: there are limited contemporary data describing the rates of catheter-related deep vein thrombosis (crdvt) and central line-associated bloodstream infection for peripherally inserted central venous catheters (piccs) and centrally inserted central venous catheters (ciccs) in the medical intensive care unit (icu)
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in purpose: there are limited contemporary data describing the rates of catheter-related deep vein thrombosis (crdvt) and central line-associated bloodstream infection for peripherally inserted central venous catheters (piccs) and centrally inserted central venous catheters (ciccs) in the medical intensive care unit (icu)
[RISK] => found associate in purpose: there are limited contemporary data describing the rates of catheter-related deep vein thrombosis (crdvt) and central line-associated bloodstream infection for peripherally inserted central venous catheters (piccs) and centrally inserted central venous catheters (ciccs) in the medical intensive care unit (icu)
[TARGET] => found infection in central line-associated bloodstream infection was defined according to federal reporting criteria
[RISK] => found associate in central line-associated bloodstream infection was defined according to federal reporting criteria
[TARGET] => found infection in only 1 central line-associated bloodstream infection occurred in a picc following icu dismissal, p > .999
[RISK] => found associate in only 1 central line-associated bloodstream infection occurred in a picc following icu dismissal, p > .999
[RISK] => found low in only 1 central line-associated bloodstream infection occurred in a picc following icu dismissal, p > .999
# 26217634 ---------
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the most common catheter-related complication was thrombosis (12, 8.8%) followed by infection (8, 5.8%)
[RISK] => found low in the most common catheter-related complication was thrombosis (12, 8.8%) followed by infection (8, 5.8%)
# 36644041 ---------
## -> Scan Factor Gender
[TARGET] => found sex in this model included variables such as age, post-operative days before anticoagulant administration, female sex, indications for surgery such as tumor and trauma, presence of a picc line, and anticoagulant administration
[TARGET] => found male in this model included variables such as age, post-operative days before anticoagulant administration, female sex, indications for surgery such as tumor and trauma, presence of a picc line, and anticoagulant administration
[TARGET] => found male in results among the 197 post-craniotomy/craniectomy patients (39.6% female; mean age 53.8±15.7 years), the incidences of dvt, svt, and vte were 4.6%, 9.6%, and 12.2%, respectively
[TARGET] => found female in this model included variables such as age, post-operative days before anticoagulant administration, female sex, indications for surgery such as tumor and trauma, presence of a picc line, and anticoagulant administration
[TARGET] => found female in results among the 197 post-craniotomy/craniectomy patients (39.6% female; mean age 53.8±15.7 years), the incidences of dvt, svt, and vte were 4.6%, 9.6%, and 12.2%, respectively
## -> Scan Factor Age
[TARGET] => found  age  in results among the 197 post-craniotomy/craniectomy patients (39.6% female; mean age 53.8±15.7 years), the incidences of dvt, svt, and vte were 4.6%, 9.6%, and 12.2%, respectively
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in this study aims to identify the incidence of deep vein thrombosis (dvt) and superficial vein thrombosis (svt) among post-craniotomy/craniectomy patients and further evaluate established hypercoagulability risk factors such as trauma, tumors, and surgery
[RISK] => found risk in this study aims to identify the incidence of deep vein thrombosis (dvt) and superficial vein thrombosis (svt) among post-craniotomy/craniectomy patients and further evaluate established hypercoagulability risk factors such as trauma, tumors, and surgery
[RISK] => found factor in this study aims to identify the incidence of deep vein thrombosis (dvt) and superficial vein thrombosis (svt) among post-craniotomy/craniectomy patients and further evaluate established hypercoagulability risk factors such as trauma, tumors, and surgery
[TARGET] => found surgery in this model included variables such as age, post-operative days before anticoagulant administration, female sex, indications for surgery such as tumor and trauma, presence of a picc line, and anticoagulant administration
[TARGET] => found surgery in the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001)
[RISK] => found risk in the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001)
[RISK] => found increase in the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001)
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in this model included variables such as age, post-operative days before anticoagulant administration, female sex, indications for surgery such as tumor and trauma, presence of a picc line, and anticoagulant administration
[TARGET] => found anticoagulant in the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001)
[RISK] => found risk in the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001)
[RISK] => found increase in the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001)
[TARGET] => found anticoagulant in future prospective studies should assess vte risk assessment models such as "3 bucket" or "caprini" to develop universal guidelines for administering anticoagulant therapy to post-craniotomy/craniectomy patients that consider the timing of post-operative therapy initiation
[RISK] => found risk in future prospective studies should assess vte risk assessment models such as "3 bucket" or "caprini" to develop universal guidelines for administering anticoagulant therapy to post-craniotomy/craniectomy patients that consider the timing of post-operative therapy initiation
# 35495896 ---------
## -> Scan Factor Age
## -> Scan Factor Slower blood flow velocity
[TARGET] => found blood flow velocity in secondly, we compared the average blood flow velocity per unit time of axillary vein at different moments
[RISK] => found low in secondly, we compared the average blood flow velocity per unit time of axillary vein at different moments
[TARGET] => found blood flow velocity in the average blood flow velocity per unit time of axillary vein in the study group was faster compared to the control at different time points (p < 0.05)
[RISK] => found low in the average blood flow velocity per unit time of axillary vein in the study group was faster compared to the control at different time points (p < 0.05)
[RISK] => found group in the average blood flow velocity per unit time of axillary vein in the study group was faster compared to the control at different time points (p < 0.05)
[TARGET] => found blood flow velocity in in terms of the average blood flow velocity per unit time of axillary vein at different time points between the two groups, there exited no significant difference before catheterization (p > 0.05)
[RISK] => found low in in terms of the average blood flow velocity per unit time of axillary vein at different time points between the two groups, there exited no significant difference before catheterization (p > 0.05)
[RISK] => found group in in terms of the average blood flow velocity per unit time of axillary vein at different time points between the two groups, there exited no significant difference before catheterization (p > 0.05)
[TARGET] => found blood flow velocity in but 14 and 28 days after catheterization, the average blood flow velocity per unit time of axillary vein in the study group was better when compared to the control (p < 0.05)
[RISK] => found low in but 14 and 28 days after catheterization, the average blood flow velocity per unit time of axillary vein in the study group was better when compared to the control (p < 0.05)
[RISK] => found group in but 14 and 28 days after catheterization, the average blood flow velocity per unit time of axillary vein in the study group was better when compared to the control (p < 0.05)
[TARGET] => found blood flow velocity in there was no significant difference in vascular diameter, peak blood flow velocity, and vascular pressure between the two groups before nursing (p > 0.05), but after nursing, the vascular diameter and peak blood flow velocity group were higher, and the vascular pressure was lower in the study (p < 0.05)
[RISK] => found high in there was no significant difference in vascular diameter, peak blood flow velocity, and vascular pressure between the two groups before nursing (p > 0.05), but after nursing, the vascular diameter and peak blood flow velocity group were higher, and the vascular pressure was lower in the study (p < 0.05)
[RISK] => found low in there was no significant difference in vascular diameter, peak blood flow velocity, and vascular pressure between the two groups before nursing (p > 0.05), but after nursing, the vascular diameter and peak blood flow velocity group were higher, and the vascular pressure was lower in the study (p < 0.05)
[RISK] => found group in there was no significant difference in vascular diameter, peak blood flow velocity, and vascular pressure between the two groups before nursing (p > 0.05), but after nursing, the vascular diameter and peak blood flow velocity group were higher, and the vascular pressure was lower in the study (p < 0.05)
# 33594508 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in assessing the thrombosis risk of peripherally inserted central catheters in cancer patients using caprini risk assessment model: a prospective cohort study
[RISK] => found risk in assessing the thrombosis risk of peripherally inserted central catheters in cancer patients using caprini risk assessment model: a prospective cohort study
[TARGET] => found cancer in purpose: there was no optimal risk assessment tool to stratify the risk of peripherally inserted central catheter-related venous thromboembolism (picc-rvt) in cancer patients
[RISK] => found risk in purpose: there was no optimal risk assessment tool to stratify the risk of peripherally inserted central catheter-related venous thromboembolism (picc-rvt) in cancer patients
[TARGET] => found cancer in this study was to assess the validity of the caprini in chinese cancer patients with piccs
[TARGET] => found cancer in conclusions: the caprini can be used for high-risk screening of the picc-rvt in cancer patients, and classification of the highest risk level using a score of 6 can be more clinically significant compared to 5 as recommended
[RISK] => found risk in conclusions: the caprini can be used for high-risk screening of the picc-rvt in cancer patients, and classification of the highest risk level using a score of 6 can be more clinically significant compared to 5 as recommended
[RISK] => found more in conclusions: the caprini can be used for high-risk screening of the picc-rvt in cancer patients, and classification of the highest risk level using a score of 6 can be more clinically significant compared to 5 as recommended
[RISK] => found high in conclusions: the caprini can be used for high-risk screening of the picc-rvt in cancer patients, and classification of the highest risk level using a score of 6 can be more clinically significant compared to 5 as recommended
# 25377903 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: of the 163 patients who represented 19104 home-catheter days, 19 (11.7%) patients experienced 25 catheter complications (ccs; 12 occlusions, 11 central line-associated bloodstream infections, one thrombosis and one line dislodgment)
[RISK] => found associate in results: of the 163 patients who represented 19104 home-catheter days, 19 (11.7%) patients experienced 25 catheter complications (ccs; 12 occlusions, 11 central line-associated bloodstream infections, one thrombosis and one line dislodgment)
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in evaluating catheter complications and outcomes in patients receiving home parenteral nutrition
[TARGET] => found parenteral nutrition in rationale, aims and objectives: we describe catheter complications and outcomes in patients who received home parenteral nutrition (hpn) therapy
## -> Scan Factor PICC infection
[TARGET] => found infection in results: of the 163 patients who represented 19104 home-catheter days, 19 (11.7%) patients experienced 25 catheter complications (ccs; 12 occlusions, 11 central line-associated bloodstream infections, one thrombosis and one line dislodgment)
[RISK] => found associate in results: of the 163 patients who represented 19104 home-catheter days, 19 (11.7%) patients experienced 25 catheter complications (ccs; 12 occlusions, 11 central line-associated bloodstream infections, one thrombosis and one line dislodgment)
# 24983259 ---------
## -> Scan Factor Gender
## -> Scan Factor BMI
[TARGET] => found obesity in hypertension (p = .022) and obesity (p = .008), defined as a body mass index ≥30, were associated with uedvt
[RISK] => found associate in hypertension (p = .022) and obesity (p = .008), defined as a body mass index ≥30, were associated with uedvt
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the most common reason for admission was infection (33.5%), and the primary reason for insertion of the picc was venous access (58.6%)
## -> Scan Factor Hypertension
[TARGET] => found hypertension in hypertension (p = .022) and obesity (p = .008), defined as a body mass index ≥30, were associated with uedvt
[RISK] => found associate in hypertension (p = .022) and obesity (p = .008), defined as a body mass index ≥30, were associated with uedvt
# 33019880 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in safe use of peripherally inserted central catheters for chemotherapy of solid malignancies in adult patients: a 1-year monocentric, prospectively-assessed, unselected cohort of 482 patients
[TARGET] => found chemotherapy in introduction: aim of this study was to analyze the overall complication and failure rates of peripherally inserted central catheters (piccs), in a 1-year consecutive unselected cohort of 482 adult patients, affected by non-hematological malignancies undergoing chemotherapy
[TARGET] => found chemotherapy in methods: adult outpatients (aged 18-75 years), with an eastern cooperative oncology group (ecog) performance status of 0-2, bearing solid tumors and candidates for intravenous chemotherapy were eligible for the study
[RISK] => found group in methods: adult outpatients (aged 18-75 years), with an eastern cooperative oncology group (ecog) performance status of 0-2, bearing solid tumors and candidates for intravenous chemotherapy were eligible for the study
[TARGET] => found chemotherapy in conclusion: this large prospective study supports the increasing use of piccs in adult oncology outpatients treated in specialized centers with chemotherapy for non-hematological malignancies
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in there were n = 13 (2.7%) thromboses, n = 11 (2.3%) irreversible occlusions, n = 7 (1.5%) accidental removals, n = 5 (1.0%) infections [two catheter related blood stream infection (crbsi) and three exit site/local infection], n = 3 (0.6%) ruptures and n = 3 (0.6%) primary or secondary malpositions
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in the inserted piccs accounted for a total of 49,718 catheter days in situ, median duration was 85.5 days [interquartile range (iqr): 56-146]
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found performance status in methods: adult outpatients (aged 18-75 years), with an eastern cooperative oncology group (ecog) performance status of 0-2, bearing solid tumors and candidates for intravenous chemotherapy were eligible for the study
[RISK] => found group in methods: adult outpatients (aged 18-75 years), with an eastern cooperative oncology group (ecog) performance status of 0-2, bearing solid tumors and candidates for intravenous chemotherapy were eligible for the study
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in exclusion criteria were active infections, coagulopathy (defined as platelet count <50,000/μl and/or prothrombin time more than 18 s), life expectancy <6 months, or inability to give written informed consent
[RISK] => found more in exclusion criteria were active infections, coagulopathy (defined as platelet count <50,000/μl and/or prothrombin time more than 18 s), life expectancy <6 months, or inability to give written informed consent
## -> Scan Factor PICC infection
[TARGET] => found infection in exclusion criteria were active infections, coagulopathy (defined as platelet count <50,000/μl and/or prothrombin time more than 18 s), life expectancy <6 months, or inability to give written informed consent
[RISK] => found more in exclusion criteria were active infections, coagulopathy (defined as platelet count <50,000/μl and/or prothrombin time more than 18 s), life expectancy <6 months, or inability to give written informed consent
[TARGET] => found infection in there were n = 13 (2.7%) thromboses, n = 11 (2.3%) irreversible occlusions, n = 7 (1.5%) accidental removals, n = 5 (1.0%) infections [two catheter related blood stream infection (crbsi) and three exit site/local infection], n = 3 (0.6%) ruptures and n = 3 (0.6%) primary or secondary malpositions
# 30348912 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in evaluation of a novel flushing protocol for a peripherally inserted central catheter (picc) in the neurological intensive care unit: a prospective randomized study
[TARGET] => found intensive care unit in methods: in this prospective randomized study, we evaluated 360 patients with piccs who were admitted to our neurological intensive care unit from march 2012 to february 201 4
## -> Scan Factor Gender
[TARGET] => found male in the rate of blockage of piccs, proportion of male subjects, age of subjects, apache ii score and length of stay in hospital showed no significant differences between the two groups
[RISK] => found group in the rate of blockage of piccs, proportion of male subjects, age of subjects, apache ii score and length of stay in hospital showed no significant differences between the two groups
## -> Scan Factor Age
[TARGET] => found  age  in the rate of blockage of piccs, proportion of male subjects, age of subjects, apache ii score and length of stay in hospital showed no significant differences between the two groups
[RISK] => found group in the rate of blockage of piccs, proportion of male subjects, age of subjects, apache ii score and length of stay in hospital showed no significant differences between the two groups
## -> Scan Factor PICC infection
[TARGET] => found infection in we investigated whether a novel flushing method for piccs could decrease the risk of venous thromboembolism (vt) and catheter-associated bloodstream infections (cabsis) compared to the traditional flushing method
[RISK] => found risk in we investigated whether a novel flushing method for piccs could decrease the risk of venous thromboembolism (vt) and catheter-associated bloodstream infections (cabsis) compared to the traditional flushing method
[RISK] => found associate in we investigated whether a novel flushing method for piccs could decrease the risk of venous thromboembolism (vt) and catheter-associated bloodstream infections (cabsis) compared to the traditional flushing method
[RISK] => found decrease in we investigated whether a novel flushing method for piccs could decrease the risk of venous thromboembolism (vt) and catheter-associated bloodstream infections (cabsis) compared to the traditional flushing method
# 33084898 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in conclusions and relevance: this cohort study suggests that, when piccs were placed for intravenous antimicrobial therapy, infectious disease physician approval of picc insertion was associated with more appropriate device use and fewer complications
[RISK] => found associate in conclusions and relevance: this cohort study suggests that, when piccs were placed for intravenous antimicrobial therapy, infectious disease physician approval of picc insertion was associated with more appropriate device use and fewer complications
[RISK] => found more in conclusions and relevance: this cohort study suggests that, when piccs were placed for intravenous antimicrobial therapy, infectious disease physician approval of picc insertion was associated with more appropriate device use and fewer complications
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in the association between infectious disease physician approval, device appropriateness, and catheter complications was assessed using multivariable models, adjusted for patient comorbidities and hospital clustering
## -> Scan Factor PICC infection
[TARGET] => found infection in complications related to piccs included catheter occlusion, deep vein thrombosis, and central line-associated bloodstream infection
[RISK] => found associate in complications related to piccs included catheter occlusion, deep vein thrombosis, and central line-associated bloodstream infection
# 28634973 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in indications for picc insertion included: chemotherapy (n = 97, 71.9%), antibiotic therapy (n = 24, 17.8%), total parenteral nutrition (n = 8, 5.9%), blood product transfusion (n = 4, 3.0%) and palliative care (n = 2, 1.5%)
## -> Scan Factor Cancer
[TARGET] => found cancer in piccs were restricted to cancer and infectious disease patients, and were followed up irrespective of the management setting (inpatient, outpatient or intermittently hospitalised after insertion)
[RISK] => found low in piccs were restricted to cancer and infectious disease patients, and were followed up irrespective of the management setting (inpatient, outpatient or intermittently hospitalised after insertion)
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: we prospectively collected data for this surveillance study from all patients who underwent picc insertion from 1 january 2014 and had the catheter removed by 31 december 2015 in our 950-bed academic hospital (bern university hospital, switzerland)
[TARGET] => found picc insertion in indications for picc insertion included: chemotherapy (n = 97, 71.9%), antibiotic therapy (n = 24, 17.8%), total parenteral nutrition (n = 8, 5.9%), blood product transfusion (n = 4, 3.0%) and palliative care (n = 2, 1.5%)
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in indications for picc insertion included: chemotherapy (n = 97, 71.9%), antibiotic therapy (n = 24, 17.8%), total parenteral nutrition (n = 8, 5.9%), blood product transfusion (n = 4, 3.0%) and palliative care (n = 2, 1.5%)
## -> Scan Factor PICC infection
[TARGET] => found infection in during a total of 10 402 catheter-days (median dwell time 62 days), there were five central line-associated bloodstream infections, including one mucosal barrier injury laboratory-confirmed bloodstream infection and two exit-site infections, yielding incidence rates of 0.48 and 0.19 infections per 1000 catheter-days, respectively
[RISK] => found associate in during a total of 10 402 catheter-days (median dwell time 62 days), there were five central line-associated bloodstream infections, including one mucosal barrier injury laboratory-confirmed bloodstream infection and two exit-site infections, yielding incidence rates of 0.48 and 0.19 infections per 1000 catheter-days, respectively
[TARGET] => found infection in infection prevention specialists should be actively involved during the introduction of new intravascular devices in order to provide quality indicators and assure patient safety
# 31236782 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in methods: this was a retrospective study of randomized, single-center, controlled clinical trial on patients hospitalized in the intensive care unit with critical neurological illness who had a picc and were not receiving anticoagulants
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in methods: this was a retrospective study of randomized, single-center, controlled clinical trial on patients hospitalized in the intensive care unit with critical neurological illness who had a picc and were not receiving anticoagulants
# 28823518 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in all patients were receiving treatment for cancer
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in forty-four patients were treated with rivaroxaban and 40 with initial lmw heparin and vitamin k antagonist with continuation of vitamin k antagonists alone once international normalized ratio was therapeutic findings: in the rivaroxaban group mean (sd) age was 51 (16) years and 57% were men, whereas in the other group respective values were 50 (16) years and 56%
[RISK] => found group in forty-four patients were treated with rivaroxaban and 40 with initial lmw heparin and vitamin k antagonist with continuation of vitamin k antagonists alone once international normalized ratio was therapeutic findings: in the rivaroxaban group mean (sd) age was 51 (16) years and 57% were men, whereas in the other group respective values were 50 (16) years and 56%
# 36676072 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in the use of umbilical venous catheters (uvcs) has become the standard of care in the neonatal intensive care unit (nicu) to administer fluids, medications and parenteral nutrition
[TARGET] => found icu in the use of umbilical venous catheters (uvcs) has become the standard of care in the neonatal intensive care unit (nicu) to administer fluids, medications and parenteral nutrition
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in the use of umbilical venous catheters (uvcs) has become the standard of care in the neonatal intensive care unit (nicu) to administer fluids, medications and parenteral nutrition
## -> Scan Factor PICC infection
[TARGET] => found infection in however, it is well known that uvcs can lead to some serious complications, both mechanical and infective, including clabsi (central line-associated bloodstream infections)
[RISK] => found associate in however, it is well known that uvcs can lead to some serious complications, both mechanical and infective, including clabsi (central line-associated bloodstream infections)
[TARGET] => found infection in these guidelines also suggest as an infection prevention strategy to remove uvc after 4 days, followed by the insertion of a picc if a central line is still needed
[RISK] => found low in these guidelines also suggest as an infection prevention strategy to remove uvc after 4 days, followed by the insertion of a picc if a central line is still needed
[TARGET] => found infection in in this study we reviewed a total of 177 articles, found by using the pubmed database with the following search strings: "uvc and neonates", "(neonate* or newborn*) and (uvc or central catheter*) and (infection*)"
[RISK] => found low in in this study we reviewed a total of 177 articles, found by using the pubmed database with the following search strings: "uvc and neonates", "(neonate* or newborn*) and (uvc or central catheter*) and (infection*)"
# 27371372 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in from april 2014 to october 2014, we analyzed a series of 245 consecutive oncology patients undergoing chemotherapy via piccs, for an overall number of 246 picc placements
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in conclusions: our prospective study suggests that the rate of picc-related upper extremity venous thrombosis in oncology patients is high, and the occurrence of symptomatic thrombosis could be lowered with regular weekly doppler screening after picc insertions
[RISK] => found high in conclusions: our prospective study suggests that the rate of picc-related upper extremity venous thrombosis in oncology patients is high, and the occurrence of symptomatic thrombosis could be lowered with regular weekly doppler screening after picc insertions
[RISK] => found low in conclusions: our prospective study suggests that the rate of picc-related upper extremity venous thrombosis in oncology patients is high, and the occurrence of symptomatic thrombosis could be lowered with regular weekly doppler screening after picc insertions
# 22948189 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in comparison of catheter-related large vein thrombosis in centrally inserted versus peripherally inserted central venous lines in the neurological intensive care unit
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in risk factors for crlvt including mannitol therapy during dwell time, previous history of venous thromboembolism, surgery longer than 1h during dwell time, and line placement in a paretic arm were also compared between groups
[RISK] => found risk in risk factors for crlvt including mannitol therapy during dwell time, previous history of venous thromboembolism, surgery longer than 1h during dwell time, and line placement in a paretic arm were also compared between groups
[RISK] => found factor in risk factors for crlvt including mannitol therapy during dwell time, previous history of venous thromboembolism, surgery longer than 1h during dwell time, and line placement in a paretic arm were also compared between groups
[RISK] => found group in risk factors for crlvt including mannitol therapy during dwell time, previous history of venous thromboembolism, surgery longer than 1h during dwell time, and line placement in a paretic arm were also compared between groups
## -> Scan Factor PICC infection
[TARGET] => found infection in objective: to compare cumulative complication rates of peripherally (picc) and centrally (cicvc) inserted central venous catheters, including catheter-related large vein thrombosis (crlvt), central line-associated bloodstream infection (clabsi), and line insertion-related complications in neurological intensive care patients
[RISK] => found associate in objective: to compare cumulative complication rates of peripherally (picc) and centrally (cicvc) inserted central venous catheters, including catheter-related large vein thrombosis (crlvt), central line-associated bloodstream infection (clabsi), and line insertion-related complications in neurological intensive care patients
# 38157768 ---------
## -> Scan Factor Gender
[TARGET] => found male in results: during the study duration, 386 nctcvcs were placed in 60 unique patients (55 % female) with a mean of 6.4 catheters per patient
[TARGET] => found female in results: during the study duration, 386 nctcvcs were placed in 60 unique patients (55 % female) with a mean of 6.4 catheters per patient
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in complications analyzed included catheter related deep venous thrombosis (dvt), central line associated blood stream infection (clabsi), and catheter related central venous stenosis
[RISK] => found associate in complications analyzed included catheter related deep venous thrombosis (dvt), central line associated blood stream infection (clabsi), and catheter related central venous stenosis
# 34177272 ---------
## -> Scan Factor Gender
[TARGET] => found sex in there were no significant differences in age, sex, race, or mean platelet levels between patients diagnosed with dvt and those without (p<0.05)
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in collected data points included patient demographics, comorbidities, central-line use, platelet count at time of scan, length of stay, and overall mortality
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in collected data points included patient demographics, comorbidities, central-line use, platelet count at time of scan, length of stay, and overall mortality
[TARGET] => found platelet in there were no significant differences in age, sex, race, or mean platelet levels between patients diagnosed with dvt and those without (p<0.05)
[TARGET] => found platelet in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found risk in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found factor in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found correlation in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found increase in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
## -> Scan Factor Hypertension
[TARGET] => found hypertension in after multinomial regression analysis, central venous catheter (cvc; 26.8% versus 78.5%, aor 1.770, 95% ci 1.150-2.725; p<0.002), peripherally inserted central catheter (picc) line (17.5% versus 82.5%, aor3.254, 95% ci 1.997-5.304; p<0.001), hypertension (67.8% versus 28.8%, aor 1.641, 95% ci 1.136-2.369; p<0.001), chronic kidney disease (ckd; 34.5% versus 65.5%, aor 1.743, 95% ci 1.201-2.531; p<0.001), and malignancy (27.1% versus 74.6%, aor 1.475, 95% ci 0.994-2.190; p<0.053) were found to be independent predictors of uedvt
[TARGET] => found hypertension in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found risk in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found factor in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found correlation in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
[RISK] => found increase in conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt
# 28822403 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in inpatient peripherally inserted central venous catheter complications: should peripherally inserted central catheter lines be placed in the intensive care unit setting? 
[TARGET] => found intensive care unit in peripherally inserted central venous catheters (piccs) are now commonly used for central access in the intensive care unit (icu) setting; however, there is a paucity of data evaluating the complication rates associated with these lines
[RISK] => found associate in peripherally inserted central venous catheters (piccs) are now commonly used for central access in the intensive care unit (icu) setting; however, there is a paucity of data evaluating the complication rates associated with these lines
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the combined thrombotic and central line associated blood stream infection rate was 6.17 per cent in the non-icu group and 10.53 per cent in the icu group (p = 0.035)
[RISK] => found associate in the combined thrombotic and central line associated blood stream infection rate was 6.17 per cent in the non-icu group and 10.53 per cent in the icu group (p = 0.035)
[RISK] => found group in the combined thrombotic and central line associated blood stream infection rate was 6.17 per cent in the non-icu group and 10.53 per cent in the icu group (p = 0.035)
[TARGET] => found infection in the thrombotic complication rate was 5.88 per cent in the non-icu group and 7.60 per cent in the icu group (p = 0.38), whereas the central line associated blood stream infection rate was 0.29 per cent in the non-icu group and 2.92 per cent in the icu group (p = 0.002)
[RISK] => found associate in the thrombotic complication rate was 5.88 per cent in the non-icu group and 7.60 per cent in the icu group (p = 0.38), whereas the central line associated blood stream infection rate was 0.29 per cent in the non-icu group and 2.92 per cent in the icu group (p = 0.002)
[RISK] => found group in the thrombotic complication rate was 5.88 per cent in the non-icu group and 7.60 per cent in the icu group (p = 0.38), whereas the central line associated blood stream infection rate was 0.29 per cent in the non-icu group and 2.92 per cent in the icu group (p = 0.002)
# 27957644 ---------
## -> Scan Factor ICU
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in tip malposition of peripherally inserted central catheters: a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement
[TARGET] => found position in the aim of our study was to compare the bst with the fluoroscopically guided technique (fgt), with specific regard to catheter tip position (ctp)
[TARGET] => found position in depending on the international guidelines for optimal ctp, patients were classified in three types: optimal, suboptimal not needing repositioning, and nonoptimal requiring additional repositioning procedures
[TARGET] => found position in in the bst groups, 23.3% of placements were suboptimal and 30% nonoptimal, requiring repositioning
[RISK] => found group in in the bst groups, 23.3% of placements were suboptimal and 30% nonoptimal, requiring repositioning
[TARGET] => found position in conclusion: tip malposition rates are high when using blind bst, exposing the patient to an increased risk of deep venous thrombosis and catheter malfunction
[RISK] => found risk in conclusion: tip malposition rates are high when using blind bst, exposing the patient to an increased risk of deep venous thrombosis and catheter malfunction
[RISK] => found high in conclusion: tip malposition rates are high when using blind bst, exposing the patient to an increased risk of deep venous thrombosis and catheter malfunction
[RISK] => found increase in conclusion: tip malposition rates are high when using blind bst, exposing the patient to an increased risk of deep venous thrombosis and catheter malfunction
[TARGET] => found position in using the fgt or emerging technologies that could help tip positioning are recommended, especially for long-term indications
[TARGET] => found position in • catheter malposition is the major technical issue with the bedside technique
[TARGET] => found position in • catheter malposition occurred in 53% of patients with the bedside technique
# 24464053 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in some initial problems with infection and pain were encountered and interventions were put in place to minimise their incidence
# 26369828 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in after systematic reviews of the literature, scenarios related to picc use, care, and maintenance were developed according to patient population (for example, general hospitalized, critically ill, cancer, kidney disease), indication for insertion (infusion of peripherally compatible infusates vs
[TARGET] => found cancer in in patients with cancer, piccs were rated as appropriate for irritant or vesicant infusion, regardless of duration
[RISK] => found less in in patients with cancer, piccs were rated as appropriate for irritant or vesicant infusion, regardless of duration
## -> Scan Factor PICC infection
[TARGET] => found infection in increasing use has led to the realization that piccs are associated with important complications, including thrombosis and infection
[RISK] => found associate in increasing use has led to the realization that piccs are associated with important complications, including thrombosis and infection
# 23633980 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors
[RISK] => found risk in upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors
[RISK] => found factor in upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors
[TARGET] => found cancer in the purpose of this study was to ascertain risk factors associated with an increased risk of picc-associated uevt in patients with cancer
[RISK] => found risk in the purpose of this study was to ascertain risk factors associated with an increased risk of picc-associated uevt in patients with cancer
[RISK] => found factor in the purpose of this study was to ascertain risk factors associated with an increased risk of picc-associated uevt in patients with cancer
[RISK] => found associate in the purpose of this study was to ascertain risk factors associated with an increased risk of picc-associated uevt in patients with cancer
[RISK] => found increase in the purpose of this study was to ascertain risk factors associated with an increased risk of picc-associated uevt in patients with cancer
[TARGET] => found cancer in methods: retrospective analysis identified 237 patients with cancer who received piccs at the dallas veterans affairs medical center from 2006 to 2009
[TARGET] => found cancer in conclusion: specific factors significantly increase the risk of uevt in patients with cancer with piccs, whereas use of apas seems to have a protective effect against uevt
[RISK] => found risk in conclusion: specific factors significantly increase the risk of uevt in patients with cancer with piccs, whereas use of apas seems to have a protective effect against uevt
[RISK] => found factor in conclusion: specific factors significantly increase the risk of uevt in patients with cancer with piccs, whereas use of apas seems to have a protective effect against uevt
[RISK] => found increase in conclusion: specific factors significantly increase the risk of uevt in patients with cancer with piccs, whereas use of apas seems to have a protective effect against uevt
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
[RISK] => found risk in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
[RISK] => found factor in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
## -> Scan Factor PICC infection
[TARGET] => found infection in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
[RISK] => found risk in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
[RISK] => found factor in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
## -> Scan Factor Erythropoiesis-stimulating agents
[TARGET] => found erythropoiesis in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
[RISK] => found risk in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
[RISK] => found factor in we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab
## -> Scan Factor Anticoagulants therapy
# 32043739 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in catheter-related thrombosis incidence and risk factors in adult cancer patients with central venous access devices
[RISK] => found risk in catheter-related thrombosis incidence and risk factors in adult cancer patients with central venous access devices
[RISK] => found factor in catheter-related thrombosis incidence and risk factors in adult cancer patients with central venous access devices
[TARGET] => found cancer in background: central venous access devices (cvad) are commonly employed in the management of cancer patients
[TARGET] => found cancer in aim: to review the incidence and risk factors for catheter-related thrombosis (crt) in cancer patients with a cvad
[RISK] => found risk in aim: to review the incidence and risk factors for catheter-related thrombosis (crt) in cancer patients with a cvad
[RISK] => found factor in aim: to review the incidence and risk factors for catheter-related thrombosis (crt) in cancer patients with a cvad
[TARGET] => found cancer in methods: we performed a prospective observational cohort study of adult patients with cancer requiring a cvad between 1 january 2004 and 29 june 2016
[TARGET] => found cancer in hodgkin lymphoma, germ cell and oesophagus cancers had the highest crt rates
[RISK] => found high in hodgkin lymphoma, germ cell and oesophagus cancers had the highest crt rates
[TARGET] => found cancer in cancer subtype and insertion side were not predictive of thrombosis
## -> Scan Factor Age
[TARGET] => found  age  in older age groups developed crt at lower rates (hr 0.57; 95% ci 0.39-0.84 for age 50-61 years, and hr 0.63; 95% ci 0.45-0.89 for age >61 years) compared to age <50 years
[RISK] => found low in older age groups developed crt at lower rates (hr 0.57; 95% ci 0.39-0.84 for age 50-61 years, and hr 0.63; 95% ci 0.45-0.89 for age >61 years) compared to age <50 years
[RISK] => found group in older age groups developed crt at lower rates (hr 0.57; 95% ci 0.39-0.84 for age 50-61 years, and hr 0.63; 95% ci 0.45-0.89 for age >61 years) compared to age <50 years
[TARGET] => found  age  in conclusions: age <50 years, picc lines and prior crt were associated with highest crt rate
[RISK] => found associate in conclusions: age <50 years, picc lines and prior crt were associated with highest crt rate
[RISK] => found high in conclusions: age <50 years, picc lines and prior crt were associated with highest crt rate
# 23354238 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found multilumen in types included multilumen (ml), introducer/hemodialysis (i/hd), and picc
## -> Scan Factor ICU
[TARGET] => found intensive care unit in which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit
[RISK] => found associate in which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit
[RISK] => found high in which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit
[TARGET] => found intensive care unit in background: catheter-associated deep venous thromboses (cadvts) are a common occurrence in the surgical intensive care unit (sicu), necessitating central venous catheter (cvc) removal and replacement
[RISK] => found associate in background: catheter-associated deep venous thromboses (cadvts) are a common occurrence in the surgical intensive care unit (sicu), necessitating central venous catheter (cvc) removal and replacement
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit
[RISK] => found associate in which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit
[RISK] => found high in which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit
[TARGET] => found catheter day in rates of cadvt were 9 per 1,000 catheter days for sc, 61 for ij (p < 0.01 vs
# 34981151 ---------
## -> Scan Factor Age
[TARGET] => found old in patients aged 18 years or older who had experienced a traumatic event and had undergone an upper extremity ultrasound (ueus) were included in the study
[TARGET] => found older in patients aged 18 years or older who had experienced a traumatic event and had undergone an upper extremity ultrasound (ueus) were included in the study
# 30111976 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in patient preference centred mainly on avoiding delays in the initiation of chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey
[RISK] => found risk in perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey
[RISK] => found factor in perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey
[TARGET] => found cancer in background: the choice of vascular access for systemic therapy administration in breast cancer remains an area of clinical equipoise, and patient preference is not consistently acknowledged
[TARGET] => found cancer in using a patient survey, we evaluated the patient experience with vascular access during treatment for early-stage breast cancer and explored perceived risk factors for lymphedema
[RISK] => found risk in using a patient survey, we evaluated the patient experience with vascular access during treatment for early-stage breast cancer and explored perceived risk factors for lymphedema
[RISK] => found factor in using a patient survey, we evaluated the patient experience with vascular access during treatment for early-stage breast cancer and explored perceived risk factors for lymphedema
[TARGET] => found cancer in methods: patients who had received systemic therapy for early-stage breast cancer were surveyed at 2 canadian cancer centres
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in self-reported rates of complications (183 evaluable responses) were infiltration with peripheral ivs (9/44, 20%), local skin infections with piccs (7/77, 9%), and thrombosis with ports (4/62, 6%)
# 24811603 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in however, a careful review of the literature and a retrospective analysis of the experience at new york hospital queens (nyhq) did not support the position of the standards
## -> Scan Factor PICC infection
[TARGET] => found infection in one suspected catheter-associated bloodstream infection did occur in the picc group
[RISK] => found associate in one suspected catheter-associated bloodstream infection did occur in the picc group
[RISK] => found group in one suspected catheter-associated bloodstream infection did occur in the picc group
## -> Scan Factor Blood vessel irritating drug_vancomycin_amphotericine
[TARGET] => found vancomycin in safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial
[TARGET] => found vancomycin in background: according to the 2011 infusion nursing standards of practice, the low ph of intravenous vancomycin requires that it be administered through a central line
[RISK] => found low in background: according to the 2011 infusion nursing standards of practice, the low ph of intravenous vancomycin requires that it be administered through a central line
[TARGET] => found vancomycin in purpose: a prospective, controlled, randomized clinical trial was conducted to determine if intravenous vancomycin could be safely administered through a novel midline catheter (powerwand®, access scientific, san diego, ca)
[TARGET] => found vancomycin in methods: patients scheduled to receive short-term (<6 days) intravenous vancomycin were randomly assigned to receive treatment through either a peripherally inserted central catheter (picc) or the midline study device
[TARGET] => found vancomycin in conclusions: short-term intravenous vancomycin can be safely and cost-efficiently administered in the deep vessels of the upper arm using the midline study device
# 22864473 ---------
## -> Scan Factor Gender
[TARGET] => found male in sixty piccs were inserted in 57 patients (23 females and 34 males; mean age 48, range 19-68 years) and remained in place for an overall period of 1,276 days
[TARGET] => found female in sixty piccs were inserted in 57 patients (23 females and 34 males; mean age 48, range 19-68 years) and remained in place for an overall period of 1,276 days
## -> Scan Factor BMI
[TARGET] => found bmi in peripherally inserted central catheters (piccs) in the management of oncohematological patients submitted to autologous stem cell transplantation
## -> Scan Factor Age
[TARGET] => found  age  in sixty piccs were inserted in 57 patients (23 females and 34 males; mean age 48, range 19-68 years) and remained in place for an overall period of 1,276 days
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in all piccs were positioned by a team of specifically trained physicians and nurses and utilized by specifically trained nurses of our hematology unit
## -> Scan Factor Transplantation
[TARGET] => found transplantation in peripherally inserted central catheters (piccs) in the management of oncohematological patients submitted to autologous stem cell transplantation
[TARGET] => found transplantation in the aim of our study was to evaluate the feasibility and the safety of the use of peripherally inserted central catheters (piccs) during autologous peripheral blood stem cell transplantation
[TARGET] => found transplantation in our data suggest that piccs are a safe and effective alternative to conventional central venous catheters even in patients particularly prone to infective and hemorrhagic complications such as patients receiving autologous stem cell transplantation
## -> Scan Factor PICC infection
[TARGET] => found infection in late complications were accidental catheter removal (5 %, 2.3 per 1,000 picc days), symptomatic catheter-related venous thrombosis (5 %, 2.3 per 1,000 picc days), and catheter-related bloodstream infection (crbsi; 3.3 %, 1.5 crbsi per 1,000 picc days)
# 31387123 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in outpatient parenteral antibiotic therapy (opat) with peripherally inserted central catheter in patients with periprosthetic joint infection
[TARGET] => found infection in background: a key factor in the successful treatment of periprosthetic joint infection is the consistent antimicrobial therapy
[RISK] => found factor in background: a key factor in the successful treatment of periprosthetic joint infection is the consistent antimicrobial therapy
[TARGET] => found infection in methods: we prospectively evaluated the systematic use of picc in 11 patients with periprosthetic joint infection
[TARGET] => found infection in the occurrence of a catheter-related bloodstream infection (crbsi) was not recorded
[TARGET] => found infection in none of our patients had picc-associated infections, thrombophlebitis or thrombosis
[RISK] => found associate in none of our patients had picc-associated infections, thrombophlebitis or thrombosis
[TARGET] => found infection in at a mean follow-up of 29 months, successful infection eradication as measured by the delphi criteria was achieved in 100%
[RISK] => found low in at a mean follow-up of 29 months, successful infection eradication as measured by the delphi criteria was achieved in 100%
[TARGET] => found infection in antimicrobial therapy for treatment of periprosthetic joint infection
[TARGET] => found infection in the successful infection control in all cases despite proven difficult-to-treat infection is promising
# 27647824 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in methods: a retrospective observational study, involving individuals ≥18 years of age who underwent tsb-cvc placement by interventional radiology at mayo clinic, rochester, mn between 1/1/2010 and 8/30/2013
[TARGET] => found  age  in findings: the study cohort included 92 patients with a median age of 55 (46-67) years, who underwent 108 tsb-cvc placements
## -> Scan Factor PICC indwelling time
[TARGET] => found indwelling time in median catheter indwelling time was 20 (11-43) days (n = 84)
## -> Scan Factor PICC infection
[TARGET] => found infection in tsb-cvc-related bloodstream infection, deep venous thrombosis (dvt), and superficial venous thrombosis (spvt) rates per line were 0.009 (1/108), 0.018 (2/108), and 0.009 (1/108), respectively
# 31565960 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary end point was the incidence of composite catheter-related adverse events that included local events, catheter dislodgment, infiltration, catheter occlusion, catheter-related venous thromboembolism, extravasation, and line-associated infection
[RISK] => found associate in the primary end point was the incidence of composite catheter-related adverse events that included local events, catheter dislodgment, infiltration, catheter occlusion, catheter-related venous thromboembolism, extravasation, and line-associated infection
# 31464692 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in background: peripherally inserted central catheters (piccs) and implantable port catheters (ipcs) are 2 most common central venous access for cancer patients receiving chemotherapy
[TARGET] => found chemotherapy in objective: to compare the differences of complications and costs of picc and ipc in the treatment of cancer patients with chemotherapy and to provide a basis for better clinical decision making
[TARGET] => found chemotherapy in conclusions: implantable port catheter has advantages over picc in reducing cancer patients' complications and less cost in terms of long-term cancer chemotherapy
[RISK] => found less in conclusions: implantable port catheter has advantages over picc in reducing cancer patients' complications and less cost in terms of long-term cancer chemotherapy
[TARGET] => found chemotherapy in implications for practice: in terms of safety, the results provide evidence for practitioners to choose which type of central venous catheters is better for cancer chemotherapy patients
## -> Scan Factor Cancer
[TARGET] => found cancer in complications and costs of peripherally inserted central venous catheters compared with implantable port catheters for cancer patients: a meta-analysis
[TARGET] => found cancer in background: peripherally inserted central catheters (piccs) and implantable port catheters (ipcs) are 2 most common central venous access for cancer patients receiving chemotherapy
[TARGET] => found cancer in objective: to compare the differences of complications and costs of picc and ipc in the treatment of cancer patients with chemotherapy and to provide a basis for better clinical decision making
[TARGET] => found cancer in conclusions: implantable port catheter has advantages over picc in reducing cancer patients' complications and less cost in terms of long-term cancer chemotherapy
[RISK] => found less in conclusions: implantable port catheter has advantages over picc in reducing cancer patients' complications and less cost in terms of long-term cancer chemotherapy
[TARGET] => found cancer in implications for practice: in terms of safety, the results provide evidence for practitioners to choose which type of central venous catheters is better for cancer chemotherapy patients
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate
[RISK] => found associate in peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate
[RISK] => found high in peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate
## -> Scan Factor PICC infection
[TARGET] => found infection in peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate
[RISK] => found associate in peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate
[RISK] => found high in peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate
# 23697825 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in in the non-comparison studies, the weighted frequency of picc-related deep vein thrombosis was highest in patients who were critically ill (13·91%, 95% ci 7·68-20·14) and those with cancer (6·67%, 4·69-8·64)
[RISK] => found high in in the non-comparison studies, the weighted frequency of picc-related deep vein thrombosis was highest in patients who were critically ill (13·91%, 95% ci 7·68-20·14) and those with cancer (6·67%, 4·69-8·64)
## -> Scan Factor Age
# 36299679 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in functions of heparin sodium injection in the prevention of peripherally inserted central catheter-related venous thrombosis in nsclc patients during postoperative chemotherapy
[TARGET] => found chemotherapy in objective: this study intended to analyze hazardous factors of venous thrombosis by comparing the effect of different doses of heparin sodium injection on the incidence rate of peripherally inserted central catheter (picc)-related venous thrombosis in non-small cell lung carcinoma (nsclc) patients during postoperative chemotherapy
[RISK] => found factor in objective: this study intended to analyze hazardous factors of venous thrombosis by comparing the effect of different doses of heparin sodium injection on the incidence rate of peripherally inserted central catheter (picc)-related venous thrombosis in non-small cell lung carcinoma (nsclc) patients during postoperative chemotherapy
[TARGET] => found chemotherapy in based on their different pathological types, patients were given two different chemotherapy regimens: pemetrexed+cisplatin or paclitaxel+cisplatin
[TARGET] => found chemotherapy in conclusion: heparin sodium could significantly lower the incidence rate of picc-related venous thrombosis in nsclc patients during postoperative chemotherapy
[RISK] => found low in conclusion: heparin sodium could significantly lower the incidence rate of picc-related venous thrombosis in nsclc patients during postoperative chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in methods: 425 nsclc patients who received picc catheterization in cancer hospital chinese academy of medical sciences, shenzhen hospital from july 2019 to july 2021 were collected
[TARGET] => found carcinoma in objective: this study intended to analyze hazardous factors of venous thrombosis by comparing the effect of different doses of heparin sodium injection on the incidence rate of peripherally inserted central catheter (picc)-related venous thrombosis in non-small cell lung carcinoma (nsclc) patients during postoperative chemotherapy
[RISK] => found factor in objective: this study intended to analyze hazardous factors of venous thrombosis by comparing the effect of different doses of heparin sodium injection on the incidence rate of peripherally inserted central catheter (picc)-related venous thrombosis in non-small cell lung carcinoma (nsclc) patients during postoperative chemotherapy
## -> Scan Factor Age
## -> Scan Factor Surgery_type of surgery
## -> Scan Factor Anticoagulants therapy
# 29153532 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in the technical success rate was 99%, with 1055 piccs (97%) placed within 120 seconds of procedure time and 1088 piccs (99%) having the tip located at the ideal position
# 23446614 ---------
## -> Scan Factor Surgery_type of surgery
## -> Scan Factor Transplantation
# 32529962 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in methods: we retrospectively evaluated the outcomes of 178 patients with cvcs referred to an italian specialized cancer center between january 2016 and december 2018
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in no significant differences in terms of catheter-related thromboses (p = 0.676) or catheter-related infections (p = 0.140) were detected
# 24436591 ---------
## -> Scan Factor Cancer
[TARGET] => found carcinoma in there was history of lymphoma in one and nonsmall cell lung carcinoma in one patient
[TARGET] => found lymphoma in there was history of lymphoma in one and nonsmall cell lung carcinoma in one patient
## -> Scan Factor Gender
[TARGET] => found gender in patients were analyzed for age, gender, race, site of thrombosis, coagulation factors, lipid panel, type of antiretroviral treatment, past or present history of infections or malignancy, cd4 absolute and helper cell counts at the beginning of thrombosis, response to treatment and outcome
[RISK] => found factor in patients were analyzed for age, gender, race, site of thrombosis, coagulation factors, lipid panel, type of antiretroviral treatment, past or present history of infections or malignancy, cd4 absolute and helper cell counts at the beginning of thrombosis, response to treatment and outcome
## -> Scan Factor Age
[TARGET] => found  age  in the mean age was 49.87 years (range, 38-58 years)
## -> Scan Factor PICC infection
[TARGET] => found infection in there are several intersecting mechanisms associated with hiv infection and antiviral therapy that are emerging, which may lead to vasculopathy and hypercoagulability in these patients
[RISK] => found associate in there are several intersecting mechanisms associated with hiv infection and antiviral therapy that are emerging, which may lead to vasculopathy and hypercoagulability in these patients
[TARGET] => found infection in patients were analyzed for age, gender, race, site of thrombosis, coagulation factors, lipid panel, type of antiretroviral treatment, past or present history of infections or malignancy, cd4 absolute and helper cell counts at the beginning of thrombosis, response to treatment and outcome
[RISK] => found factor in patients were analyzed for age, gender, race, site of thrombosis, coagulation factors, lipid panel, type of antiretroviral treatment, past or present history of infections or malignancy, cd4 absolute and helper cell counts at the beginning of thrombosis, response to treatment and outcome
# 35815563 ---------
## -> Scan Factor Cancer
## -> Scan Factor Age
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in results: anticoagulants resulted a protective factor mostly for partial cvc occlusion (p = 0.0001), preventing cvc occlusions
[RISK] => found factor in results: anticoagulants resulted a protective factor mostly for partial cvc occlusion (p = 0.0001), preventing cvc occlusions
# 28885477 ---------
# 35701467 ---------
## -> Scan Factor Diabete
[TARGET] => found diabetes in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
[RISK] => found high in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
[RISK] => found group in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
## -> Scan Factor BMI
[TARGET] => found body mass index in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
[RISK] => found high in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
[RISK] => found group in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
## -> Scan Factor Age
[TARGET] => found old in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
[RISK] => found high in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
[RISK] => found group in compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus
# 37349797 ---------
## -> Scan Factor Age
[TARGET] => found old in the cases highlight that clinicians should have a low threshold to utilise imaging modalities such as computerised tomography and transthoracic echocardiography when there is an untoward change in physiological parameters among patients with peripherally inserted central catheters, particularly those with risk factors for peripherally inserted central catheter associated venous thrombosis
[RISK] => found risk in the cases highlight that clinicians should have a low threshold to utilise imaging modalities such as computerised tomography and transthoracic echocardiography when there is an untoward change in physiological parameters among patients with peripherally inserted central catheters, particularly those with risk factors for peripherally inserted central catheter associated venous thrombosis
[RISK] => found factor in the cases highlight that clinicians should have a low threshold to utilise imaging modalities such as computerised tomography and transthoracic echocardiography when there is an untoward change in physiological parameters among patients with peripherally inserted central catheters, particularly those with risk factors for peripherally inserted central catheter associated venous thrombosis
[RISK] => found associate in the cases highlight that clinicians should have a low threshold to utilise imaging modalities such as computerised tomography and transthoracic echocardiography when there is an untoward change in physiological parameters among patients with peripherally inserted central catheters, particularly those with risk factors for peripherally inserted central catheter associated venous thrombosis
[RISK] => found high in the cases highlight that clinicians should have a low threshold to utilise imaging modalities such as computerised tomography and transthoracic echocardiography when there is an untoward change in physiological parameters among patients with peripherally inserted central catheters, particularly those with risk factors for peripherally inserted central catheter associated venous thrombosis
[RISK] => found low in the cases highlight that clinicians should have a low threshold to utilise imaging modalities such as computerised tomography and transthoracic echocardiography when there is an untoward change in physiological parameters among patients with peripherally inserted central catheters, particularly those with risk factors for peripherally inserted central catheter associated venous thrombosis
# 29148000 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in methods: from october 2010 to december 2014, 221 cancer patients with svcs in our center received real-time ultrasound-guidance of the superficial femoral vein inserted central catheters (ficcs) at the mid-thigh
[RISK] => found high in methods: from october 2010 to december 2014, 221 cancer patients with svcs in our center received real-time ultrasound-guidance of the superficial femoral vein inserted central catheters (ficcs) at the mid-thigh
[TARGET] => found cancer in picc insertion via upper extremity veins had also been investigated in 2604 cancer patients without svcs as control
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in the major complications included skin allergy to chlorhexidine gluconate (chg) dressings, exudation, catheter-related infection, catheter occlusions, unplanned catheter withdrawal, venous thrombosis, mechanical phlebitis, and catheter malposition
[TARGET] => found position in it is interesting that a higher rate of catheter malposition was observed in the upper extremity veins picc group than in the ficc group (2.15% vs
[RISK] => found high in it is interesting that a higher rate of catheter malposition was observed in the upper extremity veins picc group than in the ficc group (2.15% vs
[RISK] => found group in it is interesting that a higher rate of catheter malposition was observed in the upper extremity veins picc group than in the ficc group (2.15% vs
## -> Scan Factor Total parenteral nutrition
## -> Scan Factor PICC infection
[TARGET] => found infection in the major complications included skin allergy to chlorhexidine gluconate (chg) dressings, exudation, catheter-related infection, catheter occlusions, unplanned catheter withdrawal, venous thrombosis, mechanical phlebitis, and catheter malposition
# 28676535 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found dual-lumen in at least 1 dose of thrombolytic was required in 75 catheters (11.4% [95% ci 8.61%-13.39]), 31 (7.1%) of the 436 single-lumen catheters and 113 (25.7%) of the 440 lumina of dual-lumen catheters (p < 0.001)
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: we performed a retrospective analysis of a prospective cohort of consecutive patients undergoing picc insertion at the ottawa hospital between jan
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: the total number of catheter days was 58 486, and the median dwell time 45 days
[TARGET] => found catheter day in we observed 4 cases of catheter-related bloodstream infection (0.6% [95% ci 0.17%-1.55%]) (0.07/1000 catheter days)
[TARGET] => found catheter day in ten patients (1.5% [95% ci 0.83%-2.78%]) (0.17/1000 catheter days) had catheter-related deep venous thrombosis
## -> Scan Factor PICC infection
[TARGET] => found infection in we measured the cumulative incidence of major complications (catheter-related bloodstream infections and deep vein thrombosis) and use of a thrombolytic to alleviate occlusions
[TARGET] => found infection in we observed 4 cases of catheter-related bloodstream infection (0.6% [95% ci 0.17%-1.55%]) (0.07/1000 catheter days)
# 29377971 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found multilumen in compared to piccs placed for >5 days, variables associated with short-term piccs included difficult venous access (odds ratio [or], 1.54; 95% confidence interval [ci], 1.40-1.69), multilumen devices (or, 1.53; 95% ci, 1.39-1.69), and teaching hospitals (or, 1.25; 95% ci, 1.04-1.52)
[RISK] => found associate in compared to piccs placed for >5 days, variables associated with short-term piccs included difficult venous access (odds ratio [or], 1.54; 95% confidence interval [ci], 1.40-1.69), multilumen devices (or, 1.53; 95% ci, 1.39-1.69), and teaching hospitals (or, 1.25; 95% ci, 1.04-1.52)
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in complications associated with short-term use, including major (eg, venous thromboembolism [vte] or central lineassociated bloodstream infection [clabsi]) or minor (eg, catheter occlusion, tip migration) events were assessed
[RISK] => found associate in complications associated with short-term use, including major (eg, venous thromboembolism [vte] or central lineassociated bloodstream infection [clabsi]) or minor (eg, catheter occlusion, tip migration) events were assessed
# 25120012 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in purpose: few prospective follow-up studies evaluating the use of peripherally inserted central catheters (piccs) to deliver chemotherapy and/or home parenteral nutrition (hpn) have focused exclusively on oncology outpatients
[RISK] => found low in purpose: few prospective follow-up studies evaluating the use of peripherally inserted central catheters (piccs) to deliver chemotherapy and/or home parenteral nutrition (hpn) have focused exclusively on oncology outpatients
[TARGET] => found chemotherapy in all patients received hpn and 71 % received chemotherapy during the study period
[TARGET] => found chemotherapy in the main findings of this study were that, if accurately managed, piccs can be safely used in cancer patients receiving chemotherapy and/or hpn, recording a low incidence of crbsi, thrombosis, and mechanical complications; a long catheter life span; and a low probability of catheter removal because of complications
[RISK] => found low in the main findings of this study were that, if accurately managed, piccs can be safely used in cancer patients receiving chemotherapy and/or hpn, recording a low incidence of crbsi, thrombosis, and mechanical complications; a long catheter life span; and a low probability of catheter removal because of complications
## -> Scan Factor Cancer
[TARGET] => found cancer in peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study
[TARGET] => found cancer in the aim of this prospective study was to assess the reliability and the safety of piccs over a 5-year use in non-hospitalized cancer patients requiring long-term intravenous therapies
[TARGET] => found cancer in the main findings of this study were that, if accurately managed, piccs can be safely used in cancer patients receiving chemotherapy and/or hpn, recording a low incidence of crbsi, thrombosis, and mechanical complications; a long catheter life span; and a low probability of catheter removal because of complications
[RISK] => found low in the main findings of this study were that, if accurately managed, piccs can be safely used in cancer patients receiving chemotherapy and/or hpn, recording a low incidence of crbsi, thrombosis, and mechanical complications; a long catheter life span; and a low probability of catheter removal because of complications
[TARGET] => found cancer in conclusions: our study suggests that piccs can be successfully utilized as safe and long-lasting venous access devices in non-hospitalized cancer patients
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in methods: since june 2008, all adult oncology outpatient candidates for picc insertion were consecutively enrolled and the incidence of catheter-related complications was investigated
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: two hundred sixty-nine piccs in 250 patients (98 % with solid malignancies) were studied, for a total of 55,293 catheter days (median dwell time 184 days, range 15-1,384)
[TARGET] => found catheter day in the incidence of catheter-related bloodstream infections (crbsis) was low (0.05 per 1,000 catheter days), picc-related symptomatic thrombosis was rare (1.1 %; 0.05 per 1,000 catheter days), and mechanical complications were uncommon (13.1 %; 0.63 per 1,000 catheter days)
[RISK] => found low in the incidence of catheter-related bloodstream infections (crbsis) was low (0.05 per 1,000 catheter days), picc-related symptomatic thrombosis was rare (1.1 %; 0.05 per 1,000 catheter days), and mechanical complications were uncommon (13.1 %; 0.63 per 1,000 catheter days)
[TARGET] => found catheter day in the overall complication rate was 17.5 % (0.85 per 1,000 catheter days) and piccs were removed because of complications only in 7 % of cases
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in purpose: few prospective follow-up studies evaluating the use of peripherally inserted central catheters (piccs) to deliver chemotherapy and/or home parenteral nutrition (hpn) have focused exclusively on oncology outpatients
[RISK] => found low in purpose: few prospective follow-up studies evaluating the use of peripherally inserted central catheters (piccs) to deliver chemotherapy and/or home parenteral nutrition (hpn) have focused exclusively on oncology outpatients
## -> Scan Factor PICC infection
[TARGET] => found infection in the incidence of catheter-related bloodstream infections (crbsis) was low (0.05 per 1,000 catheter days), picc-related symptomatic thrombosis was rare (1.1 %; 0.05 per 1,000 catheter days), and mechanical complications were uncommon (13.1 %; 0.63 per 1,000 catheter days)
[RISK] => found low in the incidence of catheter-related bloodstream infections (crbsis) was low (0.05 per 1,000 catheter days), picc-related symptomatic thrombosis was rare (1.1 %; 0.05 per 1,000 catheter days), and mechanical complications were uncommon (13.1 %; 0.63 per 1,000 catheter days)
# 34293064 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in we retrospectively evaluated the vascular access procedures for intravenous chemotherapy in breast cancer patients from 2016 to 2018
[TARGET] => found chemotherapy in when selecting a catheter, a picc was considered when four cycles of chemotherapy were expected
[TARGET] => found chemotherapy in the selection of catheter considering the clinical situation was effective for providing a safe and secure chemotherapy delivery route
## -> Scan Factor Cancer
[TARGET] => found cancer in tailored approach to the choice of long-term vascular access in breast cancer patients
[TARGET] => found cancer in this study compared the possible options for vascular access in breast cancer patients by analyzing the complications of each method
[TARGET] => found cancer in we retrospectively evaluated the vascular access procedures for intravenous chemotherapy in breast cancer patients from 2016 to 2018
[TARGET] => found cancer in all three types of catheters could be used in breast cancer patients without causing serious complications
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in all but one patient with an arm port were women, with mean age of 51.7 ± 9.1 years
## -> Scan Factor PICC indwelling time
[TARGET] => found indwelling time in the total mean complication-free catheter indwelling time was 1357.6 days for chest ports, 997.8 days for arm ports, and 366.8 days for piccs (p = 0.004)
## -> Scan Factor PICC infection
[TARGET] => found infection in there was no patient with catheter related blood stream infection or deep vein thrombosis
# 34842905 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in after adjusting for patient characteristics, comorbidities, catheter lumens, and dwell time in logit models, patients who received piccs had a greater risk of developing a major complication compared with those who received midlines (odds ratio, 1.99; 95% ci, 1.61-2.47)
[RISK] => found risk in after adjusting for patient characteristics, comorbidities, catheter lumens, and dwell time in logit models, patients who received piccs had a greater risk of developing a major complication compared with those who received midlines (odds ratio, 1.99; 95% ci, 1.61-2.47)
## -> Scan Factor Gender
[TARGET] => found male in results: data on 10 863 patients, 5758 with piccs and 5105 with midlines (median [iqr] age of device recipients, 64.8 [53.4-75.4] years; 5741 [52.8%] were female), were included
[TARGET] => found female in results: data on 10 863 patients, 5758 with piccs and 5105 with midlines (median [iqr] age of device recipients, 64.8 [53.4-75.4] years; 5741 [52.8%] were female), were included
## -> Scan Factor Age
[TARGET] => found  age  in results: data on 10 863 patients, 5758 with piccs and 5105 with midlines (median [iqr] age of device recipients, 64.8 [53.4-75.4] years; 5741 [52.8%] were female), were included
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in after adjusting for patient characteristics, comorbidities, catheter lumens, and dwell time in logit models, patients who received piccs had a greater risk of developing a major complication compared with those who received midlines (odds ratio, 1.99; 95% ci, 1.61-2.47)
[RISK] => found risk in after adjusting for patient characteristics, comorbidities, catheter lumens, and dwell time in logit models, patients who received piccs had a greater risk of developing a major complication compared with those who received midlines (odds ratio, 1.99; 95% ci, 1.61-2.47)
## -> Scan Factor PICC infection
[TARGET] => found infection in main outcomes and measures: major complications, including a composite of symptomatic catheter-associated deep vein thrombosis (dvt), catheter-related bloodstream infection, and catheter occlusion
[RISK] => found associate in main outcomes and measures: major complications, including a composite of symptomatic catheter-associated deep vein thrombosis (dvt), catheter-related bloodstream infection, and catheter occlusion
[TARGET] => found infection in reduction in complications stemmed from lower rates of occlusion (2.1% vs 7.0%; p < .001) and bloodstream infection (0.4% vs 1.6%; p < .001) in midlines vs piccs; no significant difference in the risk of dvt between piccs and midlines was observed
[RISK] => found risk in reduction in complications stemmed from lower rates of occlusion (2.1% vs 7.0%; p < .001) and bloodstream infection (0.4% vs 1.6%; p < .001) in midlines vs piccs; no significant difference in the risk of dvt between piccs and midlines was observed
[RISK] => found low in reduction in complications stemmed from lower rates of occlusion (2.1% vs 7.0%; p < .001) and bloodstream infection (0.4% vs 1.6%; p < .001) in midlines vs piccs; no significant difference in the risk of dvt between piccs and midlines was observed
[TARGET] => found infection in in time-to-event models, similar outcomes for bloodstream infection and catheter occlusion were noted; however, the risk of dvt events was lower in patients who received piccs vs midlines (hazard ratio, 0.53; 95% ci, 0.38-0.74)
[RISK] => found risk in in time-to-event models, similar outcomes for bloodstream infection and catheter occlusion were noted; however, the risk of dvt events was lower in patients who received piccs vs midlines (hazard ratio, 0.53; 95% ci, 0.38-0.74)
[RISK] => found low in in time-to-event models, similar outcomes for bloodstream infection and catheter occlusion were noted; however, the risk of dvt events was lower in patients who received piccs vs midlines (hazard ratio, 0.53; 95% ci, 0.38-0.74)
[TARGET] => found infection in conclusions and relevance: in this cohort study among patients with placement of midline catheters vs piccs for short-term indications, midlines were associated with a lower risk of bloodstream infection and occlusion compared with piccs
[RISK] => found risk in conclusions and relevance: in this cohort study among patients with placement of midline catheters vs piccs for short-term indications, midlines were associated with a lower risk of bloodstream infection and occlusion compared with piccs
[RISK] => found associate in conclusions and relevance: in this cohort study among patients with placement of midline catheters vs piccs for short-term indications, midlines were associated with a lower risk of bloodstream infection and occlusion compared with piccs
[RISK] => found low in conclusions and relevance: in this cohort study among patients with placement of midline catheters vs piccs for short-term indications, midlines were associated with a lower risk of bloodstream infection and occlusion compared with piccs
# 26339941 ---------
## -> Scan Factor Gender
[TARGET] => found gender in patient factors-including greater age, height, and weight, as well as male gender-were associated with increased vein diameter
[RISK] => found factor in patient factors-including greater age, height, and weight, as well as male gender-were associated with increased vein diameter
[RISK] => found associate in patient factors-including greater age, height, and weight, as well as male gender-were associated with increased vein diameter
[RISK] => found increase in patient factors-including greater age, height, and weight, as well as male gender-were associated with increased vein diameter
## -> Scan Factor Age
# 33173567 ---------
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found duration of picc in median duration of picc usage was 24 d (25%, 75%: 12, 39)
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in this complication is more serious among patients with single ventricle physiology, as it might preclude them from undergoing further life-sustaining palliative surgery
[RISK] => found more in this complication is more serious among patients with single ventricle physiology, as it might preclude them from undergoing further life-sustaining palliative surgery
# 37254629 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: a retrospective cohort study
[TARGET] => found cancer in while implanted port catheters ("ports") have historically been the standard device for intravenous systemic anticancer therapy, the use of peripherally inserted central catheters (piccs) has increased continuously and reliable catheter selection guidelines are lacking
[RISK] => found increase in while implanted port catheters ("ports") have historically been the standard device for intravenous systemic anticancer therapy, the use of peripherally inserted central catheters (piccs) has increased continuously and reliable catheter selection guidelines are lacking
[TARGET] => found cancer in we compare complication rates of ports and piccs in cancer treatment in a retrospective study of 3365 patients with both solid organ (n = 2612) and hematologic (n = 753) malignancies, between 2001 and 2021
## -> Scan Factor PICC infection
[TARGET] => found infection in among major complications, infections and mechanical complications were more common in piccs than in ports (11.9% vs 6.4%, p = .001, 7.3% vs 4.2%, p = .002), whereas the rate of thrombosis was similar (3.4% vs 3.0%, p = .9)
[RISK] => found more in among major complications, infections and mechanical complications were more common in piccs than in ports (11.9% vs 6.4%, p = .001, 7.3% vs 4.2%, p = .002), whereas the rate of thrombosis was similar (3.4% vs 3.0%, p = .9)
# 32943968 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in objectives: central venous access is needed to facilitate chemotherapy for many cancer patients
## -> Scan Factor Cancer
[TARGET] => found cancer in central venous catheter thrombosis in cancer: a multi-centre retrospective study investigating risk factors and contemporary trends in management
[RISK] => found risk in central venous catheter thrombosis in cancer: a multi-centre retrospective study investigating risk factors and contemporary trends in management
[RISK] => found factor in central venous catheter thrombosis in cancer: a multi-centre retrospective study investigating risk factors and contemporary trends in management
[TARGET] => found cancer in objectives: central venous access is needed to facilitate chemotherapy for many cancer patients
[TARGET] => found cancer in we sought to explore the rate of cvct in a general cancer population in australia and to identify factors associated with increased risk of thrombosis
[RISK] => found risk in we sought to explore the rate of cvct in a general cancer population in australia and to identify factors associated with increased risk of thrombosis
[RISK] => found factor in we sought to explore the rate of cvct in a general cancer population in australia and to identify factors associated with increased risk of thrombosis
[RISK] => found associate in we sought to explore the rate of cvct in a general cancer population in australia and to identify factors associated with increased risk of thrombosis
[RISK] => found increase in we sought to explore the rate of cvct in a general cancer population in australia and to identify factors associated with increased risk of thrombosis
[TARGET] => found cancer in setting and participants: we analysed key patient, treatment, and cancer-related factors for 317 patients with cancer and central venous catheters inserted for systemic therapy
[RISK] => found factor in setting and participants: we analysed key patient, treatment, and cancer-related factors for 317 patients with cancer and central venous catheters inserted for systemic therapy
[TARGET] => found cancer in conclusions: this work explored rates of cvct in a general cancer population, observing increased rates in those with piccs or increased body mass index
[RISK] => found increase in conclusions: this work explored rates of cvct in a general cancer population, observing increased rates in those with piccs or increased body mass index
## -> Scan Factor BMI
[TARGET] => found body mass index in having a peripherally inserted central catheter (picc; hr = 3.78, 95% ci = 1.28-11.19, p = .02) compared with an implantable port and a body mass index of ⩾25.0 kg/m(2) (hr = 3.60, 95% ci = 1.31-9.85, p = .01) were independently associated with increased risk of thrombosis
[RISK] => found risk in having a peripherally inserted central catheter (picc; hr = 3.78, 95% ci = 1.28-11.19, p = .02) compared with an implantable port and a body mass index of ⩾25.0 kg/m(2) (hr = 3.60, 95% ci = 1.31-9.85, p = .01) were independently associated with increased risk of thrombosis
[RISK] => found associate in having a peripherally inserted central catheter (picc; hr = 3.78, 95% ci = 1.28-11.19, p = .02) compared with an implantable port and a body mass index of ⩾25.0 kg/m(2) (hr = 3.60, 95% ci = 1.31-9.85, p = .01) were independently associated with increased risk of thrombosis
[RISK] => found increase in having a peripherally inserted central catheter (picc; hr = 3.78, 95% ci = 1.28-11.19, p = .02) compared with an implantable port and a body mass index of ⩾25.0 kg/m(2) (hr = 3.60, 95% ci = 1.31-9.85, p = .01) were independently associated with increased risk of thrombosis
[TARGET] => found body mass index in conclusions: this work explored rates of cvct in a general cancer population, observing increased rates in those with piccs or increased body mass index
[RISK] => found increase in conclusions: this work explored rates of cvct in a general cancer population, observing increased rates in those with piccs or increased body mass index
## -> Scan Factor Age
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in central venous catheter-related thrombosis was managed mostly with removal of the catheter (19 of 24 cases) and anticoagulation, including direct-acting oral anticoagulants in 5 patients
# 37141269 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found triple-lumen in seven picc types were used (4 reverse tapered: 4-fr single-lumen (n = 75), 5-fr single-lumen (n = 78), 5-fr double-lumen (n = 62), and 6-fr triple-lumen (n = 61); 3 nontapered: 4-fr single-lumen (n = 73), 5-fr double-lumen (n = 30), and 6-fr triple-lumen (n = 23))
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in in total, 407 patients who had an inpatient clinic-based picc insertion between september 2019 and november 2019 were retrospectively analyzed
## -> Scan Factor PICC infection
[TARGET] => found infection in complications such as periprocedural bleeding, delayed bleeding, inadvertent removal, catheter obstruction by thrombosis, infection, and leakage were investigated
# 36034199 ---------
# 37166852 ---------
## -> Scan Factor Gender
[TARGET] => found gender in age (median [interquartile range]: 68.7 [58.6-75.7], 66.6 [57.1-75.0], and 67.6 [58.7-75.8] yr) and gender (percentage female: 50.5%, 47.3%, and 43.8%) were similar in all groups
[RISK] => found group in age (median [interquartile range]: 68.7 [58.6-75.7], 66.6 [57.1-75.0], and 67.6 [58.7-75.8] yr) and gender (percentage female: 50.5%, 47.3%, and 43.8%) were similar in all groups
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in multivariable mixed effects logistic regression models were fit to determine the association between vasopressor administration through a midline with outcomes, primarily catheter-related complications (bloodstream infection, superficial thrombophlebitis, exit site infection, or catheter occlusion)
# 31487777 ---------
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in infectious complications in home parenteral nutrition: a systematic review and meta-analysis comparing peripherally-inserted central catheters with other central catheters
[TARGET] => found parenteral nutrition in background: home parenteral nutrition (hpn) has become a common therapy
## -> Scan Factor PICC infection
[TARGET] => found infection in there is still controversy regarding the possibility that peripherally inserted central catheters (piccs) may diminish catheter-related blood stream infection (crbsi) rates
# 25374804 ---------
## -> Scan Factor Power injectable PICC
[TARGET] => found power-injectable in though, the recent development of power-injectable piccs overcomes these technical limitations and piccs have started to spread in critical care settings
[TARGET] => found power-injectable in much evidence from the medical literature and from the clinical practice supports our belief that, compared to ciccs, the so-called power-injectable peripherally inserted central catheters are a good alternative choice in critical care
## -> Scan Factor ICU
[TARGET] => found intensive care unit in some limits previously ascribed to piccs (i.e., low flow rates, difficult central venous pressure monitoring, lack of safety for radio-diagnostic procedures, single-lumen) have delayed their start up in the intensive care units as common practice
[RISK] => found low in some limits previously ascribed to piccs (i.e., low flow rates, difficult central venous pressure monitoring, lack of safety for radio-diagnostic procedures, single-lumen) have delayed their start up in the intensive care units as common practice
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in using the ultrasound-guidance for the picc insertion, the risk of hemothorax and pneumothorax can be avoided, as well as the possibility of primary malposition is very low
[RISK] => found risk in using the ultrasound-guidance for the picc insertion, the risk of hemothorax and pneumothorax can be avoided, as well as the possibility of primary malposition is very low
[RISK] => found low in using the ultrasound-guidance for the picc insertion, the risk of hemothorax and pneumothorax can be avoided, as well as the possibility of primary malposition is very low
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found ecog in second, an inappropriate cvad choice and, particularly, an inadequate insertion technique are relevant-and often not recognized-potential risk factors for complications in critically ill patients
[RISK] => found risk in second, an inappropriate cvad choice and, particularly, an inadequate insertion technique are relevant-and often not recognized-potential risk factors for complications in critically ill patients
[RISK] => found factor in second, an inappropriate cvad choice and, particularly, an inadequate insertion technique are relevant-and often not recognized-potential risk factors for complications in critically ill patients
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in venous access devices are of pivotal importance for an increasing number of critically ill patients in a variety of disease states and in a variety of clinical settings (emergency, intensive care, surgery) and for different purposes (fluids or drugs infusions, parenteral nutrition, antibiotic therapy, hemodynamic monitoring, procedures of dialysis/apheresis)
## -> Scan Factor Surgery_type of surgery
[TARGET] => found surgery in venous access devices are of pivotal importance for an increasing number of critically ill patients in a variety of disease states and in a variety of clinical settings (emergency, intensive care, surgery) and for different purposes (fluids or drugs infusions, parenteral nutrition, antibiotic therapy, hemodynamic monitoring, procedures of dialysis/apheresis)
## -> Scan Factor PICC infection
[TARGET] => found infection in however, healthcare professionals are commonly worried about the possible consequences that may result using a central venous access device (cvad) (mainly, bloodstream infections and thrombosis), both peripherally inserted central catheters (piccs) and centrally inserted central catheters (ciccs)
# 26623068 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in this is the case report of a male patient who was undergoing chemotherapy for colon cancer
## -> Scan Factor Cancer
[TARGET] => found cancer in an unusual cause of respiratory failure in a colon cancer patient
[TARGET] => found cancer in permanent central venous catheters (cvc), such as port-a-cath®, hickmann® or picc®, are widely used in oncology patients for cancer treatment
[TARGET] => found cancer in this is the case report of a male patient who was undergoing chemotherapy for colon cancer
## -> Scan Factor Gender
[TARGET] => found male in this is the case report of a male patient who was undergoing chemotherapy for colon cancer
## -> Scan Factor PICC infection
[TARGET] => found infection in thrombosis is a frequent complication that should be ruled out, as it is associated with potentially severe infection and hemodynamic consequences
[RISK] => found associate in thrombosis is a frequent complication that should be ruled out, as it is associated with potentially severe infection and hemodynamic consequences
# 33388763 ---------
## -> Scan Factor Gender
[TARGET] => found male in mean age [standard error of the mean] was 38.74 [0.06] years (range, 18-74 years), and 54% were female
[TARGET] => found female in mean age [standard error of the mean] was 38.74 [0.06] years (range, 18-74 years), and 54% were female
## -> Scan Factor Age
[TARGET] => found  age  in mean age [standard error of the mean] was 38.74 [0.06] years (range, 18-74 years), and 54% were female
[TARGET] => found  age  in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
[RISK] => found risk in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
[RISK] => found associate in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
[RISK] => found increase in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
## -> Scan Factor Others (COPD, IBD)
[TARGET] => found ibd in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
[RISK] => found risk in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
[RISK] => found associate in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
[RISK] => found increase in from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte
[TARGET] => found ibd in previous vte, picc/central line, advancing age, ibd, and intraoperative rib graft harvest were most strongly associated with vte in this population cohort
[RISK] => found associate in previous vte, picc/central line, advancing age, ibd, and intraoperative rib graft harvest were most strongly associated with vte in this population cohort
# 29659465 ---------
## -> Scan Factor Diabete
[TARGET] => found diabetic in pruevt cases were more likely to be diabetic, but this did not reach statistical significance
[RISK] => found more in pruevt cases were more likely to be diabetic, but this did not reach statistical significance
[TARGET] => found diabetic in the time that a picc was in place before pruevt was diagnosed was longer for diabetic patients, but the authors believe this result must be viewed with caution
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found hyperglycemia in does hyperglycemia affect risk of peripherally inserted central catheter-related upper extremity venous thrombosis? 
[RISK] => found risk in does hyperglycemia affect risk of peripherally inserted central catheter-related upper extremity venous thrombosis? 
# 31294320 ---------
## -> Scan Factor Cancer
## -> Scan Factor Age
[TARGET] => found old in if the confidence interval for the observed rate excludes the threshold event rate of 4%, we will conclude that treatment with apixaban is noninferior and therefore a clinically valid approach to treat uedvt
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in limited evidence exists for the use of a direct oral anticoagulant for the treatment of uedvt
# 28413891 ---------
## -> Scan Factor Gender
## -> Scan Factor PICC infection
[TARGET] => found infection in specific complications included infection (n = 4, 3.6%), mechanical (n = 5, 4.4%), deep venous thrombosis (n = 2, 1.8%) and other (n = 8, 7.1%)
# 29562836 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
# 30795912 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in complications/1000 catheter days were extracted, and a poisson model was used to compare complications between piccs and broviacs®
[TARGET] => found catheter day in results: thirty-seven patients with if were included, accounting for 19,452 catheter days
[TARGET] => found catheter day in incidences of central line associated blood stream infection and venous thrombosis were 3.95 and 0.55 per 1000 catheter days, respectively
[RISK] => found associate in incidences of central line associated blood stream infection and venous thrombosis were 3.95 and 0.55 per 1000 catheter days, respectively
[TARGET] => found catheter day in there were no significant differences in complication rates per line per catheter day between piccs and broviacs® on multivariate analysis
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in inclusion criteria: total parenteral nutrition duration >42 days or small bowel length < 25% of total for gestational age
## -> Scan Factor PICC infection
[TARGET] => found infection in incidences of central line associated blood stream infection and venous thrombosis were 3.95 and 0.55 per 1000 catheter days, respectively
[RISK] => found associate in incidences of central line associated blood stream infection and venous thrombosis were 3.95 and 0.55 per 1000 catheter days, respectively
# 28163887 ---------
## -> Scan Factor Age
# 36113076 ---------
## -> Scan Factor Power injectable PICC
[TARGET] => found power injectable in all cvads were non-valved, non-cuffed power injectable polyurethane catheters; 81% were tunneled
## -> Scan Factor Cancer
[TARGET] => found cancer in background: the use of central venous access devices (cvads) is of paramount importance to safely deliver antiblastic and support therapies in children with cancer
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in median dwelling time of cvads was 172 days, for a total number of 39,044 catheter days
[TARGET] => found catheter day in a very low incidence of both symptomatic catheter-related thrombosis (0.9%) and catheter-related blood stream infection (0.56 episodes per 1000 catheter days) was found
[RISK] => found low in a very low incidence of both symptomatic catheter-related thrombosis (0.9%) and catheter-related blood stream infection (0.56 episodes per 1000 catheter days) was found
## -> Scan Factor PICC infection
[TARGET] => found infection in a very low incidence of both symptomatic catheter-related thrombosis (0.9%) and catheter-related blood stream infection (0.56 episodes per 1000 catheter days) was found
[RISK] => found low in a very low incidence of both symptomatic catheter-related thrombosis (0.9%) and catheter-related blood stream infection (0.56 episodes per 1000 catheter days) was found
# 29293304 ---------
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in while generally safe, cvads can be associated with complications such as catheter occlusion or rupture, venous thrombosis, and bloodstream infection
[RISK] => found associate in while generally safe, cvads can be associated with complications such as catheter occlusion or rupture, venous thrombosis, and bloodstream infection
[TARGET] => found infection in a number of strategies have been used to minimize the occurrence of cvad- and picc-associated complications such as antimicrobial-impregnated lines for prevention of infection, or addition of a valve (valved catheters) to prevent occlusion by preventing reflux of blood into the catheter
[RISK] => found associate in a number of strategies have been used to minimize the occurrence of cvad- and picc-associated complications such as antimicrobial-impregnated lines for prevention of infection, or addition of a valve (valved catheters) to prevent occlusion by preventing reflux of blood into the catheter
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in flushing the catheters with saline or heparin – an agent with anticoagulant activity - have been used to reduce clot formation and occlusion of the catheters
# 35285085 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in objectives: both peripherally inserted central catheters (piccs) and implanted port catheters (ports) are commonly used for the delivery of immunochemotherapy
[TARGET] => found chemotherapy in we compared the safety of the two types of devices in a homogeneous and monocentric population of diffuse large b-cell lymphoma (dlbcl) patients who were treated with first-line immunochemotherapy by evaluating the numbers of catheter-related venous thromboses (vts) and infections that occurred in the six months after implantation according to the type of device
## -> Scan Factor Cancer
[TARGET] => found lymphoma in retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first-line treatment for patients with diffuse large b-cell lymphoma
[TARGET] => found lymphoma in we compared the safety of the two types of devices in a homogeneous and monocentric population of diffuse large b-cell lymphoma (dlbcl) patients who were treated with first-line immunochemotherapy by evaluating the numbers of catheter-related venous thromboses (vts) and infections that occurred in the six months after implantation according to the type of device
## -> Scan Factor PICC infection
[TARGET] => found infection in we compared the safety of the two types of devices in a homogeneous and monocentric population of diffuse large b-cell lymphoma (dlbcl) patients who were treated with first-line immunochemotherapy by evaluating the numbers of catheter-related venous thromboses (vts) and infections that occurred in the six months after implantation according to the type of device
[TARGET] => found infection in methods: using a propensity score, the adjusted relative risk (arr) between the type of catheter and the occurrence of catheter-related complications (infection and/or vt) of interest was retrospectively determined
[RISK] => found risk in methods: using a propensity score, the adjusted relative risk (arr) between the type of catheter and the occurrence of catheter-related complications (infection and/or vt) of interest was retrospectively determined
[TARGET] => found infection in results: 479 patients were enrolled (266 ports/213 piccs), and 26 vts (5.4%) and 30 infections (6.3%) were identified in the period following picc/port implantation
[RISK] => found low in results: 479 patients were enrolled (266 ports/213 piccs), and 26 vts (5.4%) and 30 infections (6.3%) were identified in the period following picc/port implantation
[TARGET] => found infection in the adjusted relative risk (arr) of catheter-related complications (infection and/or vt) according to the type of device was 2.6 (95% ci =1.3-5.9, p = .0075)
[RISK] => found risk in the adjusted relative risk (arr) of catheter-related complications (infection and/or vt) according to the type of device was 2.6 (95% ci =1.3-5.9, p = .0075)
[TARGET] => found infection in this risk increase associated with the picc device was significant for both infections (arr = 3.2; 95% ci = 1.3-10.9) and thrombosis (arr = 4; 95% ci = 1.5-11.6)
[RISK] => found risk in this risk increase associated with the picc device was significant for both infections (arr = 3.2; 95% ci = 1.3-10.9) and thrombosis (arr = 4; 95% ci = 1.5-11.6)
[RISK] => found associate in this risk increase associated with the picc device was significant for both infections (arr = 3.2; 95% ci = 1.3-10.9) and thrombosis (arr = 4; 95% ci = 1.5-11.6)
[RISK] => found increase in this risk increase associated with the picc device was significant for both infections (arr = 3.2; 95% ci = 1.3-10.9) and thrombosis (arr = 4; 95% ci = 1.5-11.6)
# 34148390 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in in patients with cta-tunneled external catheters, there were two dislodgments, four episodes of central line associated blood stream infections, and one local infection
[RISK] => found associate in in patients with cta-tunneled external catheters, there were two dislodgments, four episodes of central line associated blood stream infections, and one local infection
# 37477709 ---------
# 32205131 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy
[RISK] => found risk in patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy
[RISK] => found factor in patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy
[TARGET] => found chemotherapy in objective: peripherally inserted central venous catheter (picc)-related thrombosis (prt) is a serious complication that can lead to interruptions in chemotherapy and other supportive care, as well as increased hospital stay and costs
[RISK] => found increase in objective: peripherally inserted central venous catheter (picc)-related thrombosis (prt) is a serious complication that can lead to interruptions in chemotherapy and other supportive care, as well as increased hospital stay and costs
[TARGET] => found chemotherapy in we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors
[RISK] => found risk in we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors
[RISK] => found factor in we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors
[TARGET] => found chemotherapy in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[RISK] => found risk in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[RISK] => found associate in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[RISK] => found increase in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[TARGET] => found chemotherapy in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found risk in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found factor in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found associate in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found low in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
## -> Scan Factor Cancer
[TARGET] => found cancer in we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors
[RISK] => found risk in we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors
[RISK] => found factor in we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors
[TARGET] => found cancer in the symptomatic svt occurred in 42 of 938 patients with cancer (4.5%), which accounted for 68.9% of all uevt events
[TARGET] => found cancer in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found risk in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found factor in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found associate in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found low in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[TARGET] => found cancer in piccs-related svt was a frequent type of prt, which might need a better understanding and anticoagulant therapy in patients with cancer with piccs
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[RISK] => found risk in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[RISK] => found associate in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[RISK] => found increase in predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825)
[TARGET] => found  age  in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found risk in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found factor in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found associate in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found low in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in among the 28 patients who did not remove their piccs immediately after prt was diagnosed, patients with svt, dvt, and evt had similar success rates of retaining catheters in situ after anticoagulant therapy (svt, 83.3%; dvt, 62.5%; evt, 75.0%; p = .667)
[TARGET] => found anticoagulant in piccs-related svt was a frequent type of prt, which might need a better understanding and anticoagulant therapy in patients with cancer with piccs
## -> Scan Factor Hypertension
[TARGET] => found hypertension in hypertension with medication was a protective factor for prt (or, 0.306; 95% ci, 0.113-0.828)
[RISK] => found factor in hypertension with medication was a protective factor for prt (or, 0.306; 95% ci, 0.113-0.828)
[TARGET] => found hypertension in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found risk in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found factor in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found associate in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
[RISK] => found low in conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy
# 36751645 ---------
## -> Scan Factor PICC infection
[TARGET] => found infection in infection and thrombosis are the main adverse effects of these catheters
[TARGET] => found infection in the primary outcomes were catheter-related bloodstream infection (crbsi) and thrombosis
# 33356810 ---------
## -> Scan Factor Age
# 27792437 ---------
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in following the change in needle-free connector, 180 piccs were inserted by the vascular access team on one of the organisation's sites over a 12-month period, with a total dwell time of 9702 catheter days (mean: 53.9 days, median: 35 days), a pwo rate of 1/1000 catheter days and total occlusion rate of 0.4/1000 catheter days
[RISK] => found low in following the change in needle-free connector, 180 piccs were inserted by the vascular access team on one of the organisation's sites over a 12-month period, with a total dwell time of 9702 catheter days (mean: 53.9 days, median: 35 days), a pwo rate of 1/1000 catheter days and total occlusion rate of 0.4/1000 catheter days
# 25191821 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
[RISK] => found risk in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
[RISK] => found associate in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
[RISK] => found increase in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
[RISK] => found risk in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
[RISK] => found associate in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
[RISK] => found increase in not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)
# 30513003 ---------
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in introduction: thrombotic complications associated with peripherally inserted central catheters (piccs) are common, as most synthetic materials when placed in the presence of serum often result in platelet activation, fibrin deposition, thrombotic occlusion, and potentially embolization
[RISK] => found associate in introduction: thrombotic complications associated with peripherally inserted central catheters (piccs) are common, as most synthetic materials when placed in the presence of serum often result in platelet activation, fibrin deposition, thrombotic occlusion, and potentially embolization
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in introduction: thrombotic complications associated with peripherally inserted central catheters (piccs) are common, as most synthetic materials when placed in the presence of serum often result in platelet activation, fibrin deposition, thrombotic occlusion, and potentially embolization
[RISK] => found associate in introduction: thrombotic complications associated with peripherally inserted central catheters (piccs) are common, as most synthetic materials when placed in the presence of serum often result in platelet activation, fibrin deposition, thrombotic occlusion, and potentially embolization
# 24090605 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in introduction: central venous catheters (cvc) related thrombosis (crt) represents a well known complication in patients with acute myeloid leukemia (aml) receiving intensive chemotherapy but the efficacy of antithrombotic prophylaxis still remains controversial
[TARGET] => found chemotherapy in patients and methods: we analyzed 71 consecutive aml patients whose cvc was inserted before each chemotherapy cycle for an overall number of 106 cvc placements
[TARGET] => found chemotherapy in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
[RISK] => found risk in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
[RISK] => found low in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
[RISK] => found increase in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
## -> Scan Factor Cancer
[TARGET] => found leukemia in infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia
[RISK] => found risk in infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia
[RISK] => found increase in infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia
[TARGET] => found leukemia in introduction: central venous catheters (cvc) related thrombosis (crt) represents a well known complication in patients with acute myeloid leukemia (aml) receiving intensive chemotherapy but the efficacy of antithrombotic prophylaxis still remains controversial
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Total parenteral nutrition
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in lmwh was delivered regardless of the platelet (plt) count once provided that it should have been maintained above 20 x 10(9)/l by transfusions
[RISK] => found less in lmwh was delivered regardless of the platelet (plt) count once provided that it should have been maintained above 20 x 10(9)/l by transfusions
## -> Scan Factor PICC infection
[TARGET] => found infection in infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia
[RISK] => found risk in infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia
[RISK] => found increase in infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia
[TARGET] => found infection in results: of 106 insertions, we observed 19 (18%) episodes of crt, 58 (54%) of sepsis and 50 (47%) infections of cvc-exit site with no difference between lmwh and no-lmwh group
[RISK] => found group in results: of 106 insertions, we observed 19 (18%) episodes of crt, 58 (54%) of sepsis and 50 (47%) infections of cvc-exit site with no difference between lmwh and no-lmwh group
[TARGET] => found infection in occurrence of crt was significantly associated with cvc-exit site infections (14/19, p=0.01) and sepsis (16/19, p=0.005) with no difference between lmwh and no-lmwh group
[RISK] => found associate in occurrence of crt was significantly associated with cvc-exit site infections (14/19, p=0.01) and sepsis (16/19, p=0.005) with no difference between lmwh and no-lmwh group
[RISK] => found group in occurrence of crt was significantly associated with cvc-exit site infections (14/19, p=0.01) and sepsis (16/19, p=0.005) with no difference between lmwh and no-lmwh group
[TARGET] => found infection in in multivariate analysis, both cvc-exit site infections and sepsis were confirmed to be independent risk factors for crt development
[RISK] => found risk in in multivariate analysis, both cvc-exit site infections and sepsis were confirmed to be independent risk factors for crt development
[RISK] => found factor in in multivariate analysis, both cvc-exit site infections and sepsis were confirmed to be independent risk factors for crt development
[TARGET] => found infection in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
[RISK] => found risk in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
[RISK] => found low in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
[RISK] => found increase in conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis
## -> Scan Factor Anticoagulants therapy
# 32375605 ---------
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in randomized multicenter study on long-term complications of peripherally inserted central catheters positioned by electrocardiographic technique
[TARGET] => found position in this randomized clinical trial aimed to evaluate the long-term complications of peripherally inserted central catheters (piccs) positioned by the ic-ecg method
[TARGET] => found position in methods: we randomized 2250 patients who needed picc placement to either a landmark length estimation supplemented by ic-ecg positioned group (ecg group) or the traditional landmark length estimation alone group (control group) in a 2:1 allocation
[RISK] => found group in methods: we randomized 2250 patients who needed picc placement to either a landmark length estimation supplemented by ic-ecg positioned group (ecg group) or the traditional landmark length estimation alone group (control group) in a 2:1 allocation
[TARGET] => found position in post-procedural chest x-rays were applied to confirm tip position
[TARGET] => found position in results: as evaluated by post-procedural chest x-ray, tip location in the ecg group had a first-attempt success (catheter tip located at optimal position) of 91.7% (95% confidence interval (ci): 90.3%-93.1%), significantly higher than 78.9% (95% ci: 76.0%-81.9%) observed in the control group (p < 0.001)
[RISK] => found high in results: as evaluated by post-procedural chest x-ray, tip location in the ecg group had a first-attempt success (catheter tip located at optimal position) of 91.7% (95% confidence interval (ci): 90.3%-93.1%), significantly higher than 78.9% (95% ci: 76.0%-81.9%) observed in the control group (p < 0.001)
[RISK] => found group in results: as evaluated by post-procedural chest x-ray, tip location in the ecg group had a first-attempt success (catheter tip located at optimal position) of 91.7% (95% confidence interval (ci): 90.3%-93.1%), significantly higher than 78.9% (95% ci: 76.0%-81.9%) observed in the control group (p < 0.001)
## -> Scan Factor PICC infection
[TARGET] => found infection in at six-month follow-up, in the control group, frequency of total complications was 9.5%, including the exit site infection (4.0%), phlebitis (1.3%), deep venous thrombosis (1.5%), liquid extravasation (2.9%) and mechanical failure (1.9%)
[RISK] => found low in at six-month follow-up, in the control group, frequency of total complications was 9.5%, including the exit site infection (4.0%), phlebitis (1.3%), deep venous thrombosis (1.5%), liquid extravasation (2.9%) and mechanical failure (1.9%)
[RISK] => found group in at six-month follow-up, in the control group, frequency of total complications was 9.5%, including the exit site infection (4.0%), phlebitis (1.3%), deep venous thrombosis (1.5%), liquid extravasation (2.9%) and mechanical failure (1.9%)
[TARGET] => found infection in the ic-ecg group had significantly lower rates of complications (6.4%, p < 0.001), including the exit site infection (2.7%, p > 0.05), phlebitis (1.1%, p > 0.05), deep venous thrombosis (1.2%, p > 0.05), liquid extravasation (2.4%, p > 0.05) and mechanical failure (1.2%, p > 0.05)
[RISK] => found low in the ic-ecg group had significantly lower rates of complications (6.4%, p < 0.001), including the exit site infection (2.7%, p > 0.05), phlebitis (1.1%, p > 0.05), deep venous thrombosis (1.2%, p > 0.05), liquid extravasation (2.4%, p > 0.05) and mechanical failure (1.2%, p > 0.05)
[RISK] => found group in the ic-ecg group had significantly lower rates of complications (6.4%, p < 0.001), including the exit site infection (2.7%, p > 0.05), phlebitis (1.1%, p > 0.05), deep venous thrombosis (1.2%, p > 0.05), liquid extravasation (2.4%, p > 0.05) and mechanical failure (1.2%, p > 0.05)
# 37205327 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found risk in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found factor in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found increase in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found decrease in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
## -> Scan Factor Gender
[TARGET] => found sex in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found risk in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found factor in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found increase in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found decrease in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
## -> Scan Factor Age
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found risk in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found factor in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found increase in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
[RISK] => found decrease in other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use
# 30909723 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found lumens in to compare incidence of cr thrombosis between mcs and piccs and to evaluate the impact of quantity of lumens and catheter diameter on cr thrombosis
[RISK] => found impact in to compare incidence of cr thrombosis between mcs and piccs and to evaluate the impact of quantity of lumens and catheter diameter on cr thrombosis
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found old in for cr svt, mcs have a 2.29-fold greater odds of developing cr svt than piccs (4.84% mcs and 2.16% piccs; or: 2.29; p = .0002)
# 32028410 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the occurrence of pe is 4% and the death rate is 10.2%, mainly related to the severe comorbidities of patients with ue-vt.ue-vt occurs in particular clinical contexts (hematological malignancies, solid cancers, systemic infections) and in the majority of endovascular devices (86.2%)
[TARGET] => found neoplasia in forty nine percent (n = 370) of the patients had solid neoplasia or hematological malignancies
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in the occurrence of pe is 4% and the death rate is 10.2%, mainly related to the severe comorbidities of patients with ue-vt.ue-vt occurs in particular clinical contexts (hematological malignancies, solid cancers, systemic infections) and in the majority of endovascular devices (86.2%)
## -> Scan Factor PICC infection
[TARGET] => found infection in among the ue-svt it was the presence of an indurated cord (33.2%) and among the ue-dvt the indication of the doppler-ultrasound was mainly a suspicion of infection on endovascular device (35.1%)
[TARGET] => found infection in the occurrence of pe is 4% and the death rate is 10.2%, mainly related to the severe comorbidities of patients with ue-vt.ue-vt occurs in particular clinical contexts (hematological malignancies, solid cancers, systemic infections) and in the majority of endovascular devices (86.2%)
# 30589718 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition
[RISK] => found risk in however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition
[RISK] => found associate in however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition
## -> Scan Factor PICC infection
[TARGET] => found infection in however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition
[RISK] => found risk in however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition
[RISK] => found associate in however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition
[TARGET] => found infection in no infections occurred during this study
# 23002096 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days
[TARGET] => found cancer in background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients
[RISK] => found risk in background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients
[RISK] => found associate in background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients
[TARGET] => found cancer in the aim of this prospective study was to investigate the actual incidence of vad-related complications in cancer patients on hpn
[TARGET] => found cancer in methods: all adult cancer patient candidates for vad insertion and hpn were enrolled
[TARGET] => found cancer in conclusions: in cancer patients, hpn can be safely carried out with a low incidence of complications
[RISK] => found low in conclusions: in cancer patients, hpn can be safely carried out with a low incidence of complications
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days
[TARGET] => found parenteral nutrition in background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients
[RISK] => found risk in background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients
[RISK] => found associate in background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients
## -> Scan Factor PICC infection
[TARGET] => found infection in the incidence of catheter-related bloodstream infections (crbsis) was low (0.35/1000 catheter-days), particularly for piccs (0/1000; p < .01 vs hohn and tunneled catheters) and for ports (0.19/1000; p < .01 vs hohn and p < .05 vs tunneled catheters)
[RISK] => found low in the incidence of catheter-related bloodstream infections (crbsis) was low (0.35/1000 catheter-days), particularly for piccs (0/1000; p < .01 vs hohn and tunneled catheters) and for ports (0.19/1000; p < .01 vs hohn and p < .05 vs tunneled catheters)
# 25656251 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in no catheter-associated bloodstream infection occurred; main complications were symptomatic upper limb deep vein thrombosis (2%), catheter obstruction (18%) and persistent pain after catheter insertion (18%)
[RISK] => found associate in no catheter-associated bloodstream infection occurred; main complications were symptomatic upper limb deep vein thrombosis (2%), catheter obstruction (18%) and persistent pain after catheter insertion (18%)
# 34515987 ---------
## -> Scan Factor Age
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found performance status in conclusions: overall, this study offers the first report of uedvt presentations in the uk with no restrictions of patient performance status or underlying co-morbidities and provides a rounded clinical picture of patient characteristics, diagnosis, management, and prognostic associations in view of rigorous guideline development
# 25198813 ---------
## -> Scan Factor Power injectable PICC
[TARGET] => found power-injectable in purpose: few randomized studies have investigated the impact of valved and non-valved power-injectable peripherally inserted central catheters (piccs) in terms of incidence of occlusion, infection, malfunction and venous thrombosis
[RISK] => found impact in purpose: few randomized studies have investigated the impact of valved and non-valved power-injectable peripherally inserted central catheters (piccs) in terms of incidence of occlusion, infection, malfunction and venous thrombosis
[TARGET] => found power-injectable in one hundred and eighty adult patients candidate to chemotherapy were randomized into three groups: power-injectable piccs with solo-2 proximal valve (bard); power-injectable piccs with pasv (pressure activated safety valve) proximal valve (navilyst); and non-valved power-injectable piccs (medcomp)
[RISK] => found group in one hundred and eighty adult patients candidate to chemotherapy were randomized into three groups: power-injectable piccs with solo-2 proximal valve (bard); power-injectable piccs with pasv (pressure activated safety valve) proximal valve (navilyst); and non-valved power-injectable piccs (medcomp)
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in one hundred and eighty adult patients candidate to chemotherapy were randomized into three groups: power-injectable piccs with solo-2 proximal valve (bard); power-injectable piccs with pasv (pressure activated safety valve) proximal valve (navilyst); and non-valved power-injectable piccs (medcomp)
[RISK] => found group in one hundred and eighty adult patients candidate to chemotherapy were randomized into three groups: power-injectable piccs with solo-2 proximal valve (bard); power-injectable piccs with pasv (pressure activated safety valve) proximal valve (navilyst); and non-valved power-injectable piccs (medcomp)
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor PICC infection
[TARGET] => found infection in purpose: few randomized studies have investigated the impact of valved and non-valved power-injectable peripherally inserted central catheters (piccs) in terms of incidence of occlusion, infection, malfunction and venous thrombosis
[RISK] => found impact in purpose: few randomized studies have investigated the impact of valved and non-valved power-injectable peripherally inserted central catheters (piccs) in terms of incidence of occlusion, infection, malfunction and venous thrombosis
[TARGET] => found infection in results: we detected no complications at insertion; no picc-related bloodstream infections; no dislocations; five cases of transient occlusion and two cases of persistent withdrawal occlusion, evenly distributed among the groups; one episode of complete irreversible obstruction (group a); four episodes of asymptomatic peripheral venous thrombosis; one episode of symptomatic, severe central vein thrombosis (group b)
[RISK] => found group in results: we detected no complications at insertion; no picc-related bloodstream infections; no dislocations; five cases of transient occlusion and two cases of persistent withdrawal occlusion, evenly distributed among the groups; one episode of complete irreversible obstruction (group a); four episodes of asymptomatic peripheral venous thrombosis; one episode of symptomatic, severe central vein thrombosis (group b)
# 34980518 ---------
## -> Scan Factor Gender
[TARGET] => found male in most patients were male (79.5%), adults(80.8%) and injured by flame(74.4%)
## -> Scan Factor PICC infection
[TARGET] => found infection in thrombosis and infections of peripherally inserted central catheters in burn patients: a 3-year retrospective study and a systematic review
[TARGET] => found infection in burn patients need special considerations because of restricted insertion sites, burn wounds, hyper coagulation, high infection rates and others
[RISK] => found high in burn patients need special considerations because of restricted insertion sites, burn wounds, hyper coagulation, high infection rates and others
[TARGET] => found infection in this study aims to investigate the thrombosis and infections of piccs in burn patients
[TARGET] => found infection in upper extremity vein thrombosis (uevt) and central line-associated bloodstream infection (clabsi) were the main outcome
[RISK] => found associate in upper extremity vein thrombosis (uevt) and central line-associated bloodstream infection (clabsi) were the main outcome
# 24103730 ---------
## -> Scan Factor Gender
[TARGET] => found male in results: there were 231 midlines and 97 piccs inserted into 64 patients (39 male and 25 female; age range 18-47 years old)
[TARGET] => found female in results: there were 231 midlines and 97 piccs inserted into 64 patients (39 male and 25 female; age range 18-47 years old)
## -> Scan Factor Age
[TARGET] => found  age  in results: there were 231 midlines and 97 piccs inserted into 64 patients (39 male and 25 female; age range 18-47 years old)
[TARGET] => found old in results: there were 231 midlines and 97 piccs inserted into 64 patients (39 male and 25 female; age range 18-47 years old)
## -> Scan Factor PICC infection
[TARGET] => found infection in the primary outcome was a composite measure of adverse events (catheter-related blood stream infection, deep vein thrombosis, occlusion, pain, infiltration, bleeding, phlebitis, catheter leakage and dislodgement) and whether the vad was removed unexpectedly
# 33298237 ---------
## -> Scan Factor PICC insertion procedure
[TARGET] => found picc insertion in patients: adult patients undergoing picc insertion
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in results: in total, 1,142 piccs were inserted, with 153,191 catheter days (median, 79)
[TARGET] => found catheter day in complications included 66 cases of cabsi (5.78%; 0.43‰ catheter days), 38 cases of crbsi (3.33%; 0.25‰ catheter days), 28 cases of pb (2.45%; 0.18‰ catheter days), and 23 cases of uedvt (2.01%; 0.15‰ catheter days)
[TARGET] => found catheter day in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
[RISK] => found risk in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
[RISK] => found factor in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
[RISK] => found high in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in parenteral nutrition (odds ratio [or], 3.40; 95% confidence interval [ci], 1.77-6.52) and admission to the hematology ward (or, 4.90; 95% ci, 2.25-10.71) were independently associated with crbsi and pb, respectively
[RISK] => found associate in parenteral nutrition (odds ratio [or], 3.40; 95% confidence interval [ci], 1.77-6.52) and admission to the hematology ward (or, 4.90; 95% ci, 2.25-10.71) were independently associated with crbsi and pb, respectively
## -> Scan Factor PICC infection
[TARGET] => found infection in methods: catheter-associated bloodstream infection (cabsi) including catheter-related bloodstream infection (crbsi), primary bacteremia (pb), and upper extremity deep vein thrombosis (uedvt) were recorded
[RISK] => found associate in methods: catheter-associated bloodstream infection (cabsi) including catheter-related bloodstream infection (crbsi), primary bacteremia (pb), and upper extremity deep vein thrombosis (uedvt) were recorded
[TARGET] => found infection in the median times to infection were 24, 41, and 60 days for crbsi, pb, and uedvt, respectively
[TARGET] => found infection in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
[RISK] => found risk in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
[RISK] => found factor in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
[RISK] => found high in compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection
## -> Scan Factor Hospitalisation/ Medical department admission/ discharged to a skilled-nursing facility
[TARGET] => found admission to in parenteral nutrition (odds ratio [or], 3.40; 95% confidence interval [ci], 1.77-6.52) and admission to the hematology ward (or, 4.90; 95% ci, 2.25-10.71) were independently associated with crbsi and pb, respectively
[RISK] => found associate in parenteral nutrition (odds ratio [or], 3.40; 95% confidence interval [ci], 1.77-6.52) and admission to the hematology ward (or, 4.90; 95% ci, 2.25-10.71) were independently associated with crbsi and pb, respectively
[TARGET] => found admission to in admission to the hematology ward (or, 12.46; 95% ci, 2.49-62.50) or to the oncology ward (or, 7.89; 95% ci, 1.77-35.16) was independently associated with uedvt
[RISK] => found associate in admission to the hematology ward (or, 12.46; 95% ci, 2.49-62.50) or to the oncology ward (or, 7.89; 95% ci, 1.77-35.16) was independently associated with uedvt
# 23710585 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[RISK] => found risk in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[RISK] => found factor in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[RISK] => found less in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[TARGET] => found chemotherapy in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
[RISK] => found risk in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
[RISK] => found factor in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
[RISK] => found less in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
## -> Scan Factor Diabete
[TARGET] => found diabetes in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[RISK] => found risk in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[RISK] => found factor in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[RISK] => found less in the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis
[TARGET] => found diabetes in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
[RISK] => found risk in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
[RISK] => found factor in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
[RISK] => found less in the history of chemotherapy, less activities and diabetes were found to be the key risk factors
## -> Scan Factor Cancer
[TARGET] => found cancer in risk factors associated with picc-related upper extremity venous thrombosis in cancer patients
[RISK] => found risk in risk factors associated with picc-related upper extremity venous thrombosis in cancer patients
[RISK] => found factor in risk factors associated with picc-related upper extremity venous thrombosis in cancer patients
[RISK] => found associate in risk factors associated with picc-related upper extremity venous thrombosis in cancer patients
[TARGET] => found cancer in aims and objectives: to investigate the incidence and risk factors for peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer
[RISK] => found risk in aims and objectives: to investigate the incidence and risk factors for peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer
[RISK] => found factor in aims and objectives: to investigate the incidence and risk factors for peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer
[TARGET] => found cancer in background: with the widespread use of peripherally inserted central venous catheters, peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer leads to increasing morbidity and mortality
[TARGET] => found cancer in design and methods: consecutive patients with cancer who were scheduled to receive peripherally inserted central venous catheters, between september 2009 and may 2012, were prospectively studied in our centre
[TARGET] => found cancer in results: a total of 89 patients with cancer were studied in our research
## -> Scan Factor Gender
## -> Scan Factor Age
# 35268283 ---------
# 31674857 ---------
## -> Scan Factor Chemotherapy
[TARGET] => found chemotherapy in picc-port totally implantable vascular access device in breast cancer patients undergoing chemotherapy
[TARGET] => found chemotherapy in background and objectives: the increasing use of arm totally implantable vascular access devices for breast cancer patients who require chemotherapy has led to a greater risk of complications and failures and, in particular, to upper extremity deep vein thrombosis
[RISK] => found risk in background and objectives: the increasing use of arm totally implantable vascular access devices for breast cancer patients who require chemotherapy has led to a greater risk of complications and failures and, in particular, to upper extremity deep vein thrombosis
[TARGET] => found chemotherapy in a prospective study was conducted on 418 adult female breast cancer patients undergoing chemotherapy
[TARGET] => found chemotherapy in conclusion: the peripherally inserted central catheter-port is a safe vascular device for chemotherapy delivery that achieves similar clinical results as traditional long-term vascular access devices (peripherally inserted central catheter and arm totally implantable vascular access device, in particular) in breast cancer patients
## -> Scan Factor Cancer
[TARGET] => found cancer in picc-port totally implantable vascular access device in breast cancer patients undergoing chemotherapy
[TARGET] => found cancer in background and objectives: the increasing use of arm totally implantable vascular access devices for breast cancer patients who require chemotherapy has led to a greater risk of complications and failures and, in particular, to upper extremity deep vein thrombosis
[RISK] => found risk in background and objectives: the increasing use of arm totally implantable vascular access devices for breast cancer patients who require chemotherapy has led to a greater risk of complications and failures and, in particular, to upper extremity deep vein thrombosis
[TARGET] => found cancer in this study aims to investigate the outcomes of the arm peripherally inserted central catheter-port technique in breast cancer patients
[TARGET] => found cancer in a prospective study was conducted on 418 adult female breast cancer patients undergoing chemotherapy
[TARGET] => found cancer in conclusion: the peripherally inserted central catheter-port is a safe vascular device for chemotherapy delivery that achieves similar clinical results as traditional long-term vascular access devices (peripherally inserted central catheter and arm totally implantable vascular access device, in particular) in breast cancer patients
## -> Scan Factor Gender
[TARGET] => found male in a prospective study was conducted on 418 adult female breast cancer patients undergoing chemotherapy
[TARGET] => found female in a prospective study was conducted on 418 adult female breast cancer patients undergoing chemotherapy
## -> Scan Factor BMI
[TARGET] => found body mass index in with regard to the patients' characteristics, body mass index <22.5 was the only significant risk for failure (p = 0.027)
[RISK] => found risk in with regard to the patients' characteristics, body mass index <22.5 was the only significant risk for failure (p = 0.027)
## -> Scan Factor Age
## -> Scan Factor PICC indwelling time
[TARGET] => found catheter day in the main reason for removal was reservoir pocket infection: 4 (0.9%) with an infection rate of 0.012 per 1000 catheter days
## -> Scan Factor PICC infection
[TARGET] => found infection in the main reason for removal was reservoir pocket infection: 4 (0.9%) with an infection rate of 0.012 per 1000 catheter days
## -> Scan Factor Anticoagulants therapy
[TARGET] => found anticoagulant in the main complication we observed was upper extremity deep vein thrombosis, 10 (2.4%); all patients were rescued by anticoagulant treatment without peripherally inserted central catheter-port removal
# 34399039 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in the negative predictive value of peripherally inserted central catheter-associated vein thrombosis in the cancer group (80.0%, 95% ci: 73.2%-85.4%) was higher than that of the non-cancer group (60.0%, 95% ci: 35.7%-80.2%)
[RISK] => found associate in the negative predictive value of peripherally inserted central catheter-associated vein thrombosis in the cancer group (80.0%, 95% ci: 73.2%-85.4%) was higher than that of the non-cancer group (60.0%, 95% ci: 35.7%-80.2%)
[RISK] => found high in the negative predictive value of peripherally inserted central catheter-associated vein thrombosis in the cancer group (80.0%, 95% ci: 73.2%-85.4%) was higher than that of the non-cancer group (60.0%, 95% ci: 35.7%-80.2%)
[RISK] => found group in the negative predictive value of peripherally inserted central catheter-associated vein thrombosis in the cancer group (80.0%, 95% ci: 73.2%-85.4%) was higher than that of the non-cancer group (60.0%, 95% ci: 35.7%-80.2%)
# 25940453 ---------
## -> Scan Factor Gender
## -> Scan Factor Age
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found comorbiditie in peripherally inserted central catheter presence, comorbidities, venous thrombosis risk factors, and thrombotic events within 90 days from hospital admission were ascertained by phone and record review
[RISK] => found risk in peripherally inserted central catheter presence, comorbidities, venous thrombosis risk factors, and thrombotic events within 90 days from hospital admission were ascertained by phone and record review
[RISK] => found factor in peripherally inserted central catheter presence, comorbidities, venous thrombosis risk factors, and thrombotic events within 90 days from hospital admission were ascertained by phone and record review
## -> Scan Factor Hospitalisation/ Medical department admission/ discharged to a skilled-nursing facility
[TARGET] => found admission to in from hospital admission to 90 days, 876 thromboembolic events (208 upper-extremity deep vein thromboses, 372 lower-extremity deep vein thromboses, and 296 pulmonary emboli) were identified
[RISK] => found low in from hospital admission to 90 days, 876 thromboembolic events (208 upper-extremity deep vein thromboses, 372 lower-extremity deep vein thromboses, and 296 pulmonary emboli) were identified
# 33983979 ---------
## -> Scan Factor Cancer
[TARGET] => found cancer in clinical context was: hematological malignancy (40.7%), solid cancer (14.2%), infectious or inflammatory context (49.9%) and presence of venous catheters or pacemaker leads in 86.4%
## -> Scan Factor Gender
## -> Scan Factor Age
[TARGET] => found  age  in the median age was 58 years, 39.5% were women
# 37142538 ---------
## -> Scan Factor Age
[TARGET] => found  age  in the median patient age was 59-62 years; most patients were overweight/obese, with ≥2 co-morbidities
## -> Scan Factor PICC infection
# 27126759 ---------
## -> Scan Factor Diabete
[TARGET] => found diabetes in for patients with difficult intravenous access, those requiring multiple attempts, those who are obese, or have diabetes or other chronic conditions, determining the vascular access device (vad) with the lowest risk that best meets the needs of the treatment plan can be confusing
[RISK] => found risk in for patients with difficult intravenous access, those requiring multiple attempts, those who are obese, or have diabetes or other chronic conditions, determining the vascular access device (vad) with the lowest risk that best meets the needs of the treatment plan can be confusing
[RISK] => found low in for patients with difficult intravenous access, those requiring multiple attempts, those who are obese, or have diabetes or other chronic conditions, determining the vascular access device (vad) with the lowest risk that best meets the needs of the treatment plan can be confusing
## -> Scan Factor Age
## -> Scan Factor Surgery_type of surgery
## -> Scan Factor PICC infection
[TARGET] => found infection in selection of the most appropriate vad is necessary to avoid the potentially serious complications of infection and/or thrombosis
# 35323859 ---------
## -> Scan Factor Age
# 32205954 ---------
## -> Scan Factor ICU
[TARGET] => found intensive care unit in abbreviations list: abhr: alcohol-based hand rub; aicd: automated implantable cardioverter defibrillator; bsi: blood stream infection; c/ss: chg/silver sulfadiazine; cath lab: catheterization laboratory (cardiac cath lab); cdc: centers for disease control and prevention; cfu: colony forming unit; chg: chlorhexidine gluconate; cl: central line; combux: comparison of bedside ultrasound with chest x-ray (combux study); cqi: continuous quality improvement; crbsi: catheter-related blood stream infection; cus: chest ultrasonography; cvc: central venous catheter; cxr: chest x-ray; dttp: differential time to positivity; dvt: deep venous thrombosis; ecg: electrocardiography; elvis: ethanol lock and risk of hemodialysis catheter infection in critically ill patients; er: emergency room; fda: food and drug administration; fv: femoral vein; gwe: guidewire exchange; hd catheter: hemodialysis catheter; hts: hypertonic saline; icp: intracranial pressure; icu: intensive care unit; idsa: infectious disease society of america; ijv: internal jugular vein; ipc: indian penal code; irr: incidence rate ratio; isccm: indian society of critical care medicine; iv: intravenous; lcbi: laboratory confirmed blood stream infection; m/r: minocycline/rifampicin; mbi-lcbi: mucosal barrier injury laboratory-confirmed bloodstream infection; mrsa: methicillin-resistant staphylococcus aureus; nhs: national health service (uk); nhsn: national healthcare safety network (usa); ot: operation theater; picc: peripherally-inserted central catheter; piv: peripheral intravenous line; pl: peripheral line; pvi: povidone-iodine; ra: right atrium; rct: randomized controlled trial; rr: relative risk; scv/sv: subclavian vein; scvo(2): central venous oxygen saturation; sn: sensitivity; sop: standard operating procedure; svc: superior vena cava; tee: transesophageal echocardiography; upp: useful practice points; usg: ultrasonography; who: world health organization
[RISK] => found risk in abbreviations list: abhr: alcohol-based hand rub; aicd: automated implantable cardioverter defibrillator; bsi: blood stream infection; c/ss: chg/silver sulfadiazine; cath lab: catheterization laboratory (cardiac cath lab); cdc: centers for disease control and prevention; cfu: colony forming unit; chg: chlorhexidine gluconate; cl: central line; combux: comparison of bedside ultrasound with chest x-ray (combux study); cqi: continuous quality improvement; crbsi: catheter-related blood stream infection; cus: chest ultrasonography; cvc: central venous catheter; cxr: chest x-ray; dttp: differential time to positivity; dvt: deep venous thrombosis; ecg: electrocardiography; elvis: ethanol lock and risk of hemodialysis catheter infection in critically ill patients; er: emergency room; fda: food and drug administration; fv: femoral vein; gwe: guidewire exchange; hd catheter: hemodialysis catheter; hts: hypertonic saline; icp: intracranial pressure; icu: intensive care unit; idsa: infectious disease society of america; ijv: internal jugular vein; ipc: indian penal code; irr: incidence rate ratio; isccm: indian society of critical care medicine; iv: intravenous; lcbi: laboratory confirmed blood stream infection; m/r: minocycline/rifampicin; mbi-lcbi: mucosal barrier injury laboratory-confirmed bloodstream infection; mrsa: methicillin-resistant staphylococcus aureus; nhs: national health service (uk); nhsn: national healthcare safety network (usa); ot: operation theater; picc: peripherally-inserted central catheter; piv: peripheral intravenous line; pl: peripheral line; pvi: povidone-iodine; ra: right atrium; rct: randomized controlled trial; rr: relative risk; scv/sv: subclavian vein; scvo(2): central venous oxygen saturation; sn: sensitivity; sop: standard operating procedure; svc: superior vena cava; tee: transesophageal echocardiography; upp: useful practice points; usg: ultrasonography; who: world health organization
## -> Scan Factor Age
## -> Scan Factor PICC insertion procedure
[TARGET] => found position in indian society of critical care medicine position statement for central venous catheterization and management 2020
[TARGET] => found position in methods: this position statement for central venous catheterization is framed by expert committee members under the aegis of indian society of critical care medicine (isccm)
[TARGET] => found position in the final document was reviewed and accepted by all expert committee members and after a process of peer-review this document is finally accepted as an official isccm position paper.modified grade system was utilized to classify the quality of evidence and the strength of recommendations
[TARGET] => found position in indian society of critical care medicine position statement for central venous catheterization and management 2020
## -> Scan Factor Number of comorbidities/HTA/Hyperglycemia
[TARGET] => found hta in how to cite this article: javeri y, jagathkar g, dixit s, chaudhary d, zirpe kg, mehta y, et al
## -> Scan Factor Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h
[TARGET] => found ecog in committee recognizes the fact that in event of new emerging evidences this document will require update, and that shall be provided in due time
## -> Scan Factor PICC infection
[TARGET] => found infection in results: this document makes recommendations about various aspects of resource preparation, infection control, prevention of mechanical complication and surveillance related to short-term central venous catheterization
[TARGET] => found infection in abbreviations list: abhr: alcohol-based hand rub; aicd: automated implantable cardioverter defibrillator; bsi: blood stream infection; c/ss: chg/silver sulfadiazine; cath lab: catheterization laboratory (cardiac cath lab); cdc: centers for disease control and prevention; cfu: colony forming unit; chg: chlorhexidine gluconate; cl: central line; combux: comparison of bedside ultrasound with chest x-ray (combux study); cqi: continuous quality improvement; crbsi: catheter-related blood stream infection; cus: chest ultrasonography; cvc: central venous catheter; cxr: chest x-ray; dttp: differential time to positivity; dvt: deep venous thrombosis; ecg: electrocardiography; elvis: ethanol lock and risk of hemodialysis catheter infection in critically ill patients; er: emergency room; fda: food and drug administration; fv: femoral vein; gwe: guidewire exchange; hd catheter: hemodialysis catheter; hts: hypertonic saline; icp: intracranial pressure; icu: intensive care unit; idsa: infectious disease society of america; ijv: internal jugular vein; ipc: indian penal code; irr: incidence rate ratio; isccm: indian society of critical care medicine; iv: intravenous; lcbi: laboratory confirmed blood stream infection; m/r: minocycline/rifampicin; mbi-lcbi: mucosal barrier injury laboratory-confirmed bloodstream infection; mrsa: methicillin-resistant staphylococcus aureus; nhs: national health service (uk); nhsn: national healthcare safety network (usa); ot: operation theater; picc: peripherally-inserted central catheter; piv: peripheral intravenous line; pl: peripheral line; pvi: povidone-iodine; ra: right atrium; rct: randomized controlled trial; rr: relative risk; scv/sv: subclavian vein; scvo(2): central venous oxygen saturation; sn: sensitivity; sop: standard operating procedure; svc: superior vena cava; tee: transesophageal echocardiography; upp: useful practice points; usg: ultrasonography; who: world health organization
[RISK] => found risk in abbreviations list: abhr: alcohol-based hand rub; aicd: automated implantable cardioverter defibrillator; bsi: blood stream infection; c/ss: chg/silver sulfadiazine; cath lab: catheterization laboratory (cardiac cath lab); cdc: centers for disease control and prevention; cfu: colony forming unit; chg: chlorhexidine gluconate; cl: central line; combux: comparison of bedside ultrasound with chest x-ray (combux study); cqi: continuous quality improvement; crbsi: catheter-related blood stream infection; cus: chest ultrasonography; cvc: central venous catheter; cxr: chest x-ray; dttp: differential time to positivity; dvt: deep venous thrombosis; ecg: electrocardiography; elvis: ethanol lock and risk of hemodialysis catheter infection in critically ill patients; er: emergency room; fda: food and drug administration; fv: femoral vein; gwe: guidewire exchange; hd catheter: hemodialysis catheter; hts: hypertonic saline; icp: intracranial pressure; icu: intensive care unit; idsa: infectious disease society of america; ijv: internal jugular vein; ipc: indian penal code; irr: incidence rate ratio; isccm: indian society of critical care medicine; iv: intravenous; lcbi: laboratory confirmed blood stream infection; m/r: minocycline/rifampicin; mbi-lcbi: mucosal barrier injury laboratory-confirmed bloodstream infection; mrsa: methicillin-resistant staphylococcus aureus; nhs: national health service (uk); nhsn: national healthcare safety network (usa); ot: operation theater; picc: peripherally-inserted central catheter; piv: peripheral intravenous line; pl: peripheral line; pvi: povidone-iodine; ra: right atrium; rct: randomized controlled trial; rr: relative risk; scv/sv: subclavian vein; scvo(2): central venous oxygen saturation; sn: sensitivity; sop: standard operating procedure; svc: superior vena cava; tee: transesophageal echocardiography; upp: useful practice points; usg: ultrasonography; who: world health organization
# 32551112 ---------
## -> Scan Factor Two or more lumens
[TARGET] => found triple lumen in results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis
[RISK] => found factor in results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis
[RISK] => found associate in results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis
## -> Scan Factor ICU
[TARGET] => found intensive care unit in risk factors for peripherally inserted central catheter line-related deep venous thrombosis in critically ill intensive care unit patients
[RISK] => found risk in risk factors for peripherally inserted central catheter line-related deep venous thrombosis in critically ill intensive care unit patients
[RISK] => found factor in risk factors for peripherally inserted central catheter line-related deep venous thrombosis in critically ill intensive care unit patients
[TARGET] => found intensive care unit in the objective of this case-control study was to identify the risk factors associated with peripherally inserted central catheter line-related deep venous thrombosis in critically ill medical-surgical intensive care unit patients in a community hospital
[RISK] => found risk in the objective of this case-control study was to identify the risk factors associated with peripherally inserted central catheter line-related deep venous thrombosis in critically ill medical-surgical intensive care unit patients in a community hospital
[RISK] => found factor in the objective of this case-control study was to identify the risk factors associated with peripherally inserted central catheter line-related deep venous thrombosis in critically ill medical-surgical intensive care unit patients in a community hospital
[RISK] => found associate in the objective of this case-control study was to identify the risk factors associated with peripherally inserted central catheter line-related deep venous thrombosis in critically ill medical-surgical intensive care unit patients in a community hospital
## -> Scan Factor Gender
[TARGET] => found gender in results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis
[RISK] => found factor in results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis
[RISK] => found associate in results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis
## -> Scan Factor History Of Thrombosis
[TARGET] => found history of deep venous thrombo in in this retrospective study, we did not identify any association of peripherally inserted central catheter-related deep venous thrombosis with a prior history of deep venous thrombosis, use of alteplase, antiplatelet therapy, prophylactic or therapeutic anticoagulation, international normalized ratio, platelet count and the use of peripherally inserted central catheters for total parenteral nutrition
## -> Scan Factor Total parenteral nutrition
[TARGET] => found parenteral nutrition in in this retrospective study, we did not identify any association of peripherally inserted central catheter-related deep venous thrombosis with a prior history of deep venous thrombosis, use of alteplase, antiplatelet therapy, prophylactic or therapeutic anticoagulation, international normalized ratio, platelet count and the use of peripherally inserted central catheters for total parenteral nutrition
## -> Scan Factor Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen)
[TARGET] => found platelet in in this retrospective study, we did not identify any association of peripherally inserted central catheter-related deep venous thrombosis with a prior history of deep venous thrombosis, use of alteplase, antiplatelet therapy, prophylactic or therapeutic anticoagulation, international normalized ratio, platelet count and the use of peripherally inserted central catheters for total parenteral nutrition
